<SEC-DOCUMENT>0001493152-25-014965.txt : 20250925
<SEC-HEADER>0001493152-25-014965.hdr.sgml : 20250925
<ACCEPTANCE-DATETIME>20250925170545
ACCESSION NUMBER:		0001493152-25-014965
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20250919
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250925
DATE AS OF CHANGE:		20250925

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Qualigen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001460702
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				263474527
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37428
		FILM NUMBER:		251344597

	BUSINESS ADDRESS:	
		STREET 1:		2042 CORTE DEL NOGAL
		STREET 2:		CARLSBAD
		CITY:			CALIFORNIA
		STATE:			CA
		ZIP:			92011
		BUSINESS PHONE:		(760) 918-9165

	MAIL ADDRESS:	
		STREET 1:		2042 CORTE DEL NOGAL
		STREET 2:		CARLSBAD
		CITY:			CALIFORNIA
		STATE:			CA
		ZIP:			92011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RITTER PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20090402
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:QLGN="http://qlgntx.com/20250919">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_QLGN_qlgntx.com_20250919 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20250919_20250919 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001460702 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000004" name="dei:EntityCentralIndexKey">0001460702</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="qlgn-20250919.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001460702</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-19</xbrli:startDate>
        <xbrli:endDate>2025-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20250919__20250919_zgeK1qTdPGI2"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported) <b><span id="xdx_906_edei--DocumentPeriodEndDate_c20250919__20250919_z5CbgusVYZaf"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 19, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20250919__20250919_zs05Y9r6sQgb"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000011" name="dei:EntityRegistrantName">Qualigen Therapeutics, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20250919__20250919_zixpiNtt2wn9"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20250919__20250919_zD3QvEXFZYR6"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000013" name="dei:EntityFileNumber">001-37428</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20250919__20250919_z2WCKXAtlpNe"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000014" name="dei:EntityTaxIdentificationNumber">26-3474527</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction<br/>
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer<br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_900_edei--EntityAddressAddressLine1_c20250919__20250919_zk5gCknrsGLb"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000015" name="dei:EntityAddressAddressLine1">5857
    Owens Avenue</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20250919__20250919_zb9miV709NP9"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressCityOrTown_c20250919__20250919_zM2Of2z42lFl"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000017" name="dei:EntityAddressCityOrTown">Carlsbad</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20250919__20250919_zVfoAWeVtDP3"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250919__20250919_zPC1WF2sBXd1"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000019" name="dei:EntityAddressPostalZipCode">92008</ix:nonNumeric></span></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code <b><span id="xdx_902_edei--CityAreaCode_c20250919__20250919_zUDkVovAnG68"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000020" name="dei:CityAreaCode">(760)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20250919__20250919_zGwOiIiTM36"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000021" name="dei:LocalPhoneNumber">452-8111</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20250919__20250919_zFKpgkAa3EQ8"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20250919__20250919_z1Qhm0PtAu8f"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20250919__20250919_zrRXvyVTKSb3"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20250919__20250919_zPblXobJBHxd"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20250919__20250919_zMFgLt3ODYnj"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000026" name="dei:Security12bTitle">Common
    stock (par value $0.001 per share)</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20250919__20250919_z3R7wmbiClul"><ix:nonNumeric contextRef="AsOf2025-09-19" id="Fact000027" name="dei:TradingSymbol">QLGN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_907_edei--SecurityExchangeName_c20250919__20250919_zAvuyu3Kv3t5"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20250919__20250919_zJAJhdmJ6Ghk"><ix:nonNumeric contextRef="AsOf2025-09-19" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement Offering</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2025, Qualigen Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;) entered into a Subscription Agreement
(the &#8220;Subscription Agreement&#8221;) with certain investors (the &#8220;Suscribers&#8221;), including Faraday Future Intelligent
Electric Inc. (NASDAQ: FFAI)(the &#8220;Lead Investor&#8221;) pursuant to which the investors agreed to purchase $41,000,000 in cash
(the &#8220;Offering&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) and shares
of a newly created Series B Convertible Preferred Stock, par value $0.001 per share (the &#8220;Series B Stock&#8221;). The purchase
price of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the &#8220;Stated
Value&#8221;). At the closing of the Offering (the &#8220;Closing&#8221;), the shares of Common Stock and Series B Stock will be allocated
among the investors so that no purchaser&#8217;s ownership of Common Stock will exceed 19.99% of the number of shares outstanding (the
&#8220;Exchange Cap&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> The Company intends to use up to $6,800,000 of the
net cash proceeds from the Offering to pay existing debt and fund the Company&#8217;s existing business operations, and the balance
of the cash proceeds and contributed currency will be used for the establishment of the Company&#8217;s cryptocurrency treasury operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rights and preferences of the Series B Stock are set forth in the Certificate of Designation of Rights and Preferences of Series B Convertible
Preferred Stock (the &#8220;Certificate of Designation&#8221;). The Series B Stock is convertible into a number of shares of Common Stock
equal to the Stated Value of the number of Series B Stock being converted divided by the conversion price of $2.246 (the &#8220;Conversion
Shares&#8221;). The Series B Stock may not be converted until the Company has obtained the vote of a majority of its stockholders with
respect to the transactions contemplated by this Subscription Agreement, including the issuance of Conversion Shares as an issuance greater
than the Exchange Cap pursuant to Nasdaq Rule 5635 and the issuance of shares of Common Stock or Common Stock Equivalents to certain
advisors of the Company in connection with the transactions contemplated by the Subscription Agreement (the &#8220;Stockholder Approval&#8221;).
Following the Stockholder Approval, the Series B Stock may be exercised at any time until all of the Series B Stock has been converted
in full, subject to certain beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Series B Stock will vote
together with the Common Stock on an as-converted basis, other than modification of the rights relating to the holders of Series B Stock,
which requires the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Stock. Upon any liquidation,
dissolution or winding-up of the Company, whether voluntary or involuntary (a &#8220;Liquidation&#8221;), the holders of the Series B
Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to $1,000, plus any
accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under the Certificate of Designation,
for each share of Series B Stock before any distribution or payment shall be made to the holders of any Junior Securities (as defined
under the Certificate of Designation), and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire
assets to be distributed to the holders shall be ratably distributed among the holders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company agreed to use its best efforts to obtain Stockholder Approval by the written consent of its stockholders or at a special meeting
of stockholders (the &#8220;Stockholders&#8217; Meeting&#8221;) no later than October 29, 2025 (or November 28, 2025 in the event that
the staff of the Securities and Exchange Commission conducts a review of the preliminary information statement filed in connection with
any written consent of stockholders or preliminary proxy statement filed in connection with the Stockholders&#8217; Meeting. If the Company
is unable to obtain the Stockholder Approval by written consent of its stockholders in accordance with applicable law, the Company shall
use its commercially reasonable efforts to (i) solicit its stockholders&#8217; approval of such resolutions, including engaging a proxy
solicitor reasonably acceptable to the requisite holders and causing such proxy solicitor to reasonably assist in the solicitation of
proxies in connection with the Stockholders&#8217; Meeting and (ii) cause the Board of Directors to recommend to the stockholders that
they approve such resolutions, and all management-appointed proxyholders shall vote their proxies in favor of such resolutions. If Stockholder
Approval is not obtained at the Stockholders&#8217; Meeting, the Issuer shall cause an additional stockholder meeting to be held within
ninety (90) days of the date of such Stockholders&#8217; Meeting. If the Company does not obtain Stockholder Approval at the first meeting,
the Company is obligated to call a meeting every ninety (90) days thereafter to seek Stockholder Approval until the date on which Stockholder
Approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance and sale of the Common Stock, the Series B Stock and the Conversion Shares (the &#8220;Securities&#8221;) will not be, and are
not, registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or any state securities laws. The Securities
will be issued in reliance on the exemption from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation
D promulgated thereunder for transactions not involving a public offering. Pursuant to the terms of the Registration Rights Agreement
(as defined herein), the Company is required to file a registration statement providing for the resale of the Common Stock and the Conversion
Shares within 45 days of the Closing and use its best efforts to have the registration statement declared effective 45 days thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Offering is expected to occur on or about September 29, 2025, subject to the satisfaction of customary closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Placement
Agency Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a Placement Agency Agreement with Univest Securities LLC (the &#8220;Placement Agent&#8221;), dated September 19,
2025, pursuant to which the Placement Agent will act as the exclusive placement agent for the Company in connection with the Offering.
Pursuant to the Placement Agency Agreement, the Company agreed to pay the Placement Agent a cash fee of 5.5% of the gross proceeds from
the Offering and to issue to the Placement Agent (or its designees) warrants to purchase that number of shares of Common Stock equal
to 6% of the securities sold in the Offering, which will be exercisable immediately following the closing date, and have an initial exercise
price per share of Common Stock of $2.47 (the &#8220;Placement Agent Warrants&#8221;). In addition, the Company agreed to reimburse the
Placement Agent for up to $150,000 of its fees and expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the Placement Agent Warrants and the shares of Common Stock underlying the Placement Agent Warrants (the &#8220;Placement
Agent Warrant Shares&#8221;) will not be registered under the Securities Act or any state securities laws. The Placement Agent Warrant
Shares will be issued in reliance on the exemption from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation
D promulgated thereunder for transactions not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agency Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company, other obligations of the parties, and termination provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
on September 19, 2025, the Company and the Subscribers entered into a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;)
pursuant to which the Company agreed to file a registration statement (the &#8220;Resale Registration Statement&#8221;), providing for
the resale of the Common Stock and Conversion Shares within 45 days of the closing of the Closing, to have such registration statement
declared effective with 45 days of the filing date (or 60 days, if the Securities and Exchange Commission conducts a full review) (the
date of such effectiveness, the &#8220;Effective Date&#8221;), and to maintain the effectiveness of such registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lead
Investor Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2025, the Company and the Lead Investor entered into a Lead Investor Agreement (the &#8220;Lead Investor Agreement&#8221;),
pursuant to which: (i) the Company agreed to adopt a treasury reserve policy suitable to the Lead Investor; (ii) at the Closing the Company
has agreed not to reduce the size of the Board of Directors to five members including the resignations of Cody Price, Campbell Becher
and Robert Lim and the appointment of two designees of the Lead Investor; (iii) for as long as the Lead Investor owns at least 5% of
the outstanding Common Stock (the &#8220;Minimum Threshold&#8221;) , the Lead Investor may appoint a number of directors in proportion
to such ownership; (iv) the Company shall expand the size of the Board, at the request of the Lead Investor, if any Board nominee of
the Lead Investor is not elected to the Board at a meeting of the stockholders and the Lead Investor shall have the exclusive right to
fill such vacancy; (v) the Company shall appoint Jiawei Wang as the Co-Chief Executive Officer of the Company and Koti Meka as the Chief
Financial Officer; (vi) if the Lead Investor&#8217;s ownership falls below the Minimum Threshold, the Lead Investor shall have the right
to obtain Board meetings as a non-voting observer; and (vii) the Company agreed to not adversely amend any of the rights of the Lead
Investor under the Lead Investor Agreement. In addition, until the Lead Investor&#8217;s ownership falls below the Minimum Threshold,
the Lead Investor shall have the right to participate in such Subsequent Financing up to an amount of the Subsequent Financing equal
to the percentage of the Lead Investor&#8217;s beneficial ownership percentage of the Common Stock on the date of closing of such Subsequent
Financing on the same terms, conditions and price provided for in the Subsequent Financing</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Support Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as of September 19, 2025, certain holders of the Company&#8217;s Series A-2 Convertible Preferred Stock (the &#8220;Voting
Stockholders&#8221;) agreed to vote any and all of the Company&#8217;s securities held by the Voting Stockholders in favor of the Stockholder
Approval. As of the date of the Closing, it is anticipated the Voting Stockholders will hold a number of shares of the Company&#8217;s
voting capital stock to adopt the Stockholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Advisory
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company entered into a Capital Market Advisory Agreement (the &#8220;Advisory Agreement&#8221;) with About Investment
Pte. (the &#8220;Advisor&#8221;). Pursuant to the Advisory Agreement, the Advisor shall provide the Company independent capital markets
advisory and consulting in connection with the Offering with the Lead Investor, assisting the Company with structuring and financing
and other capital markets advice. In consideration for such services, the Company shall issue to the Advisor approximately 60,257 shares
of Common Stock equal to five percent of the Company&#8217;s outstanding Common Stock following the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the Certificate of Designation, Placement Agent Warrants, the Subscription Agreement, , the Registration Rights
Agreement, the Lead Investor Agreement, the Advisory Agreement, the Voting Support Agreement and the Placement Agency Agreement do not
purport to be complete descriptions thereof and are qualified in their entirety by reference to the full text of such documents or the
forms of such documents, copies of which are attached hereto as Exhibits 4.1, 4.2, 10.1, 10.2, 10.3, 10.4, 10.5, and 10.6, respectively.
The representations, warranties, and covenants made by the Company in any agreement that is filed as an exhibit hereto were made solely
for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such
agreement. In addition, the assertions embodied in any representations, warranties, and covenants contained in such agreements may be
subject to qualifications with respect to knowledge and materiality different from those applicable to securityholders generally. Moreover,
such representations, warranties, or covenants were accurate only as of the date when made, except where expressly stated otherwise.
Accordingly, such representations, warranties, and covenants should not be relied on as accurately representing the current state of
the Company&#8217;s affairs at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information under Item 1.01 of this Current Report on Form 8-K related to the Offering, the Common Shares, the Series B Stock the Conversion
Shares, the Placement Agent Warrants, and the Placement Agent Warrant Shares is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;8.01.
Other Events. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2025, the Company issued a press release announcing the Offering, The press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K and incorporated into this Item 8.01 by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Stock Designation of Rights and Preferences of Series B Convertible Preferred Stock</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Subscription Agreement, dated as of September 19, 2025, between Qualigen Therapeutics, Inc. and each Subscriber (as defined therein)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Registration Rights Agreement, dated as September 19, 2025, between Qualigen Therapeutics, Inc. and each Subscriber</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-3.htm">Lead Investor Agreement, dated September 19, 2025, between Qualigen Therapeutics, Inc. and Faraday Future Intelligent Electric Inc.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advisory Agreement dated September 19, 2025, between Qualigen Therapeutics, Inc. and About Investment Pte.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Voting Support Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-6.htm">Placement Agency Agreement dated September 19, 2025 between Qualigen Therapeutics, Inc. and Univest Securities LLC</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated September 19, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUALIGEN
    THERAPEUTICS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    September 25, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Kevin A. Richardson II</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hevin
    A. Richardson II</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LfupKLhLh4o4RYaIt9VFKW7NSOvUR/It7TbEEAjJOV+OECOxoqWukOE0L3I4YN1UyiEUeEVGc0HvyNabFPws8KatY2Vcv/7AjDyDnpmGydnfe2erLZYpxLNIJpGcQDxJ5Rj2WxF0ekbmqks0TqsKlClhz9SwRqf4PXw4qBcZqt990hHZajIpJGE8yB+QcSJhR616Et8t5HkmglFfgVgxPRrvWrwcmo6ERYW1j7MD/e/gC8ysSl4= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUALIGEN
THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURSUANT
TO SECTION 151 OF THE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DELAWARE
GENERAL CORPORATION LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Kevin A. Richardson II, does hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
He is the Chief Executive Officer of QUALIGEN THERAPEUTICS, INC., a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo; or the
&ldquo;<U>Company</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Corporation is authorized to issue up to 15,000,000 shares of preferred stock, of which 2,765 are currently issued and outstanding.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Articles of Incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting of
Fifteen Million (15,000,000) shares, $0.001 par value per share, issuable from time to time in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of
redemption and liquidation preferences of any wholly unissued series of Preferred Stock and the number of shares constituting any series
and the designation thereof, of any of them; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to Series B Preferred Stock, a series of the Preferred Stock, which shall consist of, except as otherwise set
forth in the Subscription Agreement, up to 500,000 shares of the Preferred Stock which the Corporation has the authority
to issue, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of Series B Preferred Stock, a series of
Preferred Stock for cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences,
restrictions and other matters relating to such series of Preferred Stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMS
OF SERIES B PREFERRED STOCK</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section&nbsp;7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bankruptcy
Event</U>&rdquo; means any of the following events: (a)&nbsp;the Corporation or any Significant Subsidiary (as such term is defined in
Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment
of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Corporation or
any Significant Subsidiary thereof, (b)&nbsp;there is commenced against the Corporation or any Significant Subsidiary thereof any such
case or proceeding that is not dismissed within sixty (60) days after commencement, (c)&nbsp;the Corporation or any Significant Subsidiary
thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered,
(d)&nbsp;the Corporation or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial
part of its property that is not discharged or stayed within sixty (60) calendar days after such appointment, (e)&nbsp;the Corporation
or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors, (f)&nbsp;the Corporation or any Significant
Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts,
or (g)&nbsp;the Corporation or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates its consent to,
approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section&nbsp;5(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a)&nbsp;an acquisition after the date hereof
by an individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of
49% of the voting securities of the Corporation (other than by means of conversion or exercise of Series B Preferred Stock and the Securities
issued together with the Series B Preferred Stock), (b)&nbsp;the Corporation merges into or consolidates with any other Person, or any
Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation
immediately prior to such transaction own less than 33% of the aggregate voting power of the Corporation or the successor entity of such
transaction, (c)&nbsp;the Corporation sells or transfers all or substantially all of its assets to another Person and the stockholders
of the Corporation immediately prior to such transaction own less than 33% of the aggregate voting power of the acquiring entity immediately
after the transaction, (d)&nbsp;a replacement at one time or within a one year period of more than one-half of the members of the Board
of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue
Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors
was approved by a majority of the members of the Board of Directors who are members on the Original Issue Date), or (e)&nbsp;the execution
by the Corporation of an agreement to which the Corporation is a party or by which it is bound, providing for any of the events set forth
in clauses (a)&nbsp;through (d)&nbsp;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1 of the respective Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the applicable Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto and all conditions precedent to (i)&nbsp;each Holder&rsquo;s obligations to pay the Subscription Amount for a Closing
and (ii)&nbsp;the Corporation&rsquo;s obligations to deliver the Securities have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
or the &ldquo;<U>SEC</U>&rdquo; means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities into
which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.65pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the sum of the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section&nbsp;5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section&nbsp;5(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series B Preferred Stock
in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Designation,
Amount and Par Value&rdquo;</U> The series of Preferred Stock shall be designated as &ldquo;Series B Convertible Preferred Stock&rdquo;
and the number of shares so designated shall be up to 500,000 (which shall not be subject to increase without the written consent
of all of the Holders of the Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value
of $1,000, subject to increase set forth in Section&nbsp;3 and/or elsewhere in this Certificate of Designation below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend</U>&rdquo;
shall have the meaning set forth in Section&nbsp;2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>New
York Courts</U>&rdquo; shall have the meaning set forth in Section&nbsp;12(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section&nbsp;7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holders</U>&rdquo;
means Holders of the Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 11(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means (a)&nbsp;any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in
the ordinary course of business), (b)&nbsp;all guaranties, endorsements and other contingent obligations in respect of indebtedness of
others, whether or not the same are or should be reflected in the Corporation&rsquo;s balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business, and (c)&nbsp;the
present value of any lease payments in excess of $10,000 due under leases required to be capitalized in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Junior
Securities</U>&rdquo; means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities which
are explicitly senior or <U>pari passu</U> to the Preferred Stock in dividend rights or liquidation preference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Late
Fees</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section&nbsp;4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 11(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section&nbsp;5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Governmental Indebtedness</U>&rdquo; means Indebtedness for the purpose of supporting product sales by the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Indebtedness</U>&rdquo; means (i)) Indebtedness of the Corporation set forth in Corporation&rsquo;s most recent SEC report filed with
the SEC by the Corporation on Form 10-Q or Form 10-K (the &ldquo;<U>SEC Reports</U>&rdquo;) provided none of such Indebtedness, has been
increased, extended and/or otherwise changed), (ii) Indebtedness secured by Permitted Liens described in clauses &ldquo;(iii)&rdquo;
of the definition of Permitted Liens, and (iv) Permitted Governmental Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Liens</U>&rdquo; means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for
which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business
by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as
materialmen&rsquo;s liens, mechanics&rsquo; liens and other similar liens, arising in the ordinary course of business with respect to
a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (a) upon
or in any equipment acquired or held by the Borrower or any of its Subsidiaries to secure the purchase price of such equipment or indebtedness
incurred solely for the purpose of financing the acquisition or lease of such equipment, and (b) existing on such equipment at the time
of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds
of such equipment and (v) any Liens for Permitted Indebtedness set forth in (i) and (ii) of the definition of Permitted Indebtedness
<U>provided</U> as to &ldquo;(ii)&rdquo; of Permitted Indebtedness such Liens were in existence and not amended, supplemented and/or
modified since the original issuance date any such Indebtedness was incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.65pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
Stock</U>&rdquo; shall mean Series B Convertible Preferred Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.65pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Premium
Rate</U>&rdquo; shall have the meaning set forth in Section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.65pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; shall have the meaning set forth in Section 11(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock and the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section&nbsp;5(c)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stated
Value</U>&rdquo; shall mean $1,000, subject to increase set forth in Section&nbsp;3 and/or elsewhere in this Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.8pt; text-align: justify; text-indent: 20.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in">&ldquo;<U>Subscription
Agreement</U>&rdquo; means that certain Subscription Agreement, dated on or about the Original Issue Date, among the Corporation and
the original Holders, as amended, modified or supplemented from time to time in accordance with its terms.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to the Subscription
Agreement as specified below such Holder&rsquo;s name on the signature page of the Subscription Agreement and next to the heading
&ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation as set forth on <U>Schedule 3.1(a)</U> of the Subscription Agreement and shall, where
applicable, also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Subscription
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section&nbsp;3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day or Date</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock (or any other common stock of any other Person
that references the Trading Market for its common stock) is listed or quoted for trading on the date in question: The NASDAQ Global Market,
The NASDAQ Global Select Market, The NASDAQ Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, or the OTCQX Marketplace,
the OTCQB Marketplace, the OTC Pink Marketplace or any other tier operated by OTC Markets Group Inc. (or any successor to any of the
foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Certificate of Designation, the Subscription Agreement, all exhibits and schedules thereto and
hereto and any other documents or agreements executed in connection with the transactions contemplated pursuant to the Subscription
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Triggering
Event</U>&rdquo; shall have the meaning set forth in Section&nbsp;10(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Triggering
Redemption Amount</U>&rdquo; means, for each share of Series B Preferred Stock, the sum of (a)&nbsp;135% of the Stated Value and (b)&nbsp;all
accrued but unpaid dividends thereon and (c)&nbsp;all liquidated damages, Late Fees and other costs, expenses or amounts due in respect
of the Series B ` including, but not limited to legal fees and expenses of legal counsel to the Holder in connection with, related to
and/or arising out of a Triggering Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Triggering
Redemption Payment Date</U>&rdquo; shall have the meaning set forth in Section&nbsp;10(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Dividends
in Cash.</U> Each share of Series B Preferred Stock shall be entitled to receive, and the Corporation shall pay, dividends on an as-converted
basis as and when the Corporation declares a dividend on the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Other
Securities</U>. So long as any Series B Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof
shall redeem, purchase or otherwise acquire directly or indirectly any Junior Securities or pari passu securities other than any Series
B Preferred Stock purchased to the terms of this Certificate of Designation. So long as any Series B Preferred Stock shall remain outstanding,
neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make any distribution
upon (other than a dividend or distribution described in Section&nbsp;2 or dividends due and paid in the ordinary course on preferred
stock of the Corporation at such times when the Corporation is in compliance with its payment and other obligations hereunder), nor shall
any distribution be made in respect of, any Junior Securities or <U>pari passu</U> securities as long as any dividends due on the Series
B Preferred Stock remain unpaid, nor shall any monies be set aside for or applied to the purchase or redemption (through a sinking fund
or otherwise) of any Junior Securities or <U>pari passu</U> securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting Rights</U>. The Series B Preferred Stock will vote together with the common stock on an as-converted
basis. However, as long as any shares of Series B Preferred Stock are outstanding, the Corporation shall not, without the affirmative
vote of the Holders of a majority of the then outstanding shares of the Series B Preferred Stock directly and/or indirectly (a)&nbsp;alter
or change adversely the powers, preferences or rights given to the Series B Preferred Stock or alter or amend this Certificate of Designation,
(b)&nbsp;authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in
Section&nbsp;5) senior to, or otherwise <U>pari passu</U> with, the Series B Preferred Stock or, authorize or create any class of stock
ranking as to dividends senior to, or otherwise <U>pari passu</U> with, the Series B Preferred Stock, (c)&nbsp;amend its Articles of
Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d)&nbsp;increase the number
of authorized shares of Series B Preferred Stock, or (e)&nbsp;enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary
or involuntary (a &ldquo;<U>Liquidation</U>&rdquo;), the Holders shall be entitled to receive out of the assets, whether capital or surplus,
of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated
damages then due and owing thereon under this Certificate of Designation, for each share of Series B Preferred Stock before any distribution
or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in
full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance
with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. A Fundamental Transaction
or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation,
not less than forty-five (45) days prior to the payment date stated therein, to each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Conversions
at Option of Holder</U>. Each share of Series B Preferred Stock shall be convertible, at any time and from time to time from and after
the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set
forth in Section&nbsp;5(d)) determined by dividing the Stated Value of such share of Series B Preferred Stock by the Conversion Price.
Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as <U>Annex A</U> (a
&ldquo;<U>Notice of Conversion</U>&rdquo;). Each Notice of Conversion shall specify the number of shares of Series B Preferred Stock
to be converted, the number of shares of Series B Preferred Stock owned prior to the conversion at issue, the number of shares of Series
B Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may
not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date,
the &ldquo;<U>Conversion Date</U>&rdquo;). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be
the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required.
The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To
effect conversions of shares of Series B Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing
the shares of Series B Preferred Stock to the Corporation unless all of the shares of Series B Preferred Stock represented thereby are
so converted, in which case such Holder shall deliver the certificate representing such shares of Series B Preferred Stock promptly following
the Conversion Date at issue. Shares of Series B Preferred Stock converted into Common Stock or redeemed in accordance with the terms
hereof shall be canceled and shall not be reissued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Conversion Price</U>. The conversion price (the &ldquo;<U>Conversion Price</U>&rdquo;) for the Series B Preferred Stock shall be $2.246,
as may be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that
proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder&rsquo;s right
to pursue actual damages including, but not limited to, as a result of a Triggering Event pursuant to Section 10 hereof and the Holder
shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of
specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce
damages pursuant to any other Section hereof or under applicable law. Following an &ldquo;Event of Default,&rdquo; as defined in the
Subscription Agreement, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price
per share equaling eighty percent (80%) of the lowest traded price for the Company&rsquo;s common stock during the fifteen (15) Trading
Days immediately preceding, but not including, the Conversion Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Mechanics of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Conversion Shares Upon Conversion</U>. Not later than two (2)&nbsp;Trading Days after each Conversion Date (the &ldquo;<U>Share
Delivery Date</U>&rdquo;), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A)&nbsp;the number of Conversion
Shares being acquired upon the conversion of the Series B Preferred Stock, which Conversion Shares shall be free of restrictive legends
and trading restrictions, and (B)&nbsp;a bank check in the amount of accrued and unpaid dividends (if the Corporation has elected or
is required to pay accrued dividends in cash). The Corporation shall deliver the Conversion Shares electronically through the Depository
Trust Company or another established clearing corporation performing similar functions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Failure to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to
or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation
at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly
return to the Holder any original Series B Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return
to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Conversion Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Obligation Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion Shares
upon conversion of Series B Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action
or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach
or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law
by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation
to such Holder in connection with the issuance of such Conversion Shares; <U>provided</U>, <U>however</U>, that such delivery shall not
operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. In the event a Holder shall
elect to convert any or all of the Stated Value of its Series B Preferred Stock, the Corporation may not refuse conversion based on any
claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, agreement or for
any other reason, unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the
Series B Preferred Stock of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit
of such Holder in the amount of 150% of the Stated Value of Series B Preferred Stock which is subject to the injunction, which bond shall
remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable
to such Holder to the extent it obtains judgment. In the absence of such injunction, the Corporation shall issue Conversion Shares and,
if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant
to Section 5 on the second Trading Day after the Share Delivery Date applicable to such conversion, the Corporation shall pay to such
Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of Stated Value of Series B Preferred Stock being converted,
$100 per Trading Day (increasing to $150 per Trading Day on the third Trading Day and increasing to $200 per Trading Day on the sixth
Trading Day after such damages begin to accrue) for each Trading Day after such second Trading Day after the Share Delivery Date until
such Conversion Shares are delivered or Holder rescinds such conversion. All liquidated damages shall be paid to the Holder not later
than the fifth (5<SUP>th</SUP>) Trading Day after notice is provided to the Company by the Holder stating that any such liquidated damages
are due pursuant to this Section 5. Nothing herein shall limit a Holder&rsquo;s right to pursue actual damages or declare a Triggering
Event pursuant to Section&nbsp;10 hereof for the Corporation&rsquo;s failure to deliver Conversion Shares within the period specified
herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from
seeking to enforce damages pursuant to any other Section hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available
to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery
Date pursuant to Section&nbsp;5, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in
an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating
to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A)&nbsp;pay in cash to such Holder (in addition
to any other remedies available to or elected by such Holder) the amount, if any, by which (x)&nbsp;such Holder&rsquo;s total purchase
price (including any brokerage commissions) for the Common Stock so purchased exceeds (y)&nbsp;the product of (1)&nbsp;the aggregate
number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2)&nbsp;the actual
sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B)&nbsp;at
the option of such Holder, either reissue (if surrendered) the shares of Series B Preferred Stock equal to the number of shares of Series
B Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number
of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section&nbsp;5.
For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to
an attempted conversion of shares of Series B Preferred Stock with respect to which the actual sale price of the Conversion Shares (including
any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A)&nbsp;of the immediately preceding
sentence, the Corporation shall be required to pay such Holder $1,000. The payment of all amounts due by the Company to the Holder shall
be paid in cash no later than the fifth (5<SUP>th</SUP>) Business Day after notice is provided by a Holder to the Company requesting
the payment of any such liquidated damages. The Holder shall provide the Corporation written notice indicating the amounts payable to
such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall
limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver the Conversion
Shares upon conversion of the shares of Series B Preferred Stock as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>Reservation of Shares Issuable Upon Conversion</U>. The Company covenants that it will reserve and keep available out of its authorized
and unissued shares of Common Stock, 50,000,000 shares of Common Stock (appropriately adjusted for any stock dividend, stock split, stock
combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock) for the sole purpose
of issuance upon conversion of the Series B Preferred Stock and payment of dividends on the Series B Preferred Stock, all as herein provided,
free from preemptive rights or any other actual contingent purchase rights of Persons other than the Purchasers, not less than such aggregate
number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Subscription Agreement) be
issuable (taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of the
Series B Preferred Stock and payment of dividends hereunder. The Company covenants that all shares of Common Stock that shall be so issuable
shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable, and, at such times as a registration statement covering
such shares is then effective under the Securities Act, will be registered for public resale in accordance with such registration statement.
Such common stock reserve shall be increased from time to time to ensure appropriate coverage for Securities issued or issuable to Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Series
B Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation
shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Conversion Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this P Series B referred Stock shall be made without
charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion
Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in
the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Series
B Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or
Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction
of the Corporation that such tax has been paid. In the event that the Holder requests same-day processing for a Notice of Conversion,
such Holder shall pay all Transfer Agent fees required for such same-day processing and all fees to the Depository Trust Company (or
another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Trading Market Regulation</U>. The Corporation shall not issue any Common Stock upon conversion of the Series B Preferred Stock if
the issuance of such Common Stock would exceed the aggregate number of shares of Common Stock which the Corporation may issue upon conversion
of the Series B Preferred Stock without breaching the Corporation&rsquo;s obligations under the rules or regulations of The Trading Market
(the number of shares which may be issued without violating such rules and regulations, including rules related to the aggregate of offerings
under NASDAQ Listing Rule 5635(d), the &ldquo;<U>Exchange Cap</U>&rdquo;), except that such limitation shall not apply in the event that
the Corporation (A) obtains the approval of its stockholders as required by the applicable rules of the Trading Market for issuances
of Common Stock in excess of such amount or (B) obtains a written opinion from counsel to the Corporation that such approval is not required,
which opinion shall be reasonably satisfactory to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intentionally Omitted</U>.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
7.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 77.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while this Series B Preferred Stock is outstanding: (i)&nbsp;pays
a stock dividend or otherwise makes a distribution or distributions that is payable in shares of Common Stock on shares of Common Stock
or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation
upon conversion of, or payment of a dividend on, the Series B Preferred Stock), (ii)&nbsp;subdivides outstanding shares of Common Stock
into a larger number of shares, (iii)&nbsp;combines (including by way of a reverse stock split) outstanding shares of Common Stock into
a smaller number of shares, or (iv)&nbsp;issues, in the event of a reclassification of shares of the Common Stock, any shares of capital
stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section&nbsp;7(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Most Favored Nation Provision</U>.&nbsp; From the date hereof until the date when the Holder no longer holds any Series B Preferred
Stock, upon any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration,
Indebtedness or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;), the Holder may elect, in its sole discretion,
to exchange (in lieu of conversion), if applicable, all or some of the shares of Series B Preferred Stock then held for any securities
or units issued in a Subsequent Financing on a $1.00 for $1.00 basis.&nbsp; The Company shall provide the Holder with notice of any such
Subsequent Financing in the manner set forth below&nbsp; Additionally, if in such Subsequent Financing there are any contractual provisions
or side letters that provide terms more favorable to the investors than the terms provided for hereunder, then the Company shall specifically
notify the Holder of such additional or more favorable terms and such terms, at Holder&rsquo;s option, shall become a part of the transaction
documents with the Holder.&nbsp; The types of terms contained in another security that may be more favorable to the holder of such security
include, but are not limited to, terms addressing stock sale price, private placement price per share, and warrant coverage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section&nbsp;7(a) above, if at any time the Corporation
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if
the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Series B Preferred
Stock immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Series B Preferred Stock is outstanding, if the Corporation shall declare or
make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Series B Preferred Stock, then, in each such case, the Holder shall be entitled to participate
in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Series B Preferred Stock immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1) <U>General</U>.
The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (as defined below) assumes
in writing all of the obligations of the Company under this Certificate of Designation in accordance with the provisions of this Section
7.e) pursuant to written agreements in form and substance satisfactory to the Holder and approved by the Holder prior to such Fundamental
Transaction, including agreements to deliver to the Holder in exchange for shares of Series B Preferred Stock a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to the Series B Preferred Stock, including, without
limitation, which is convertible into a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable
and receivable upon conversion of the Series B Preferred Stock (without regard to any limitations on the conversion of the Series B Preferred
Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares
of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and
the value of such shares of capital stock, such adjustments to the number of shares of capital stock and such conversion price being
for the purpose of protecting the economic value of the Series B Preferred Stock immediately prior to the consummation of such Fundamental
Transaction) and (ii) if the Fundamental Transaction occurs within six (6) months of the Closing Date, the Successor Entity (including
its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon
the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of the applicable Fundamental Transaction, the provisions of this Certificate of Designation referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Company herein.
Upon consummation of each Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be
issued upon conversion of the Series B Preferred Stock at any time after the consummation of the applicable Fundamental Transaction,
in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of the Series
B Preferred Stock prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of
the Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable
Fundamental Transaction had the Series B Preferred Stock been converted immediately prior to the applicable Fundamental Transaction (without
regard to any Series B limitations on the conversion of the Series B Preferred Stock), as adjusted in accordance with the provisions
of this Certificate of Designation. Notwithstanding the foregoing, and without limiting Section 5 hereof, the Holder may elect, at its
sole option, by delivery of written notice to the Company to waive this Section 7.e) to permit the Fundamental Transaction without the
assumption of the Series B Preferred Stock. In addition to and not in substitution for any other rights hereunder, prior to the consummation
of each Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets
with respect to or in exchange for shares of Common Stock (a &ldquo;<U>Corporate Event</U>&rdquo;), the Company shall make appropriate
provision to insure that the Holder will thereafter have the right to receive upon a conversion of the Series B Preferred Stock at any
time after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the
Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of the Series B Preferred Stock prior
to such Fundamental Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants
or other purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental
Transaction had the Preferred Shares been exercised immediately prior to the applicable Fundamental Transaction (without regard to any
limitations on the conversion of the Series B Preferred Stock). Provision made pursuant to the preceding sentence shall be in a form
and substance reasonably satisfactory to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2) <U>Black
Scholes Value</U>. Notwithstanding the foregoing and the provisions of Section 5 above, at the request of the Holder delivered at any
time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the consummation of any Fundamental
Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the date that is ninety (90) days after the
public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current Report on Form 8-K filed with
the SEC, the Company or the Successor Entity (as the case may be) shall purchase the Series B Preferred Stock from the Holder on the
date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3) <U>Fundamental
Transaction</U>.   If, at any time while any Series B Preferred Stock is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent conversion of the Series B Preferred Stock, the Holder shall
have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 6 on the conversion of the
Series B Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock into which each share of Series B Preferred Stock
is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6 on the conversion of
the Series B Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any conversion of this preferred stock following such Fundamental
Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction, purchase the shares of Series B Preferred Stock from the Holder by paying to the Holder an amount of cash equal to the Black
Scholes Value of the remaining unconverted shares of Series B Preferred Stock on the date of the consummation of such Fundamental Transaction.
&ldquo;<U>Black Scholes Value</U>&rdquo; means the value of the unconverted shares of Series B Preferred Stock remaining on the date
of the Holder&rsquo;s request pursuant to Section 7(e)(2) which value is calculated using the Black Scholes Option Pricing Model for
a &ldquo;call&rdquo; or &ldquo;put&rdquo; option, as elected by the Holder, as obtained from the &ldquo;OV&rdquo; function on Bloomberg
utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock during the
period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to Section
7(e)(2) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus the value
of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal to the Conversion
Price in effect on the date of the Holder&rsquo;s request pursuant to Section 7(e)(2), (iii) a risk-free interest rate corresponding
to the U.S. Treasury rate as of the date of the Holder&rsquo;s request pursuant to Section 7(e)(2) if such request is prior to the date
of the consummation of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to the
greater of 100% and the 30 day volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental
Transaction, (B) the consummation of the applicable Fundamental Transaction and (C) the date on which the Holder first became aware of
the applicable Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this
Certificate of Designation and the other Transaction Documents in accordance with the provisions of this Section 7(e) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for the Series B Preferred
Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Series
B Preferred Stock which is convertible into a corresponding number of shares of capital stock of such Successor Entity (or its parent
entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Series B Preferred Stock (without regard
to any limitations on the conversion of the Series B Preferred Stock) prior to such Fundamental Transaction, and with a conversion price
which applies the Conversion Price hereunder to such shares of capital stock (but taking into account the relative value of the shares
of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
stock and such conversion price being for the purpose of protecting the economic value of the Series B Preferred Stock immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Series B Preferred Stock and the other Transaction Documents referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and
shall assume all of the obligations of the Company under this Series B Preferred Stock and the other Transaction Documents with the same
effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section&nbsp;7 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section&nbsp;7, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and
outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section&nbsp;7, the
Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth
a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Conversion by Holder</U>. If (A)&nbsp;the Corporation shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B)&nbsp;the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C)&nbsp;the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for
or purchase any shares of capital stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Corporation shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party,
any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common
Stock is converted into other securities, cash or property (E)&nbsp;the Corporation shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Corporation (F) the Corporation shall take any action to effectuate an Corporation Redemption,
or (G) a Triggering Event shall have occurred, then, in each case, the Corporation shall cause to be filed at each office or agency maintained
for the purpose of conversion of this Series B Preferred Stock, and shall cause to be delivered to each Holder at its last address as
it shall appear upon the stock books of the Corporation, at least twenty (20)&nbsp;calendar days prior to the applicable record or effective
date hereinafter specified (unless a greater or lesser time period is expressly required elsewhere in this Certificate of Designation),
a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights
or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such
dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation
or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on
Form&nbsp;8-K. The Holder shall remain entitled to convert the Conversion Amount of this Series B Preferred Stock (or any part hereof)
during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except
as may otherwise be expressly set forth in this Certificate of Designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section 8.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section 9.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Negative Covenants</U>. From the date hereof until the date no shares of Series B Preferred Stock are issued and outstanding, unless
Holders of at least 75% in Stated Value of the then outstanding shares of Series B Preferred Stock shall have otherwise given prior written
consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money
of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired
or any interest therein or any income or profits therefrom;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
other than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of
its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
amend its charter documents, including, without limitation, its articles of incorporation and bylaws, in any manner that materially and
adversely affects any rights of the Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
repay, repurchase or offer to repay, repurchase or otherwise acquire of any shares of its Common Stock, Common Stock Equivalents or Junior
Securities, other than as to the Conversion Shares as permitted or required under the Transaction Documents,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
pay cash dividends or distributions on Junior Securities of the Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
enter into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the
Commission, unless such transaction is made on an arm&rsquo;s-length basis and expressly approved by a majority of the disinterested
directors of the Corporation (even if less than a quorum otherwise required for board approval); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section 10.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Redemption Upon Triggering Events</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Triggering Event</U>&rdquo; means, wherever used herein any of the following events (whatever the reason for such event and
whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of
any court, or any order, rule or regulation of any administrative or governmental body):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
the Corporation shall fail to deliver Conversion Shares issuable upon a conversion hereunder that comply with the provisions hereof prior
to the fifth Trading Day after such shares are required to be delivered hereunder, or the Corporation shall provide written notice to
any Holder, including by way of public announcement, at any time, of its intention not to comply with requests for conversion of any
shares of Series B Preferred Stock in accordance with the terms hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
the Corporation shall fail for any reason to pay in full the amount of cash due pursuant to a Buy-In within five (5) Trading Days after
notice therefor is delivered hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
the Corporation shall fail to have available a sufficient number of authorized and unreserved shares of Common Stock to issue to such
Holder upon a conversion hereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
unless specifically addressed elsewhere in this Certificate of Designation as a Triggering Event, the Corporation shall fail to observe
or perform any other covenant, agreement or warranty contained in, or otherwise commit any breach of the Transaction Documents, and such
failure or breach shall not, if subject to the possibility of a cure by the Corporation, have been cured within 5 calendar days after
the date on which written notice of such failure or breach shall have been delivered;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
the Corporation shall redeem Junior Securities or <U>pari passu</U> securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
the Corporation shall be party to a Change of Control Transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
there shall have occurred a Bankruptcy Event;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.
any monetary judgment, writ or similar final process shall be entered or filed against the Corporation, any subsidiary or any of their
respective property or other assets for more than $50,000 (provided that amounts covered by the Corporation&rsquo;s insurance policies
are not counted toward this $50,000 threshold), and such judgment, writ or similar final process shall remain unvacated, unbonded or
unstayed for a period of thirty (30) Trading Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ix.
the electronic transfer by the Corporation of shares of Common Stock through the Depository Trust Company or another established clearing
corporation once established subsequent to the date of this Certificate of Designation is no longer available or is subject to a &lsquo;freeze&rdquo;
and/or &ldquo;chill&rdquo;; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x.
any &ldquo;Event of Default,&rdquo; as defined in the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Upon the occurrence of a Triggering Event, each Holder shall (in addition to all other rights it may have hereunder or under applicable
law) have the right, exercisable at the sole option of such Holder, to require the Corporation to (A) redeem all of the Series B Preferred
Stock then held by such Holder for a redemption price, in cash, equal to the Triggering Redemption Amount, or (B)&nbsp;at the option
of each Holder either (i)&nbsp;redeem all of the Series B Preferred Stock then held by such Holder though the issuance to such Holder
of such number of shares of Common Stock equal to the quotient of (x) the Triggering Redemption Amount, divided by (y) the lowest of
(1) the Conversion Price, and (2) 80% of the lowest traded price of the Common Stock during the fifteen (15) Trading Days immediately
prior to the date of election hereunder, and (ii)&nbsp;increase the dividend rate on all of the outstanding Series B Preferred Stock
held by such Holder retroactively to the initial Closing Date to 15%&nbsp;per annum thereafter. The Triggering Redemption Amount, whether
payable in cash or in shares, shall be due and payable or issuable, as the case may be, within five (5) Trading Days of the date on which
the notice for the payment therefor is provided by a Holder (the &ldquo;<U>Triggering Redemption Payment Date</U>&rdquo;). If the Corporation
fails to pay in full the Triggering Redemption Amount hereunder on the date such amount is due in accordance with this Section (whether
in cash or shares of Common Stock), the Corporation will pay interest thereon at a rate equal to the lesser of 18%&nbsp;per annum or
the maximum rate permitted by applicable law, accruing and compounding daily from such date until the Triggering Redemption Amount, plus
all such interest thereon, is paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
11.</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally or sent by a nationally recognized overnight courier
service and by facsimile or e-mail, addressed to the Corporation, at 5857 Owens Avenue, Suite 300, Carlsbad, California 92008;
Attention: Chief Executive Officer, e-mail: kevin@pridescapital.com, or such other e-mail or address as the Corporation may specify
for such purposes by prior written notice to the Holders delivered in accordance with this Section&nbsp;12. Any and all notices or other
communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile,
or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder
appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation, at the
principal place of business of such Holder, as set forth in the Subscription Agreement. Any notice or other communication or deliveries
hereunder shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii)&nbsp;the
next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set
forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii)&nbsp;the
second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)&nbsp;upon
actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Absolute Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair
the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest,
as applicable, on the shares of Series B Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Lost or Mutilated </U>Series B <U>Preferred Stock Certificate</U>. If a Holder&rsquo;s Series B Preferred Stock certificate shall
be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation
of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares
of Series B Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction
of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation
shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense
of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates,
directors, officers, stockholders, employees or agents) shall be commenced in the state and federal courts sitting in the Borough of
Manhattan, New York, New York (the &ldquo;<U>New York Courts</U>&rdquo;). Each party hereto hereby irrevocably submits to the exclusive
jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New
York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each
party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any
legal proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby. If any party
shall commence an action or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party in such
action or proceeding shall be reimbursed by the other party for its attorneys&rsquo; fees and other costs and expenses incurred in the
investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Waiver</U>. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate
as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of
Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term
of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder)
of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other
occasion. Any waiver by the Corporation or a Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate
of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain
applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-align: justify; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Status of Converted or Redeemed Preferred Stock</U>. Shares of Series B Preferred Stock may only be issued pursuant to a Subscription
Agreement. If any shares of Series B Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall
resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series B Preferred Stock.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be
and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations
in accordance with the foregoing resolution and the provisions of Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 24th day of September, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Kevin A. Richardson II</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
    A. Richardson II</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.8pt; text-indent: 20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(TO
BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES OF SERIES B PREFERRED STOCK)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert the number of shares of Series B Convertible Preferred Stock indicated below into shares of common
stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of QUALIGEN THERAPEUTICS, INC., a Delaware corporation (the
&ldquo; <U>Corporation</U> &rdquo;), according to the conditions hereof, as of the date written below. If shares of Common Stock are
to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto
and is delivering herewith such certificates and opinions as may be required by the Corporation in accordance with the Subscription
Agreement. No fee will be charged to the Holders for any conversion, except for any such transfer taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    to Effect Conversion:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Series B Preferred Stock owned prior to Conversion:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Series B Preferred Stock to be Converted:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
    Value&nbsp;of shares of Series B Preferred Stock to be Converted:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dollar
    amount of Interest to be Converted:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other amounts owed to the Undersigned
    by the Corporation under the Certificate of Designation and/or any other Transaction Document to be Converted:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock to be Issued:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Conversion Price:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Series B <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stock subsequent to Conversion:</FONT></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Or</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC Instructions:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker&nbsp;no:</FONT> ______________</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account&nbsp;no:</FONT> _______________</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Entity Holder______________ (Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name of Individual Holder______________ (Please Print)</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">______________________ (Signature of Individual Holder)</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENT COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>QUALIGEN
THERAPEUTICS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares:
[&#9679;]</FONT></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Exercise Date: September [&#9679;], 2025</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [&#9679;] or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New
York City time) on [&#9679;] (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Qualigen
Therapeutics Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [&#9679;] shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>.&#9;<U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the placement agency agreement, dated as of September 19, 2025, among the Company and Univest
Securities LLC, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company LLC, the current transfer agent of the Company, with a mailing address of 28 Liberty Street,
53<SUP>rd</SUP> Floor, New York, NY 10005 and an email address of Kimberly.Schams@equiniti.com, and any successor transfer agent of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Placement Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>.&#9;<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[&#9679;], subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may only be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 95.25pt; text-align: justify; text-indent: -20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT> =
                                            </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">as
applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the Common Stock on the principal
Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable
Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day)
pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 75pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT> =</TD><TD STYLE="text-align: justify">the
Exercise Price of this Warrant, as adjusted hereunder; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT> =
</TD><TD STYLE="text-align: justify">the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Placement Agency Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>.&#9;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) [Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control,
including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the
Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value
of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to 100%, (C) the underlying
price per share used in such calculation shall be the sum of the price per share being offered in cash, if any, plus the value of any
non-cash consideration, if any, being offered in such Fundamental Transaction, (D) a remaining option time equal to the time between
the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost
of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration)
within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of
this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>.&#9;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>.&#9;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
County of New York for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at 5857 Owens Avenue, Suite 300, Carlsbad, California 92008, Attention: Kevin A. Richardson, email address:
kevin@pridescapital.com, or such other email address or address as the Company may specify for such purposes by notice to the Holders.
Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of
such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and
effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address
set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to
be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>QUALIGEN THERAPEUTICS INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin Richardson II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:&#9;&nbsp;&nbsp;QUALIGEN
THERAPEUTICS INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT>___</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________________________________________________________________________________</FONT>____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________
    __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:__________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address: __________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">Exhibit 10.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">FORM
OF SUBSCRIPTION AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>SUBSCRIPTION AGREEMENT</B> (this &ldquo;<U>Subscription Agreement</U>&rdquo;) is entered into on September 19, 2025, by and between
Qualigen Therapeutics, Inc., a Delaware corporation (the &ldquo;<U>Issuer</U>&rdquo;), and the undersigned investor (&ldquo;<U>Subscriber</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
subject to the terms and conditions set forth in this Subscription Agreement and pursuant to the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act (as defined below), and Rule 506 promulgated thereunder, the Issuer desires to issue
and sell to Subscriber, and Subscriber desires to purchase in cash or one or more of the cryptocurrencies listed on <U>Schedule A</U>
hereto from the Issuer (i) the number of shares of the Issuer&rsquo;s common stock, par value $0.001 per share (the &ldquo;<U>Common
Stock</U>,&rdquo; and such purchased shares, the &ldquo;<U>Common Shares</U>&rdquo;), at a purchase price equal to $2.246 per Common
Share (the &ldquo;<U>Common Share Purchase Price</U>&rdquo;) and/or (ii) the number of shares of the Issuer&rsquo;s Series B preferred
stock, par value $0.001 per share (the &ldquo;<U>Preferred Stock</U>,&rdquo; and such purchased shares, the &ldquo;<U>Preferred Shares</U>&rdquo;
and together with the Common Shares and the Conversion Shares (as defined below), the &ldquo;<U>Securities</U>&rdquo;) set forth on the
signature page hereto, if any, at a purchase price equal to $1,000.00 per Preferred Share (the &ldquo;<U>Preferred Share Purchase Price</U>&rdquo;
and, the aggregate purchase price set forth on the signature page hereto for the Securities, the &ldquo;<U>Purchase Price</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Issuer intends to use the net proceeds of the sale of Securities to facilitate the purchase of a pool of cryptocurrencies to the
extent consistent with the Issuer&rsquo;s investment policy, as amended or otherwise modified from time to time, and general corporate
purposes;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Univest Securities, LLC, in its capacity as placement agent for the offer and sale of the Securities (in such capacity, the &ldquo;<U>Placement
Agent</U>&rdquo;) may identify and solicit certain other &ldquo;qualified institutional buyers&rdquo; (as defined in Rule 144A under
the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;)) or institutional &ldquo;accredited investors&rdquo;
(as such term is defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act, and each such &ldquo;qualified institutional buyer&rdquo;
or institutional &ldquo;accredited investor,&rdquo; an &ldquo;<U>Other Subscriber</U>&rdquo;), each of which shall have entered into
subscription agreements with the Issuer substantially similar to this Subscription Agreement contemporaneously herewith (the &ldquo;<U>Other
Subscription Agreements</U>&rdquo;), pursuant to which such Other Subscribers have agreed to subscribe for and purchase, and the Issuer
has agreed to issue and sell to such Other Subscribers, on the Closing Date (as defined herein), shares of Common Stock and/or Preferred
Stock at the Common Share Purchase Price and/or the Preferred Share Purchase Price (the &ldquo;<U>Other Subscriptions</U>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
contemporaneously with the sale of the Common Shares and the Preferred Shares, the parties hereto will execute and deliver a Registration
Rights Agreement, substantially in the form attached hereto as <U>Exhibit C</U> (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;),
pursuant to which the Issuer will agree to provide certain registration rights in respect of the Common Shares and the shares of Common
Stock issuable upon conversion of the Preferred Stock (the &ldquo;<U>Conversion Shares</U>&rdquo;) in an amount up to the Exchange Cap
(as defined below), under the Securities Act and applicable state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions,
herein contained, and intending to be legally bound hereby, the Issuer and Subscriber hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>. In addition to the terms defined elsewhere in this Subscription Agreement, the following terms have the meetings
set forth in this <U>Section 1</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advisory
Agreements</U>&rdquo; means the advisory agreements, between the Issuer and each of Cody Price, Campbell Becher and Robert Lim in form
satisfactory to such directors and the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Certificate
of Designations</U>&rdquo; means the Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred
Stock to be filed prior to the Closing Date by the Issuer with the Secretary of State of Delaware, in the form of <U>Exhibit A</U> attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Contingent
Obligation</U>&rdquo; means, as to any Person, any direct liability, contingent or otherwise, of that Person with respect to any Indebtedness,
lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the
primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that
any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part)
against loss with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Director
Agreements&rdquo; means the director agreements, between the Issuer and each of Kevin Richardson II, Braeden Lichti and Graydon Bensler
in form satisfactory to such directors and the Issuer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Issuer delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Cap</U>&rdquo; means the Company&rsquo;s principal Trading Market&rsquo;s limitation against a Purchaser&rsquo;s acquisition of shares
of Common Stock pursuant to the Transaction Documents, to the extent that after giving effect thereto, the aggregate number of shares
of Common Stock that would be issued pursuant to the Transaction Documents and the transactions contemplated thereby would exceed 19.99%
of the number of shares of Common Stock issued and outstanding immediately prior to the execution of this Agreement, which number of
shares would be reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction
or series of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Trading
Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fully
Diluted Capitalization</U>&rdquo; means the sum of the total number of issued and outstanding shares of Common Stock (assuming the full
conversion and exercise of all convertible and/or exercisable securities of the Issuer without regard to any vesting or limitations or
restrictions on conversion or exercise) after giving effect to consummation of the transactions contemplated by this Subscription Agreement,
including the issuance or deemed issuance of the Common Shares, the Preferred Shares and the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
of any Person means, without duplication (i) all indebtedness for borrowed money, (ii) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services (including &ldquo;capital leases&rdquo; to the extent required by GAAP) (other
than trade payables entered into in the ordinary course of business consistent with past practice), (iii) all reimbursement or payment
obligations with respect to letters of credit, surety bonds and other similar instruments, (iv) all obligations evidenced by notes, bonds,
debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets
or businesses, (v) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as
financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights
and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property),
(vi) all indebtedness referred to in clauses (i) through (v) above secured by (or for which the holder of such Indebtedness has an existing
right, contingent or otherwise, to be secured by) any lien upon or in any property or assets (including accounts and contract rights)
owned by any Person, even though the Person which owns such assets or property has not assumed or become liable for the payment of such
indebtedness, and (vii) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses
(i) through (vi) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property</U>&rdquo; means all patents, patent applications, trademarks, trademark registrations, service marks, service mark registrations,
trade names, copyrights, copyright registrations, licenses, inventions, trade secrets, Internet domain names, Internet domain name registrations,
technology, registrations, know-how and other intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer&rsquo;s
Counsel</U>&rdquo; means Lucosky Brookman, LLP, with offices located at 100 Wood Avenue South, Woodbridge, New Jersey 08830.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lead
Investor Agreement</U>&rdquo; means the Lead Investor Agreement dated the date hereof to be entered into by the Company and Faraday Future
Intelligent Electric, Inc. (&ldquo;<U>Faraday</U>&rdquo;), substantially in the form of <U>Exhibit E</U> attached hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Nasdaq</U>&rdquo;
means The Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; have the meaning set forth in the recitals hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means the Common Shares, the Conversion Shares and any shares of Common Stock issued or issuable in connection
with this Subscription Agreement, the Other Subscription Agreements and the Preferred Stock as a result of any stock split or subdivision,
stock dividend, recapitalization, exchange or similar event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Trading Market from the Issuer&rsquo;s
stockholders with respect to the transactions contemplated by this Subscription Agreement, including the issuance of Conversion Shares
as an issuance greater than the Exchange Cap pursuant to Nasdaq Rule 5635 and the issuance of shares of Common Stock or Common Stock
Equivalents to certain advisors of the Company in connection with the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Support Agreement</U>&rdquo; means the stockholder support agreement to be entered into by the directors and executive officers of the
Issuer and the Persons set forth in <U>Exhibit D</U> hereto (which, for the avoidance doubt, shall not include the Subscriber) pursuant
to which, among other things, they agree to vote in favor of Stockholder Approval, substantially in the form of <U>Exhibit B</U> attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Subscription Agreement, the Other Subscription Agreements, the Certificate of Designations, the Registration
Rights Agreement, the Lead Investor Agreement, the Stockholder Support Agreements, the Advisory Agreements and the Director Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Subscription</U>. Subject to the terms and conditions hereof, Subscriber hereby agrees to subscribe for and purchase, and the Issuer
hereby agrees to issue and sell to Subscriber, upon the payment of the Purchase Price, the Common Shares and Preferred Shares, if any,
set forth on the signature page hereto (such subscription and issuance, the &ldquo;<U>Subscription</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The closing of the Subscription contemplated hereby (the &ldquo;<U>Closing</U>&rdquo;) shall take place on the date on which the satisfaction
or waiver of the conditions set forth in <U>Sections 3.c</U>, <U>3.d</U>, and <U>3.e</U> (other than those conditions that by their nature
are to be satisfied at Closing, but without affecting the requirement that such conditions be satisfied or waived at Closing) (such date,
the &ldquo;<U>Closing Date</U>&rdquo;) and is contingent upon the occurrence of the closing of Other Subscriptions, plus the Subscription,
for an aggregate Purchase Price of at least $30 million. In the event that the Closing does not occur on or before the fourth (4<SUP>th</SUP>)
Business Day following the date hereof, upon the request of one or more Subscribers, the Issuer shall promptly (but not later than two
(2) Business Days thereafter) return the previously wired amount to such respective Subscriber by wire transfer of United States dollars
in immediately available funds to the account specified by such Subscriber, and any book entries for the Common Shares or Preferred Shares,
as applicable, contemplated to be issued to such Subscriber shall be deemed cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
The Purchase Price shall be paid in either cash (the &ldquo;Cash Purchase Price&rdquo;), in the cryptocurrency stablecoin commonly referred
to as USDC (&ldquo;<U>USDC</U>&rdquo;), or one or more of the cryptocurrencies set forth on <U>Schedule A</U> hereto (each, an &ldquo;<U>Authorized
Cryptocurrency</U>&rdquo;), as mutually agreed between the Issuer and Subscriber, in such amounts as indicated in Subscriber&rsquo;s
signature page of this Subscription Agreement. If Subscriber elects to pay all or a portion of the Purchase Price in one or more Authorized
Cryptocurrencies, then the number or amount of each such Authorized Cryptocurrency to be paid to Issuer shall equal the amount of the
Purchase Price to by paid in such Authorized Cryptocurrency divided by the value of such Authorized Cryptocurrency set forth on <U>Schedule
A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
On or prior to the date the conditions set forth in <U>Sections 3.c</U>, <U>3.d</U> and <U>3.e</U> (other than those conditions that
by their nature are to be satisfied at Closing) are waived or satisfied (the &ldquo;<U>Payment Deadline</U>&rdquo;), if Subscriber is
paying in cash, Subscriber will pay its total Cash Purchase Price by wire transfer of immediately available funds in accordance with
wire instructions provided by the Issuer to Subscriber. On or prior to the Closing Date, if Subscriber is paying all or a portion of
its Purchase Price in Authorized Cryptocurrency (the &ldquo;Cryptocurrency Purchase Price&rdquo;), Subscriber will pay the amount of
such Cryptocurrency Purchase Price, as applicable, in such Authorized Cryptocurrency, free and clear of any liens, encumbrances or other
restrictions, to the Issuer&rsquo;s wallet address in accordance with the written instructions provided by the Issuer to Subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
At the Closing, the Issuer shall deliver or cause to be delivered to Subscriber a number of Securities, registered in the name of Subscriber
(or its nominee in accordance with Subscriber&rsquo;s delivery instructions), equal to the number of Securities indicated on Subscriber&rsquo;s
signature page to this Subscription Agreement. The Issuer will deliver to Subscriber as promptly as practicable after the Closing, evidence
from the Issuer&rsquo;s transfer agent of the issuance to Subscriber of their Common Stock or Preferred Stock, as the case may be, on
and as of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
Subject to the satisfaction or waiver of the conditions set forth in <U>Sections 3.c</U> and <U>3.d</U> (other than those conditions
that by their nature are to be satisfied at Closing, but without affecting the requirement that such conditions be satisfied or waived
at Closing):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Subscriber shall deliver to the Issuer (A) no later than the Payment Deadline, the Cash Purchase Price for the Securities by wire transfer
of U.S. dollars in immediately available funds to the account specified by the Issuer, or if paying by Authorized Cryptocurrency, the
Cryptocurrency Purchase Price for the Securities in such Authorized Cryptocurrency by transfer to a wallet account specified by Subscriber,
and (B) no later than two (2) business days in advance of the anticipated Closing, any other information that is reasonably requested
in the notice provided by Issuer (the &ldquo;<U>Closing Notice</U>&rdquo;) that is reasonably required or advisable in order to enable
the Issuer to issue the Securities, including the legal name of the person (or nominee) in whose name such Securities are to be issued
and a duly executed Internal Revenue Service Form W-9 or W-8, as applicable; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
On the Closing Date, the Issuer shall deliver to Subscriber the Securities against and upon payment by Subscriber in book-entry form,
free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws), in the
name of Subscriber (or its nominee in accordance with its delivery instructions) or to a custodian designated by Subscriber, as applicable.
Each book entry for the Common Stock or Preferred Stock shall contain a legend in substantially the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;). THE SECURITIES HAVE BEEN ACQUIRED SOLELY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD
RESALE AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
The Issuer&rsquo;s obligation to effect the Closing shall be subject to the satisfaction on the Closing Date, or, to the extent permitted
by applicable law, the waiver by the Issuer, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
all representations and warranties of Subscriber contained in this Subscription Agreement shall be true and correct in all material respects
(other than representations and warranties that are qualified as to materiality or Subscriber Material Adverse Effect (as defined herein),
which representations and warranties shall be true and correct in all respects) at and as of the Closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Issuer shall have received copies of the applicable Transaction Documents duly executed by Subscriber (which, for the avoidance of
doubt, shall not include the Stockholder Support Agreement unless the Subscriber is included in the definition of each such agreement);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Subscriber shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing, except where the failure
of such performance, satisfaction or compliance would not or would not be reasonably expected to prevent, materially delay or materially
impair the ability of Subscriber to consummate the Closing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
no applicable governmental authority with competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any judgment,
order, law, rule or regulation (whether temporary, preliminary or permanent) that is then in effect and has the effect of making consummation
of the Subscription illegal or otherwise preventing or prohibiting consummation of the Subscription, and no governmental authority with
competent jurisdiction shall have instituted or threatened in writing a proceeding seeking to impose any such prevention or prohibition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
The several obligations of Subscriber to effect the Closing shall be subject to the satisfaction on the Closing Date, or the written
waiver by Subscriber, of each of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
all representations and warranties of the Issuer contained in this Subscription Agreement shall be true and correct in all material respects
(other than representations and warranties that are qualified as to materiality or Material Adverse Effect, which representations and
warranties shall be true and correct in all respects) at and as of the Closing (except for representations and warranties made as of
a specific date, which shall be true and correct in all material respects or in all respects, as applicable as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Issuer shall have performed, satisfied and complied (unless waived) in all material respects with all covenants, agreements and conditions
required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
no applicable governmental authority with competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any judgment,
order, law, rule or regulation (whether temporary, preliminary or permanent) that is then in effect and has the effect of making consummation
of the Subscription illegal or otherwise preventing or prohibiting consummation of the Subscription and no governmental authority with
competent jurisdiction shall have instituted or threatened in writing a proceeding seeking to impose any such prevention or prohibition;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Subscriber shall have received copies of the applicable Transaction Documents duly executed by the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the directors and executive officers of the Issuer and the Persons set forth on <U>Exhibit E</U> hereto shall have entered into Stockholder
Support Agreements with the Issuer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
no Material Adverse Effect shall have occurred and be continuing on the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
a copy of the irrevocable instructions to the transfer agent instructing the transfer agent to (x) deliver via restricted book entry
Common Shares and Preferred Shares equal to the number of shares of Common Stock and Preferred Stock set forth on the signature page
hereto, registered in the name of Subscriber; and (y) from time to time, upon conversion of the Preferred Shares, the Conversion Shares,
in form and substance reasonably satisfactory to Subscriber, signed by the Chief Executive Officer or Chief Financial Officer of the
Issuer certifying to the fulfillment of the conditions set forth in <U>Section 3.e;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
a legal opinion of Issuer&rsquo;s Counsel, directed to the Placement Agent and the Subscriber, in a form reasonably acceptable to the
Placement Agent and the Subscriber. The Placement Agent shall be entitled to rely on, to be protected in acting upon and, as applicable,
be the third-party beneficiary of any opinion delivered in connection with this Subscription Agreement or any Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
the Issuer shall have furnished to the Subscriber a certificate, dated the Closing Date, of its Chief Executive Officer and its Chief
Financial Officer stating in their respective capacities as officers of the Issuer on behalf of the Issuer and not in their individual
capacities that (i) for the period from and including the date of this Subscription Agreement through and including the Closing Date,
there has not occurred any Material Adverse Effect, (ii) to their knowledge, after reasonable investigation, as of the Closing Date,
the representations and warranties of the Issuer in this Subscription Agreement are true and correct in all material respects and the
Issuer has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to
the Closing Date, and (iii) there has not been, subsequent to the date of the most recent audited financial statements included or incorporated
by reference in SEC Documents (as defined below), any Material Adverse Effect in the financial position or results of operations of the
Issuer, or any change or development that, singularly or in the aggregate, would reasonably be expected to involve a Material Adverse
Effect, except as set forth in the SEC Documents. As used herein, &ldquo;<U>knowledge</U>&rdquo; means the actual knowledge of the officers
of the Issuer; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
the Issuer shall have taken all necessary corporate action such that following the Closing and after obtaining Stockholder Approval the
Issuer shall implement the Governance Changes (as defined below) as discussed in Section 6(i) below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
Prior to or at the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as
the parties reasonably may deem to be practical and necessary in order to consummate the Subscription as contemplated by this Subscription
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Issuer Representations and Warranties</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed
a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding section
thereof, the Issuer represents and warrants as of the date hereof and as of the Closing Date, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<U>Organization and Qualification</U>. The Issuer owns, directly or indirectly, all of the capital stock or other equity interests of
each &ldquo;significant subsidiary&rdquo;, as such term is defined in Rule 1-02 of Regulation S-X under the Securities Act (each a &ldquo;<U>Significant
Subsidiary</U>&rdquo;) free and clear of any liens, charges, security interests, encumbrances, rights of first refusal, preemptive rights
or other restrictions (collectively, &ldquo;<U>Liens</U>&rdquo;), and all of the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase
securities. Each of the Issuer and its Significant Subsidiaries has been duly incorporated or organized, as applicable, is validly existing
and is in good standing under the laws of its jurisdiction of incorporation or organization. Each of the Issuer and its Significant Subsidiaries
is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which
the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect (as defined
below) and no action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened (&ldquo;<U>Proceeding</U>&rdquo;), has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<U>Authorization; Enforcement; Validity</U>. The Issuer has the requisite corporate power and authority to enter into and perform its
obligations under this Subscription Agreement and the other Transaction Documents to which it is a party and to issue the Securities
in accordance with the terms hereof and thereof. The execution and delivery of this Subscription Agreement and the other Transaction
Documents by the Issuer and the consummation by the Issuer of the transactions contemplated hereby and thereby have been duly authorized
by the Board of Directors and no further filing, consent or authorization is required by the Issuer or the Board of Directors or other
governmental authority with competent jurisdiction other than any filing, consent or authorization the failure of which to obtain would
not reasonably be expected to have a Material Adverse Effect. This Subscription Agreement has been, and the other Transaction Documents
to which the Issuer is a party will be prior to the Closing, duly executed and delivered by the Issuer, and each constitutes the legal,
valid and binding obligations of the Issuer, enforceable against the Issuer in accordance with its respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo; rights and remedies and except as rights to
indemnification and to contribution may be limited by federal or state securities law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<U>Issuance of Securities</U>. The Securities being purchased by Subscriber hereunder will be duly and validly authorized and, upon issuance
pursuant to the terms hereof, against full payment therefor in accordance with the terms of this Subscription Agreement, will be duly
and validly issued, fully paid and non-assessable, will be issued free and clear of any liens or other restrictions (other than those
as provided in the Transaction Documents or restrictions on transfer under applicable state and federal securities laws) and will not
have been issued in violation of or subject to any preemptive or similar rights created under the Issuer&rsquo;s certificate of incorporation
and bylaws (as in effect at such time of issuance, the &ldquo;<U>Certificate of Incorporation</U>&rdquo; and &ldquo;<U>Bylaws</U>,&rdquo;
respectively) or under the laws of the State of Delaware, and a holder of the Common Shares or Preferred Shares shall be entitled to
all rights accorded to a holder of Common Stock or Preferred Stock, as applicable. The Conversion Shares will be duly authorized and
reserved for issuance and, upon issuance upon conversion of the Preferred Stock in accordance with the terms of the Certificate of Designations,
will be duly and validly issued, fully paid and non-assessable and will be issued free and clear of any liens or other restrictions (other
than those as provided in the Transaction Documents or restrictions on transfer under applicable state and federal securities laws) and
will not have been issued in violation of or subject to any preemptive or similar rights created under the Certificate of Incorporation
and Bylaws or under the laws of the State of Delaware, and a holder of the Conversion Shares shall be entitled to all rights accorded
to a holder of Common Stock. Subject to the accuracy of the representations and warranties made by Subscriber in <U>Section 5</U> hereof,
the offer and sale of the Securities to Subscriber is and will be in compliance with applicable exemptions from (i) the registration
and prospectus delivery requirements of the Securities Act and (ii) the registration and qualification requirements of applicable securities
laws of the states of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<U>Private Placement</U>. Assuming the accuracy of Subscriber&rsquo;s representations and warranties set forth in <U>Section 5</U>, no
registration under the Securities Act is required for the offer and sale of the Securities by the Issuer to Subscriber or the Other Subscribers
in the manner contemplated by this Subscription Agreement or the Other Subscription Agreements, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<U>No Conflicts</U>. Assuming the accuracy of Subscriber&rsquo;s representations and warranties in <U>Section 5</U>, the execution and
delivery by the Issuer of the Transaction Documents, and the performance by the Issuer of its obligations under the Transaction Documents,
including the issuance and sale of the Securities, do not and will not conflict with or result in a breach or violation of any of the
terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon
any of the property or assets of the Issuer pursuant to the terms of any (i) indenture, mortgage, deed of trust, loan agreement, lease,
license or other agreement or instrument to which the Issuer is a party or by which the Issuer is bound or to which any of the property
or assets of the Issuer is subject, which would reasonably be expected to have, individually or in the aggregate, a material adverse
effect on: (1) the business, properties, assets, liabilities, or financial condition of the Issuer and its subsidiaries, taken as a whole,
(2) the transactions contemplated hereby or in any of the other Transaction Documents or any other agreements or instruments to be entered
into by the Issuer in connection herewith or therewith or (3) the authority or ability of the Issuer to perform any of its obligations
under any of the Transaction Documents (a &ldquo;<U>Material Adverse Effect</U>&rdquo;) or materially affect the validity of the Securities
or the legal authority of the Issuer to comply in all material respects with the terms of this Subscription Agreement; (ii) the organizational
documents of the Issuer; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental authority with
competent jurisdiction, domestic or foreign, having jurisdiction over the Issuer or any of its properties, including the rules and regulations
of the Trading Market, and including all applicable laws, rules and regulations of the jurisdiction of incorporation of the Issuer, applicable
to the Issuer or any of its subsidiaries or by which any property or asset of the Issuer or any of its subsidiaries is bound, encumbered
or otherwise affected that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or materially
affect the validity of the Common Shares, the Preferred Shares or the Conversion Shares or the legal authority of the Issuer to comply
in all material respects with the terms of this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<U>Conduct of Business; Regulatory Permits</U>. Except as set forth on <U>Schedule 4(f)</U>, neither the Issuer nor any of its subsidiaries
is in violation of any judgment, decree or order or any statute, ordinance, rule or regulation applicable to the Issuer or any of its
subsidiaries, and neither the Issuer nor any of its subsidiaries will conduct its business in violation of any of the foregoing, except
in all cases for violations which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
Without limiting the generality of the foregoing, except as set forth on <U>Schedule 4(f)</U>, the Issuer is not in violation of any
material rules, regulations or requirements of the Trading Market and has no knowledge of any facts or circumstances that would reasonably
lead to delisting or suspension of trading of the Common Stock by the Trading Market in the foreseeable future. Since the date on which
the Issuer consummated its initial public offering of Common Stock (the &ldquo;<U>IPO Date</U>&rdquo;), (i) the Common Stock has been
listed or designated for quotation on the Trading Market, (ii) trading in the Common Stock has not been suspended by the Commission or
the Trading Market and (iii) except as publicly disclosed in filings with the Commission, the Issuer has received no communication, written
or oral, from the Commission or the Trading Market regarding the suspension or delisting of the Common Stock from the Trading Market,
which has not been publicly disclosed. The Issuer and each of its subsidiaries possess all certificates, authorizations and permits issued
by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such
certificates, authorizations or permits would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, and neither the Issuer nor any of its subsidiaries has received any written notice of proceedings relating to the revocation
or modification of any such certificate, authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree
binding upon the Issuer or any of its subsidiaries or to which the Issuer or any of its subsidiaries is a party which has or would reasonably
be expected to have the effect of prohibiting or materially impairing any business practice of the Issuer or any of its subsidiaries,
any acquisition of property by the Issuer or any of its subsidiaries or the conduct of business by the Issuer or any of its subsidiaries
as currently conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably be expected
to have a Material Adverse Effect on the Issuer or any of its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
<U>Anti-Dilution</U>. There are no securities or instruments issued by or to which the Issuer is a party containing anti-dilution or
similar provisions that will be triggered by the issuance of (i) the Securities or (ii) the Securities to be issued pursuant to any Other
Subscription Agreement or upon conversion of the Preferred Shares, in each case, that have not been or will not be validly waived on
or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
<U>Brokerage Fee</U>. Except for any placement fees payable to the Placement Agent, the Issuer has not paid, and is not obligated to
pay, any brokerage, finder&rsquo;s or other commission or similar fee in connection with its issuance and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Filings, Consents and Approvals</U>. Subject to the receipt of the Stockholder Approval (solely with respect to the Governance Changes)
and assuming the accuracy of Subscriber&rsquo;s representations and warranties in <U>Section 5</U>, the Issuer is not required to obtain
any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority with competent jurisdiction, self-regulatory organization (including the Trading Market)
or other Person in connection with the execution, delivery and performance by the Issuer of this Subscription Agreement (including the
issuance of the Securities), other than (i) the filing with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
of the Registration Statement (as defined in the Registration Rights Agreement), (ii) the filings required by applicable state or federal
securities laws, (iii) the filings required in accordance with <U>Section 9.n</U>, (iv) those required by the Issuer&rsquo;s principal
Trading Market and (v) the failure of which to obtain would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect or have a material adverse effect on the Issuer&rsquo;s ability to consummate the transactions contemplated hereby, including
the sale and issuance of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j. <U>SEC
Documents; Financial Statements</U>. Since January 1, 2024, the Issuer has filed all reports, schedules, forms, proxy statements,
statements and other documents required to be filed by it with the Commission pursuant to the reporting requirements of the Exchange
Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and financial statements,
notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &ldquo;<U>SEC
Documents</U>&rdquo;), which SEC Documents, as of their respective filing dates, complied in all material respects with the
requirements of the Exchange Act applicable to the SEC Documents and the rules and regulations of the Commission promulgated
thereunder applicable to the SEC Documents. None of the SEC Documents filed under the Exchange Act (except to the extent that
information contained in any SEC Document has been superseded by a later timely filed SEC Document) contained, when filed, any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the
statements therein not misleading, in the case of any SEC Document that is a registration statement, or included, when filed, any
untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading, in the case of all other SEC Documents. As of their
respective dates, the financial statements of the Issuer included in the SEC Documents complied in all material respects with
applicable accounting requirements and the published rules and regulations of the Commission with respect thereto as in effect as of
the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles
(&ldquo;<U>GAAP</U>&rdquo;), consistently applied, during the periods involved (except (i) as may be otherwise indicated in such
financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude
footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the
Issuer as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate). The
Issuer is not currently contemplating to amend or restate any of the financial statements (including any notes or any letter of the
independent accountants of the Issuer with respect thereto) included in the SEC Documents (the &ldquo;<U>Financial
Statements</U>&rdquo;), nor is the Issuer currently aware of facts or circumstances which would require the Issuer to amend or
restate any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance with GAAP
and the rules and regulations of the SEC. The Issuer has not been informed by its independent accountants that they recommend that
the Issuer amend or restate any of the Financial Statements or that there is any need for the Issuer to amend or restate any of the
Financial Statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
<U>Indebtedness and Other Contracts</U>. Except as set forth on <U>Schedule 4(k)</U>, the Issuer is not in default or violation (and
no event has occurred which, with notice or the lapse of time or both, would constitute a default or violation) of any term, condition
or provision of (i) the organizational documents of the Issuer, (ii) any loan or credit agreement, note, bond, mortgage, indenture, lease
or other agreement, permit, franchise or license to which the Issuer is now a party or by which the Issuer&rsquo;s properties or assets
are bound or (iii) any statute or any judgment, order, rule or regulation of any court or governmental authority with competent jurisdiction,
domestic or foreign, having jurisdiction over the Issuer or any of its properties, except, in the case of clauses (ii) and (iii), for
defaults or violations that have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect. Neither the Issuer nor any of its subsidiaries, (i) has any outstanding debt securities, notes, credit agreements, credit facilities
or other agreements, documents or instruments evidencing Indebtedness of the Issuer or any of its subsidiaries or by which the Issuer
or any of its subsidiaries is or may become bound, (ii) is a party to any contract, agreement or instrument, the violation of which,
or default under which, by the other party(ies) to such contract, agreement or instrument would reasonably be expected to result in a
Material Adverse Effect, (iii) has any financing statements securing obligations in any amounts filed in connection with the Issuer or
any of its subsidiaries; or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance of
which, in the judgment of the Issuer&rsquo;s officers, has or is expected to have a Material Adverse Effect. Neither the Issuer nor any
of its subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the
SEC Documents, other than those incurred in the ordinary course of the Issuer&rsquo;s or its subsidiaries&rsquo; respective businesses
and which, individually or in the aggregate, do not or could not have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l.
<U>Capitalization</U>. The capitalization of the Issuer as of the date hereof is as set forth on <U>Schedule 4(1)</U>, which <U>Schedule
4(1)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Issuer as of
the date hereof. The Issuer has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other
than pursuant to the exercise of employee stock options under the Issuer&rsquo;s stock option plans, the issuance of shares of Common
Stock to employees pursuant to the Issuer&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common
Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. Except as a result of
the purchase and sale of the Securities and set forth on <U>Schedule 4(l)</U>, no Person has any right of first refusal, preemptive right,
right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as
set forth on <U>Schedule 4(l)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving
any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of the Issuer or any of its subsidiaries,
or contracts, commitments, understandings or arrangements by which the Issuer or any of its subsidiaries is or may become bound to issue
additional shares of Common Stock or Common Stock Equivalents or capital stock of any subsidiary. The issuance and sale of the Securities
will not obligate the Issuer or any of its subsidiaries to issue shares of Common Stock or other securities to any Person (other than
Subscriber). Except as set forth on <U>Schedule 4(l)</U>, there are no outstanding securities or instruments of the Issuer or any subsidiary
with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of
securities by the Issuer or any of its subsidiaries. Except as set forth on <U>Schedule 4(l)</U>, there are no outstanding securities
or instruments of the Issuer or any of its subsidiaries that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Issuer or any of its subsidiaries is or may become bound to redeem a security
of the Issuer or such subsidiary. The Issuer does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Issuer are duly authorized, validly issued, fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares
was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. Except as set forth on
<U>Schedule 4(l)</U>, there are no stockholders agreements, voting agreements or other similar agreements with respect to the Issuer&rsquo;s
capital stock to which the Issuer is a party or, to the knowledge of the Issuer, between or among any of the Issuer&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m.
<U>Absence of Certain Changes</U>. Since the date of the Issuer&rsquo;s most recent audited financial statements contained in the Issuer&rsquo;s
Annual Report on Form 10-K through the date hereof, there has been no Material Adverse Effect, nor any event or occurrence affecting
the Issuer or its subsidiaries that, individually or in the aggregate, would be reasonably expected to result in a Material Adverse Effect.
Since the date of the Issuer&rsquo;s most recent audited financial statements contained in the Issuer&rsquo;s Annual Report on Form 10-K,
neither the Issuer nor any of its subsidiaries has (i) declared or paid any dividends, (ii) sold any material assets, individually or
in the aggregate, outside of the ordinary course of business consistent with past practice or (iii) made any material capital expenditures,
individually or in the aggregate, outside of the ordinary course of business consistent with past practice. Neither the Issuer nor any
of its subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency, reorganization,
receivership, liquidation or winding up, nor does the Issuer or any subsidiary have any knowledge or reason to believe that any of their
respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact which would reasonably
lead a creditor to do so. The Issuer and its subsidiaries, on a consolidated basis, after giving effect to the transactions contemplated
hereby to occur at the Closing, are not insolvent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.
<U>[RESERVED]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o.
<U>Shell Company Status</U>. The Issuer has never been a shell company, as described in Rule 144(i)(1) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p.
<U>Material Changes; No Undisclosed Events, Liabilities, Developments or Circumstances</U>. Since the date of the latest audited financial
statements included within the SEC Documents, except as disclosed in the SEC Documents or as set forth on <U>Schedule 4(p)</U>, (i) there
has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Issuer has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred
in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Issuer&rsquo;s
financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Issuer has not altered its method of
accounting, (iv) the Issuer has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Issuer has not issued any equity securities
to any officer, director or Affiliate, except pursuant to existing Issuer stock option plans. The Issuer does not have pending before
the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by the Transaction
Documents or disclosed in the SEC Documents, no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Issuer or its Significant Subsidiaries or their respective businesses,
prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Issuer under applicable
securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading
Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q.
<U>Acknowledgment Regarding Subscriber&rsquo;s Purchase of Securities</U>. The Issuer acknowledges and agrees Subscriber is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to this Subscription Agreement and the transactions contemplated hereby.
The Issuer further acknowledges that Subscriber is not acting as a financial advisor or fiduciary of the Issuer (or in any similar capacity)
with respect to this Subscription Agreement and the transactions contemplated hereby and thereby and any advice given by Subscriber or
any of their respective representatives or agents in connection with this Subscription Agreement and the transactions contemplated hereby
and thereby is merely incidental to Subscriber&rsquo;s purchase of the Securities. The Issuer further represents to Subscriber that the
Issuer&rsquo;s decision to enter into this Subscription Agreement has been based solely on the independent evaluation of the transactions
contemplated hereby by the Issuer and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">r. <U>Application
of Takeover Protections</U>. The Issuer and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, interested shareholders, business combination, poison pill (including, without
limitation, any distribution under a rights agreement), shareholders rights plan or other similar anti-takeover provision under the
Certificate of Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or
otherwise which is or could become applicable to Subscriber as a result of the transactions contemplated by this Subscription
Agreement and the other Transaction Documents, including, without limitation, the Issuer&rsquo;s issuance of the Securities and
Subscriber&rsquo;s ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">s.
<U>Common Stock Listing</U>. At Closing, the issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of
the Exchange Act and are listed for trading on the Issuer&rsquo;s principal Trading Market. Except as disclosed in the SEC Documents,
there is no suit, action, proceeding or investigation pending or, to the knowledge of the Issuer, threatened against the Issuer by such
Trading Market or the Commission with respect to any intention by such entity to deregister the Common Stock or prohibit or terminate
the listing of the Common Stock on such Trading Market. The Issuer has taken no action that is designed to terminate the registration
of the Common Stock under the Exchange Act or the listing of the Common Stock on such Trading Market. Except as disclosed in the SEC
Documents or as set forth on <U>Schedule 4(s)</U>, the Issuer is, and has no reason to believe that it will not in the foreseeable future
continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic
transfer through the Depository Trust Company or another established clearing corporation and the Issuer is current in payment of the
fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">t.
<U>Applicable Law Violations</U>. The Issuer has not received any written communication from a governmental authority with competent
jurisdiction that alleges that the Issuer is not in compliance with or is in default or violation of any applicable law, except where
such non-compliance, default or violation would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">u.
<U>Side Agreements</U>. The Issuer has not entered into any subscription agreement, side letter or other agreement with any Other Subscriber
or any other investor (except with respect to payment method and timing) in connection with such Other Subscriber&rsquo;s or investor&rsquo;s
direct or indirect investment in the Issuer other than (i) the Other Subscription Agreements, and (ii) the other Transaction Agreements.
The terms and conditions of the Other Subscription Agreements are substantially similar to the terms and conditions of this Agreement,
and no Other Subscription Agreement (or other agreements or understandings (including side letters) entered into in connection therewith
or in connection with the sale of the Securities) has been amended, modified or waived or shall be amended, modified or waived in a manner
that materially benefits any Other Subscriber unless the Subscriber is offered in writing the same benefits (other than terms particular
to the legal or regulatory requirements of such Other Subscriber or its affiliates or related persons).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No General Solicitation</U>. Neither the Issuer, nor any of its affiliates, nor any Person acting on its or their behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection
with the offer or sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">w.
<U>Disclosure</U>. The Issuer confirms that neither it nor any other Person acting on its behalf has provided Subscriber or its agents
or counsel with any information that constitutes or would reasonably be expected to constitute material, non-public information concerning
the Issuer or any of its subsidiaries, other than the information in the investor presentation, provided to Subscriber in connection
with the transactions contemplated by this Subscription Agreement, and the existence of the transactions contemplated by this Subscription
Agreement and the other Transaction Documents; <I>provided </I>that nothing herein shall be construed as an admission that any such documents
contained an material, non-public information. The Issuer understands and confirms that Subscriber may rely on the foregoing representations
in effecting transactions in securities of the Issuer. All disclosures provided to Subscriber regarding the Issuer and its subsidiaries,
their businesses and the transactions contemplated hereby, including the schedules to this Subscription Agreement, furnished by or on
behalf of the Issuer or any of its subsidiaries, taken as a whole, are true and correct and do not contain any untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. All of the written information furnished after the date hereof by or on behalf of the Issuer
or any of its subsidiaries to Subscriber pursuant to or in connection with this Subscription Agreement and the other Transaction Documents,
taken as a whole, will be true and correct in all material respects as of the date on which such information is so provided and will
not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in the light of the circumstances under which they were made, not misleading. No event or circumstance has occurred, and no
information exists, with respect to the Issuer or any of its subsidiaries or its or their business, properties, liabilities, prospects,
operations (including results thereof) or conditions (financial or otherwise), which, under applicable law, rule or regulation, requires
public disclosure at or before the date hereof or announcement by the Issuer but which has not been so publicly disclosed. All financial
projections and forecasts that have been prepared by or on behalf of the Issuer or any of its subsidiaries and made available to Subscriber
have been prepared in good faith based upon reasonable assumptions and represented, at the time each such financial projection or forecast
was delivered to Subscriber, the Issuer&rsquo;s best estimate of future financial performance (it being recognized that such financial
projections or forecasts are not to be viewed as facts and that the actual results during the period or periods covered by any such financial
projections or forecasts may differ materially from the projected or forecasted results). The Issuer acknowledges and agrees that no
Subscriber makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those
specifically set forth in <U>Section 5</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x.
<U>Certain Fees</U>. Except as set forth in the Transaction Documents, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Issuer to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person
with respect to the transactions contemplated by this Agreement and the transactions contemplated pursuant to the Transaction Documents.
Subscriber shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for
fees of a type contemplated in this <U>Section 4.x</U> that may be due in connection with the transactions contemplated by this Agreement
and the transactions contemplated pursuant to the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">y.
<U>Investment Company Status</U>. The Issuer is not, and immediately after receipt of payment for the Securities will not be, an &ldquo;investment
company&rdquo; within the meaning of the Investment Company Act of 1940, as amended (the &ldquo;<U>Investment Company Act</U>&rdquo;).
The Issuer shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">z.
<U>Registration Rights</U>. Except (i) as set forth on <U>Schedule 4(z)</U>, (ii) as have been waived and (iii) as provided for in the
Registration Rights Agreement, no Person has any right to cause the Issuer to effect the registration under the Securities Act of any
securities of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">aa.
<U>Derivative Transactions</U>. Anything in this Subscription Agreement or elsewhere herein to the contrary notwithstanding (except for
<U>Section 6</U> hereof), it is understood and acknowledged by the Issuer that: (i) Subscriber has not been asked by the Issuer to agree,
nor has Subscriber agreed, to desist from purchasing or selling, long and/or short, securities of the Issuer, or &ldquo;derivative&rdquo;
securities based on securities issued by the Issuer or to hold the Securities for any specified term following the Closing; (ii) past
or future open market or other transactions by Subscriber, specifically including, without limitation, Short Sales (as defined in <U>Section
6</U>) or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Issuer&rsquo;s publicly-traded securities; (iii) Subscriber, and counter-parties in &ldquo;derivative&rdquo;
transactions to which Subscriber is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common
Stock, and (iv) Subscriber shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any
&ldquo;derivative&rdquo; transaction, in each case subject to applicable law. The Issuer further understands and acknowledges that (y)
Subscriber may engage in hedging activities at various times during the period that the Securities are outstanding, including without
limitation, during the periods that the value of the Conversion Shares issuable with respect to Preferred Shares are being determined
and (z) such hedging activities (if any) could reduce the value of the existing shareholders&rsquo; equity interests in the Issuer at
and after the time that the hedging activities are being conducted, in each case subject to applicable law. The Issuer acknowledges that
such aforementioned hedging activities do not constitute a breach of this Subscription Agreement or any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bb.
<U>Litigation</U>. Except as set forth on <U>Schedule 4(bb)</U>, there is no action, suit, inquiry, notice of violation, proceeding or
investigation pending or, to the knowledge of the Issuer, threatened against or affecting the Issuer, any Significant Subsidiary or any
of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal,
state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth in <U>Schedule 4(bb)</U>
(i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or
(ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the
Issuer nor any Significant Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim
of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to
the knowledge of the Issuer, there is not, pending or contemplated, any investigation by the Commission involving the Issuer or any current
or former director or officer of the Issuer. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Issuer or any Significant Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc.
<U>Real Property</U>. The Issuer and its subsidiaries have good and marketable title to all property (whether real or personal) owned
by them which is material to the Issuer and its subsidiaries taken as a whole, in each case free and clear of all liens, claims, security
interests, other encumbrances or defects except as would not, individually or in the aggregate, be reasonably expected to result in a
Material Adverse Effect. The property held under lease by the Issuer and its subsidiaries is held by them under valid, subsisting and
enforceable leases with only such exceptions with respect to any particular lease as do not interfere in any material respect with the
conduct of the business of the Issuer or its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dd.
<U>Intellectual Property</U>. The Issuer and each of its subsidiaries owns, possesses, or can acquire on reasonable terms, all Intellectual
Property necessary for the conduct of the Issuer&rsquo;s and it subsidiaries&rsquo; business as now conducted, except as such failure
to own, possess, or acquire such rights would not reasonably be expected to result in a Material Adverse Effect. Furthermore: (A) to
the knowledge of the Issuer, there is no infringement, misappropriation or violation by third parties of any such Intellectual Property,
except as such infringement, misappropriation or violation would not result in a Material Adverse Effect; (B) there is no pending or,
to the knowledge of the Issuer, threatened, action, suit, proceeding or claim by others challenging the Issuer&rsquo;s or any of its
subsidiaries&rsquo; rights in or to any such Intellectual Property, and the Issuer is unaware of any material objective facts which would
form a reasonable basis for any such claim, except as such action, suit, proceeding or claim would not reasonably be expected to result
in a Material Adverse Effect; (C) the Intellectual Property owned by the Issuer and its subsidiaries, and to the knowledge of the Issuer,
the Intellectual Property licensed to the Issuer and its subsidiaries, has not been adjudged invalid or unenforceable, in whole or in
part, except as such adjudgment would not result in a Material Adverse Effect, and there is no pending or, to the knowledge of the Issuer,
threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, except as
such action, suit, proceeding or claim would not reasonably be expected to result in a Material Adverse Effect; (D) there is no pending
or, to the knowledge of the Issuer, threatened action, suit, proceeding or claim by others that the Issuer or any of its subsidiaries
infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary rights of others, and neither the Issuer
or any of its subsidiaries has received any written notice of such claim, except as such action, suit, proceeding or claim would not
reasonably be expected to result in a Material Adverse Effect; and (E) to the Issuer&rsquo;s knowledge, no employee of the Issuer or
any of its subsidiaries is in or has ever been in violation of any term of any employment contract, patent disclosure agreement, invention
assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or
with a former employer where the basis of such violation relates to such employee&rsquo;s employment with the Issuer or any of its subsidiaries
or actions undertaken by the employee while employed with the Issuer or any of its subsidiaries, except as such violation would not result
in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ee.
<U>Insurance</U>. The Issuer and each of its subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as management of the Issuer believes to be prudent and customary in the businesses in which the
Issuer and its subsidiaries are engaged. Neither the Issuer nor any such subsidiary has any reason to believe that it will be unable
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may
be necessary to continue its business at a cost that would not have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ff.
<U>Environmental Laws</U>. Except as set forth on <U>Schedule 4(ff)</U>, neither the Issuer nor any of its subsidiaries (i) is in violation
of any statute, any rule, regulation, decision or order of any governmental authority or any court, domestic or foreign, relating to
the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human
exposure to hazardous or toxic substances (collectively, &ldquo;<U>Environmental Laws</U>&rdquo;), (ii) owns or operates any real property
contaminated with any substance that is subject to any Environmental Laws, (iii) is liable for any off-site disposal or contamination
pursuant to any Environmental Laws, or (iv) is subject to any claim relating to any Environmental Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gg.
<U>Foreign Corrupt Practices</U>. None of the Issuer or any of its subsidiaries nor, to the knowledge of the Issuer, any director, officer,
agent, employee or other person associated with or acting on behalf of the Issuer or any of its subsidiaries has: (i) used any corporate
funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made any direct
or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in
violation of any provision of the Foreign Corrupt Practices Act of 1977; or (iv) made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hh.
<U>Tax Status</U>. Except as set forth on <U>Schedule 4(hh)</U>, the Issuer and its subsidiaries (A) have timely filed all federal, state,
local and foreign income and franchise tax returns required to be filed and (B) are not in default in the payment of any taxes which
were payable pursuant to said returns or any assessments with respect thereto, other than any which the Issuer or any of its subsidiaries
is contesting in good faith; except those, in each of the cases described in clauses (A) and (B) of this paragraph (hh), that would not,
singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no pending material dispute with any
taxing authority relating to any of such returns, and the Issuer has no knowledge of any proposed material liability for any tax to be
imposed upon the properties or assets of the Issuer for which there is not an adequate reserve reflected in the Issuer&rsquo;s latest
filed financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Internal Accounting and Disclosure Controls</U>. The Issuer and each of its subsidiaries maintains internal control over financial
reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that is designed to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including
policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions
and dispositions of the assets of the Issuer, (ii) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Issuer are being made only in
accordance with authorizations of management and directors of the Issuer and (iii) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use or disposition of the Issuer&rsquo;s assets that could have a material effect on
its financial statements. The Issuer maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the
Exchange Act) that are designed to ensure that information required to be disclosed by the Issuer in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the
Commission, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the
Issuer in the reports that it files or submits under the Exchange Act, as applicable, is accumulated and communicated to the Issuer&rsquo;s
management, including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to
allow timely decisions regarding required disclosure. Except as disclosed in the SEC Documents, neither the Issuer nor any of its subsidiaries
has received any notice or correspondence from any accountant, governmental entity or other Person relating to any potential material
weakness or significant deficiency in any part of the internal controls over financial reporting of the Issuer or any of its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jj.
<U>IT Systems and Data</U>. (i) The Issuer and its subsidiaries are presently in compliance in all material respects with all applicable
laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of the Issuer&rsquo;s or any subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;)
and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not,
individually or in the aggregate, have a Material Adverse Effect, (ii) the Issuer and its subsidiaries have implemented and maintained
commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation,
redundancy and security of all IT Systems and Data, and (iii) the Issuer and its subsidiaries have implemented backup and disaster recovery
technology consistent with commercially reasonable industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">kk.
<U>Sanctions Matters</U>. Neither the Issuer nor any of its subsidiaries or, to the knowledge of the Issuer, any director, officer or
controlled affiliate of the Issuer or any director or officer of any subsidiary, is a Person that is, or is owned or controlled by a
Person that is (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s Office of Foreign
Asset Control (&ldquo;<U>OFAC</U>&rdquo;), the United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury, or
other relevant sanctions authorities, including designation on OFAC&rsquo;s Specially Designated Nationals and Blocked Persons List or
OFAC&rsquo;s Foreign Sanctions Evaders List or other relevant sanctions authority (collectively, &ldquo;<U>Sanctions</U>&rdquo;), or
(ii) located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that
country or territory (including the Crimea, Zaporizhzhia and Kherson regions, the Donetsk People&rsquo;s Republic and Luhansk People&rsquo;s
Republic in Ukraine, Cuba, Iran, North Korea, Russia, Sudan and Syria (the &ldquo;<U>Sanctioned Countries</U>&rdquo;)). Neither the Issuer
nor any of its subsidiaries nor any director, officer or controlled affiliate of the Issuer or any of its subsidiaries, has ever had
funds blocked by a United States bank or financial institution, temporarily or otherwise, as a result of OFAC concerns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ll.
<U>Placement Agent</U>. The Issuer hereby acknowledges and agrees that (i) the Placement Agent is acting solely as placement agent in
connection with the execution, delivery and performance of the Transaction Documents and is not acting as an underwriter or in any other
capacity and is not and shall not be construed as a fiduciary for Subscriber, the Issuer or any other person or entity in connection
with the execution, delivery and performance of the Transaction Documents, (ii) the Placement Agent has not made nor will make any representation
or warranty, whether express or implied, of any kind or character and the Placement Agent has not provided any advice or recommendation
in connection with the execution, delivery and performance of the Transaction Documents and (iii) the Placement Agent will not have any
responsibility with respect to (A) any representations, warranties or agreements made by any person or entity under or in connection
with the execution, delivery and performance of the Transaction Documents, or the execution, legality, validity or enforceability (with
respect to any person) thereof, or (B) the business, affairs, financial condition, operations or properties of, or any other matter concerning
the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mm.
<U>No Disqualification Events; Notice of Disqualification Events</U>. With respect to Securities to be offered and sold hereunder in
reliance on Rule 506(b) under the Securities Act (&ldquo;<U>Regulation D Securities</U>&rdquo;), none of the Issuer, any predecessor
or affiliated issuer of the Issuer, any director, executive officer or other officer of the Issuer or, to the Issuer&rsquo;s knowledge,
any beneficial owner of 20% or more of the Issuer&rsquo;s outstanding voting equity securities, calculated on the basis of voting power,
or any promoter connected with the Issuer in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and,
together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;), is subject to any of the &ldquo;bad actor&rdquo; disqualifications within the
meaning of Rule 506(d) under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event
covered by Rule 506(d)(2) or (d)(3). The Issuer has exercised reasonable care to determine whether any Issuer Covered Person is subject
to a Disqualification Event. The Issuer has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and
has furnished to Subscriber a copy of any disclosures provided thereunder. The Issuer will notify Subscriber in writing, prior to the
Closing Date, of (i) &#8239;any Disqualification Event relating to any Issuer Covered Person and (ii)&#8239;any event that would, with
the passage of time, become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">nn.
<U>Anti-Money Laundering</U>. To the knowledge of the Issuer, the operations of the Issuer and its subsidiaries are and have been conducted
in material compliance with applicable anti-money laundering laws, including, but not limited to, the Bank Secrecy Act of 1970, as amended
by the USA PATRIOT ACT of 2001, and the rules and regulations promulgated thereunder, and the anti-money laundering laws of the various
jurisdictions in which the Issuer and its subsidiaries conduct business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">oo.
<U>Certificates</U>. Any certificate signed by an officer of the Issuer and delivered to Subscriber or to counsel for Subscriber shall
be deemed to be a representation and warranty by the Issuer to Subscriber as to the matters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pp.
<U>Reliance</U>. The Issuer acknowledges that Subscriber will rely upon the accuracy and truthfulness of the foregoing representations
and warranties and hereby consents to such reliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">qq.
<U>Use of Proceeds</U>. Of the net proceeds from the sale of the Securities, as detailed on <U>Schedule B</U> annexed hereto, (a) up
to $1,400,000 million will be utilized for general corporate purposes initiated in the six-month period immediately after the Closing,
(b) up to $4,000,000 million may be utilized to (i) for the satisfaction of any portion of the Issuer&rsquo;s debt (other than payment
of trade payables in the ordinary course of the Issuer&rsquo;s business and prior practices), (ii) for the redemption of any Common Stock
or (iii) for the settlement of any outstanding litigation, and (c) the remaining funds will be utilized for the establishment of a new
cryptocurrency-related business and to facilitate the purchase of additional cryptocurrency to the extent consistent with the Issuer&rsquo;s
investment policy, as amended or otherwise modified from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rr.
<U>Manipulation of Price</U>. The Issuer has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Issuer to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Issuer, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ss.
<U>Subscriber Representations</U>. The Issuer acknowledges that there have been no representations, warranties, covenants and agreements
made to Issuer by or on behalf of Subscriber, any of its respective affiliates or any of its or their control persons, officers, directors,
employees, partners, agents or representatives, expressly or by implication, regarding the transactions contemplated by this Subscription
Agreement other than those representations, warranties, covenants and agreements included in this Subscription Agreement (inclusive of
the exhibits and schedules attached hereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tt.
<U>Other Covered Persons</U>. Other than the Placement Agent, the Issuer is not aware of any Person that has been or will be paid (directly
or indirectly) remuneration for solicitation of Subscriber or potential purchasers in connection with the sale of any Regulation D Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">uu.
<U>Financial Condition</U>. Based on the consolidated financial condition of the Issuer as of the Closing Date, after giving effect to
the receipt by the Issuer of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Issuer&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Issuer&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Issuer&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Issuer, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Issuer, together with the proceeds the Issuer would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Issuer does not intend to incur debts beyond its ability to pay such debts
as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Issuer has no knowledge
of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one (1) year from the Closing Date. All outstanding secured and unsecured Indebtedness of the Issuer
or any Significant Subsidiary, or for which the Issuer or any Significant Subsidiary has commitments, is set forth in the SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vv.
<U>Off Balance Sheet Arrangements</U>. There is no transaction, arrangement, or other relationship between the Issuer or any of its subsidiaries
and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Issuer in its filings under the Exchange
Act, and is not so disclosed or that otherwise would be reasonably likely to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ww.
<U>Sarbanes-Oxley Act</U>. The Issuer is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley
Act of 2002 and all applicable rules and regulations promulgated thereunder or implementing provisions thereof that are then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xx.
<U>No Integrated Offering</U>. Assuming the accuracy of Subscriber&rsquo;s representations and warranties set forth in <U>Section 5</U>,
neither the Issuer, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Issuer for purposes of (i) the Securities Act which would require the registration of any
such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of
the securities of the Issuer are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">yy.
<U>Transactions with Affiliates and Employees</U>. Except as set forth in the SEC Documents, none of the officers or directors of the
Issuer or any Significant Subsidiary and, to the knowledge of the Issuer, none of the employees of the Issuer or any Significant Subsidiary
is presently a party to any transaction with the Issuer or any Significant Subsidiary (other than for services as employees, officers
and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring
payments to or from any officer, director or such employee or, to the knowledge of the Issuer, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in
excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred
on behalf of the Issuer and (iii) other employee benefits, including stock option agreements under any stock option plan of the Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">zz.
<U>Labor Relations</U>. No material labor dispute exists or, to the knowledge of the Issuer, is imminent with respect to any of the employees
of the Issuer, which could reasonably be expected to result in a Material Adverse Effect. None of the Issuer&rsquo;s or its subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Issuer or such subsidiary, and neither the
Issuer nor any of its subsidiaries is a party to a collective bargaining agreement, and the Issuer and its subsidiaries believe that
their relationships with their employees are good. No executive officer of the Issuer or any subsidiary, to the knowledge of the Issuer,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Issuer or any of its subsidiaries to any liability
with respect to any of the foregoing matters. The Issuer and its subsidiaries are in compliance with all U.S. federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">aaa.
<U>Stock Option Plans</U>. Each stock option granted by the Issuer under the Issuer&rsquo;s stock option or equity incentive plans was
granted (i) in accordance with the terms of the Issuer&rsquo;s applicable stock option or equity incentive plan and (ii) with an exercise
price at least equal to the fair market value of the Common Stock on the date such stock option or award would be considered granted
under GAAP and applicable law. No stock option or award granted under the Issuer&rsquo;s stock option or equity incentive plan has been
backdated. The Issuer has not knowingly granted, and there is no and has been no Issuer policy or practice to knowingly grant, stock
options or awards prior to, or otherwise knowingly coordinate the grant of stock options or awards with, the release or other public
announcement of material information regarding the Issuer or its Significant Subsidiaries or their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bbb.
<U>Accountants</U>. The Issuer&rsquo;s accounting firm is set forth in its SEC Reports. To the knowledge and belief of the Issuer, such
accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect
to the financial statements to be included in the Issuer&rsquo;s Annual Report on Form 10-K for the fiscal year ending December 31, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ccc.
<U>U.S. Real Property Holding Corporation</U>. The Issuer is not and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Issuer shall so certify upon Subscriber&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ddd.
<U>Bank Holding Company Act</U>. Neither the Issuer nor any of its subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Issuer nor any of its subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Issuer nor any of its
subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Subscriber Representations and Warranties</U>. Subscriber represents and warrants, as of the date hereof and the Closing Date, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
Subscriber has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of incorporation
or formation, with the requisite entity power and authority to enter into, deliver and perform its obligations under this Subscription
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
This Subscription Agreement has been duly authorized, executed and delivered by Subscriber. This Subscription Agreement is enforceable
against Subscriber in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally and (ii) principles of
equity, whether considered at law or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
The execution and delivery by Subscriber of this Subscription Agreement, and the performance by Subscriber of its obligations under this
Subscription Agreement, including the purchase of the Securities and the consummation of the other transactions contemplated herein,
will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result
in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of Subscriber pursuant to the terms
of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Subscriber is
a party or by which Subscriber is bound or to which any of the property or assets of Subscriber is subject, which would reasonably be
expected to have a material adverse effect on the business, properties, financial condition, stockholders&rsquo; equity or results of
operations of Subscriber (a &ldquo;<U>Subscriber Material Adverse Effect</U>&rdquo;), or materially affect the legal authority of Subscriber
to comply in all material respects with the terms of this Subscription Agreement; (ii) the organizational documents of Subscriber; or
(iii) any statute or any judgment, order, rule or regulation of any court or governmental authority with competent jurisdiction, domestic
or foreign, having jurisdiction over Subscriber or any of Subscriber&rsquo;s properties including all applicable laws, rules and regulations
of the jurisdiction of incorporation of Subscriber, applicable to Subscriber or any of its subsidiaries or by which any property or asset
of Subscriber or any of its subsidiaries is bound, encumbered or otherwise affected that would reasonably be expected to have, individually
or in the aggregate, a Subscriber Material Adverse Effect or materially affect the legal authority of Subscriber to comply in all material
respects with this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
Subscriber (i) is either (a) an institutional &ldquo;accredited investor&rdquo; (as such term is defined in Rule 501(a)(1), (2), (3)
or (7) of Regulation D under the Securities Act) or (b) a qualified institutional buyer as defined in Rule 144A under the Securities
Act, in either case acknowledges that the sale contemplated hereby is being made in reliance on Section 506(b) of Regulation D under
the Securities Act and similar exemptions under state law and is an &ldquo;institutional account&rdquo; as defined by FINRA 4512(c),
(ii) is acquiring the Common Shares and/or the Preferred Shares, as applicable, and upon the conversion of the Preferred Shares, will
acquire the Conversion Shares issuable upon conversion of the Preferred Shares only for its own account and not for the account of others,
or if Subscriber is subscribing for the Common Shares and/or the Preferred Shares as a fiduciary or agent for one or more investor accounts,
each owner of such account is a &ldquo;qualified institutional buyer&rdquo; or an institutional &ldquo;accredited investor&rdquo; and
Subscriber has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements,
representations and agreements herein on behalf of each owner of each such account and (iii) is not acquiring the Common Shares and/or
Preferred Shares, and upon the conversion of the Preferred Shares, will not acquire the Conversion Shares issuable upon exercise of Preferred
Shares, with a view to or for offer or sale in connection with, any distribution thereof in violation of the Securities Act. Subscriber
is not an entity formed for the specific purpose of acquiring the Common Shares and/or the Preferred Shares and upon the conversion of
the Preferred Shares, acquiring the Conversion Shares issuable upon conversion of the Preferred Shares, unless Subscriber is a newly-formed
entity in which all of the equity owners are accredited investors and is an &ldquo;institutional account&rdquo; as defined by FINRA Rule
4512(c). Accordingly, Subscriber is aware that this offering of the Securities meets the exemptions from filing under FINRA Rule 5123(b)(1)(A),
(C) or (J).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
Subscriber understands that the Securities are being offered in a transaction not involving any public offering within the meaning of
the Securities Act and that the Securities have not been registered under the Securities Act. Subscriber understands that the Securities
may not be offered, resold, transferred, pledged or otherwise disposed of by Subscriber absent an effective registration statement under
the Securities Act, except (i) to the Issuer or a subsidiary thereof, (ii) to non-U.S. Persons pursuant to offers and sales that occur
outside the United States within the meaning of Regulation S under the Securities Act, (iii) pursuant to Rule 144 under the Securities
Act; <I>provided</I> that all of the applicable conditions thereof have been met, or (iv) pursuant to another applicable exemption from
the registration requirements of the Securities Act (including, without limitation, a private resale pursuant to the so-called &ldquo;Section
4(a)(1 1/2) exemption&rdquo;), and in each case, in accordance with any applicable securities laws of the states of the United States
and other applicable jurisdictions, and that any certificates or book-entry records representing the Securities shall contain a legend
to such effect. Subscriber acknowledges that the Securities will not be eligible for resale pursuant to Rule 144A promulgated under the
Securities Act. Subscriber understands and agrees that the Securities will be subject to the foregoing transfer restrictions and, as
a result of these transfer restrictions, Subscriber may not be able to readily resell the Common Shares and may be required to bear the
financial risk of an investment in the Securities for an indefinite period of time. Subscriber acknowledges and agrees that the Securities
will not be eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144 until at least six months from the filing
of certain required information with the Commission after the Closing Date. Subscriber understands that it has been advised to consult
legal counsel prior to making any offer, resale, pledge or transfer of any of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
Subscriber understands and agrees that Subscriber is purchasing the Securities directly from the Issuer. Subscriber further acknowledges
that there have been no representations, warranties, covenants and agreements made to Subscriber by or on behalf of the Issuer, any of
its affiliates or control persons, officers, directors, employees, partners, agents or representatives, expressly or by implication,
regarding the transactions contemplated by this Subscription Agreement, other than those representations, warranties, covenants and agreements
included in this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
Subscriber&rsquo;s acquisition and holding of the Securities will not constitute or result in a non-exempt prohibited transaction under
section 406 of the Employee Retirement Income Security Act of 1974, as amended (&ldquo;<U>ERISA</U>&rdquo;), section 4975 of the Internal
Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), or any applicable similar law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
In making its decision to subscribe for and purchase the Securities, Subscriber represents that it has relied solely upon its own independent
investigation, the investor presentation provided to Subscriber and the Issuer&rsquo;s representations, warranties and covenants set
forth in this Subscription Agreement. Without limiting the generality of the foregoing, Subscriber has not relied on any statements,
representations or warranties or other information provided by (i) the Placement Agent or any of its affiliates, or any of its officers,
directors, employees or representatives or (ii) any other Subscriber&rsquo;s business and/or legal counsel, concerning the Issuer or
the Securities or the offer and sale of the Securities and confirms that none of such Persons has made any representations or warranties
to Subscriber in connection with the transactions contemplated by the Transaction Documents. Subscriber acknowledges and agrees that
Subscriber has received and has had the opportunity to review such information as Subscriber deems necessary in order to make an investment
decision with respect to the Securities and the Issuer, including the SEC Documents and the risk factors set forth therein. Subscriber
understands that nothing in this Subscription Agreement or any other materials presented by or on behalf of the Issuer to Subscriber
in connection with the purchase of the Securities constitutes legal, tax or investment advice. Subscriber has consulted such legal, tax
and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities.
Subscriber represents and agrees that Subscriber and Subscriber&rsquo;s professional advisor(s), if any, have had the full opportunity
to ask such questions, receive such answers and obtain such information as Subscriber and Subscriber&rsquo;s professional advisor(s),
if any, have deemed necessary to make an investment decision with respect to the Securities. Subscriber understands, based on its experience,
the disadvantage to which Subscriber is subject due to the disparity of information between Subscriber and the Issuer. Notwithstanding
such disparity, Subscriber has deemed it appropriate to enter into this Subscription Agreement and to consummate the transactions contemplated
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
Subscriber became aware of this offering of the Securities solely by means of direct contact between Subscriber and the Issuer, the Placement
Agent or a representative of the Issuer or the Placement Agent, and the Securities were offered to Subscriber solely by direct contact
between Subscriber and the Issuer, the Placement Agent or a representative of the Issuer or the Placement Agent. Subscriber did not become
aware of this offering of the Securities, nor were the Securities offered to Subscriber, by any other means. Subscriber acknowledges
that the Issuer represents and warrants that the Securities (i) were not offered by any form of general solicitation or general advertising
and (ii) are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act,
or any state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.
Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Securities, including
the risks related to the Issuer&rsquo;s anticipated cryptocurrency treasury strategy as discussed in the investor presentation provided
to Subscriber in connection with the transactions contemplated by this Subscription Agreement. Subscriber has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Securities, and Subscriber
has sought such accounting, legal and tax advice as Subscriber has considered necessary to make an informed investment decision. Accordingly,
Subscriber is aware that the offering of the Securities meets the institutional account exemptions under FINRA Rule 2111(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
Subscriber understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Securities
or made any findings or determination as to the fairness of an investment in the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l.
Neither Subscriber nor any of its officers, directors, managers, managing members, general partners nor any other Person acting in a
similar capacity or carrying out a similar function is (i) a person or entity designated under or the subject of any sanctions, export
restrictions, restricted party list, or blocking measures administered by a governmental authority, including but not limited to the
List of Specially Designated Nationals and Blocked Persons, the Foreign Sanctions Evaders List, the Menu-Based Sanctions List, the Chinese
Military-Industrial Complex Companies List, the Sectoral Sanctions Identification List, the Russia-Related Sanctions Programs or any
other sanctions-related list or program administered by OFAC (collectively, &ldquo;<U>Sanctions Lists</U>&rdquo;), (ii) directly or indirectly
owned or controlled by, or acting on behalf of, a person that is named on a Sanctions List, (iii) organized, incorporated, established,
located, operating, conducting business, participating in or facilitating any transaction involving, a resident or born in, or a citizen,
national, or the government, including any political subdivision, agency, or instrumentality thereof, of Cuba, Iran, North Korea, Syria,
Russia, certain regions of Ukraine, or any other country or territory embargoed or subject to comprehensive trade restrictions by the
United States, the European Union or any European Union individual member state, including the United Kingdom (collectively, &ldquo;<U>Sanctioned
Jurisdictions</U>&rdquo;), (iv) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, (v) the
Government of Venezuela, as defined in Executive Order 13884, or (vi) a non-U.S. shell bank or providing banking services indirectly
to a non-U.S. shell bank. Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. section
5311 et seq.), as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively, the &ldquo;<U>BSA/PATRIOT Act</U>&rdquo;),
that Subscriber maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act.
Subscriber also represents that, to the extent required, it maintains policies and procedures reasonably designed to ensure compliance
with the regulations promulgated by OFAC (31 C.F.R. Parts 500-599) and corresponding enabling statutes, executive orders, and guidance
and any similar economic sanctions laws of any country in which Subscriber is performing activities, including for the screening of its
investors against the Sanctions Lists. Subscriber further represents and warrants that, to the extent required, it maintains policies
and procedures reasonably designed to ensure that the funds held by Subscriber and used to purchase the Securities were legally derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m.
Subscriber is not currently (and at all times through the Closing will refrain from being or becoming) a member of a &ldquo;group&rdquo;
(within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or any successor provision) acting for the purpose of
acquiring, holding, voting or disposing of equity securities of the Issuer (within the meaning of Rule 13d-5(b)(1) under the Exchange
Act), other than any &ldquo;group&rdquo; consisting solely of Subscriber and one or more of its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.
If Subscriber is or is acting on behalf of (i) an employee benefit plan that is subject to Title I of ERISA, (ii) a plan, an individual
retirement account or other arrangement that is subject to section 4975 of the Code, (iii) an entity whose underlying assets are considered
to include &ldquo;plan assets&rdquo; of any such plan, account or arrangement described in clauses (i) and (ii) (each, an &ldquo;<U>ERISA
Plan</U>&rdquo;), or (iv) an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan
(as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA) or other plan that is not subject
to the foregoing clauses (i), (ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or other
laws or regulations that are similar to such provisions of ERISA or the Code (collectively, &ldquo;<U>Similar Laws</U>,&rdquo; and together
with the ERISA Plans, the &ldquo;<U>Plans</U>&rdquo;), Subscriber represents and warrants that (i) neither the Issuer, nor any of its
affiliates (the &ldquo;<U>Transaction Parties</U>&rdquo;) has provided investment advice or has otherwise acted as the Plan&rsquo;s fiduciary,
with respect to its decision to acquire and hold the Securities, and none of the Transaction Parties is or shall at any time be the Plan&rsquo;s
fiduciary with respect to any decision to acquire and hold the Securities, and none of the Transaction Parties is or shall at any time
be the Plan&rsquo;s fiduciary with respect to any decision in connection with Subscriber&rsquo;s investment in the Securities and (ii)
its purchase of the Securities will not result in a non-exempt prohibited transaction under section 406 of ERISA or section 4975 of the
Code, or any applicable Similar Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o.
Subscriber has, and at the Closing, will have, sufficient funds to pay the Purchase Price pursuant to <U>Section 3.b.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Additional Subscriber and Issuer Agreements</U><SUP>.</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
Subscriber hereby agrees that, from the date of this Subscription Agreement until the Disclosure Time, neither Subscriber nor any Person
or entity acting on behalf of Subscriber or pursuant to any understanding with Subscriber shall, directly or indirectly, offer, sell,
pledge, contract to sell, engage in any hedging activities or execute Short Sales (as defined herein) with respect to securities of the
Issuer. For purposes of this <U>Section 6</U>, &ldquo;<U>Short Sales</U>&rdquo; shall include all &ldquo;short sales&rdquo; as defined
in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges (other than pledges
in the ordinary course of business as part of prime brokerage arrangements), and sales and other transactions through non-U.S. broker
dealers or foreign regulated brokers. For purposes of this <U>Section 6</U>, &ldquo;Short Sales&rdquo; shall not include forward sale
contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis). Notwithstanding the foregoing, (a)
nothing herein shall prohibit other entities under common management with Subscriber that have no knowledge of this Subscription Agreement
(including Subscriber&rsquo;s controlled affiliates and/or affiliates) from entering into any Short Sales and (b) in the case that Subscriber
is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of Subscriber&rsquo;s assets and the
portfolio managers have no knowledge of the investment decisions made by the portfolio managers managing other portions of Subscriber&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities pursuant to this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
Notwithstanding anything to the contrary set forth in this Subscription Agreement, Subscriber (and any of Subscriber&rsquo;s affiliates
or any other Person who would be a beneficial owner of Common Stock beneficially owned by Subscriber for purposes of Section 13(d) or
Section 16 of the Exchange Act and the applicable rules and regulations of the Commission, including any &ldquo;group&rdquo; (as determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder) of which Subscriber is a member)
shall be subject to a beneficial ownership limitation (the &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;) of 19.99% (or such other
percentage as notified to the Issuer in writing at least one day prior to the issuance of any Common Stock beneficially owned by Subscriber,
provided that in no event shall such percentage exceed 19.99%) of the number of shares of Common Stock outstanding as of the applicable
measurement date; provided further that Subscriber (and any of Subscriber&rsquo;s affiliates) may suspend the Beneficial Ownership Limitation
in its entirety if, and for so long as, such Beneficial Ownership Limitation is not required to be in effect to ensure compliance with
applicable Nasdaq listing requirements with respect to stockholder approval. The Issuer shall be entitled to rely on representations
made to it by Subscriber regarding its Beneficial Ownership Limitation. Notwithstanding the foregoing, by written notice to the Issuer
(which may be via email), Subscriber may increase or decrease the Beneficial Ownership Limitation to any other percentage specified in
such written notice, provided that (A) in no event shall such percentage exceed 19.99% unless such Beneficial Ownership Limitation is
not required to be in effect to ensure compliance with applicable Nasdaq listing requirements with respect to stockholder approval and
(B) any increase shall not be effective until the sixty-first (61st) day after such written notice is delivered to the Issuer. Upon any
such increase by Subscriber of the Beneficial Ownership Limitation applicable to Subscriber, the Beneficial Ownership Limitation may
not be further amended by Subscriber without first providing the minimum notice required by this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
The Issuer shall use its commercially reasonable efforts to obtain the Stockholder Approval by written consent of stockholders or at
a special meeting of shareholders (the &ldquo;<U>Stockholders&rsquo; Meeting</U>&rdquo;) no later than forty (40) days following the
date hereof (or seventy (70) days following the date hereof in the event that the staff of the Commission conducts a review of the preliminary
information statement filed in connection with any written consent of stockholders or preliminary proxy statement filed in connection
with the Stockholders&rsquo; Meeting).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
If the Issuer is unable to obtain the Stockholder Approval by written consent of its stockholders in accordance with applicable law,
the Issuer shall use its commercially reasonable efforts to (i) solicit its stockholders&rsquo; approval of such resolutions, including
engaging a proxy solicitor reasonably acceptable to the requisite holders and causing such proxy solicitor to reasonably assist in the
solicitation of proxies in connection with the Stockholders&rsquo; Meeting and (ii) cause the Board of Directors to recommend to the
shareholders that they approve such resolutions, and all management-appointed proxyholders shall vote their proxies in favor of such
resolutions. If Stockholder Approval is not obtained at the Stockholders&rsquo; Meeting, the Issuer shall cause an additional stockholder
meeting to be held within ninety (90) days of the date of such Stockholders&rsquo; Meeting (the &ldquo;<U>Extended Stockholder Approval
Period</U>&rdquo;). If the Stockholder Approval is not obtained within the Extended Stockholder Approval Period, then the Issuer shall
convene additional shareholder meetings every ninety (90) days thereafter until the Stockholder Approval is obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
The Issuer shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Issuer shall, sell, offer
for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that
will be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act
of the sale of the Securities to Subscriber, or that will be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction
unless stockholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent
to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to Subscriber
and the Other Subscribers. For clarification purposes, this provision constitutes a separate right granted to Subscriber by the Issuer
and negotiated separately by Subscriber, and is intended for the Issuer to treat Subscriber and the Other Subscribers as a class and
shall not in any way be construed as Subscriber and the Other Subscribers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
The Issuer shall not be obligated to issue any Conversion Shares to a Subscriber pursuant to any of the Transaction Documents if the
issuance, when aggregated with all prior issuances of Securities to such Persons, would exceed the Exchange Cap, except that such limitation
shall not apply in the event that (A) the Stockholder Approval. Until such Stockholder Approval is obtained the Subscribers shall not
be able to convert the Preferred Stock and no Subscriber shall be issued Conversion Shares, upon conversion of any of its Preferred Stock,
in an amount greater than the Exchange Cap</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
Effective upon the Closing, the Issuer shall adopt a policy in the form previously agreed to by the Issuer and Faraday in the Lead Investor
Agreement (the &ldquo;<U>Treasury Reserve Policy</U>&rdquo;), under which the Issuer&rsquo;s treasury reserve assets will consist of
(i) cash and cash equivalents and short-term investments (&ldquo;<U>Cash Assets</U>&rdquo;) that exceed working capital requirements
and (ii) cryptocurrencies which will serve as the primary treasury reserve asset of the Issuer on an ongoing basis, subject to market
conditions and anticipated needs of the business for Cash Assets and oversight by the Co-Chief Executive Officer (as defined below).
Prior to the New Directors (as defined below) being appointed to the Board of Directors, the Treasury Reserve Policy shall not be amended,
modified or waived without the prior written consent of Co-Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Following the Closing and after obtaining Stockholder Approval, the Issuer shall take all necessary corporate action such that (a) the
authorized size of the Board of Directors shall be seven, (b) at least two (2) and up to four (4) individuals designated by Faraday shall
be appointed to the Board of Directors (each a &ldquo;<U>New Director</U>&rdquo; and collectively, the &ldquo;<U>New Directors</U>&rdquo;),
(c) certain of the New Directors shall be appointed to the Audit Committee, Nominating and Corporate Governance and Compensation Committees
of the Board of Directors as shall be designated by Faraday, and (d) an individual designated by Faraday shall be appointed the Co-Chief
Executive Officer of the Issuer, and the by-laws of the Issuer shall be amended to create the office of the Co-Chief Executive Officer
of the Issuer and to provide that the Co-Chief Executive Officer of the Issuer shall have exclusive control and authority over the implementation
of the Treasury Reserve Policy ((a) through (d) collectively, the &ldquo;<U>Governance Changes</U>&rdquo;). Promptly following such Board
appointments, the Issuer shall (y) add each New Director as a covered party under the Issuer&rsquo;s current director and officer insurance
policy, and (z) deliver to each New Director an indemnification agreement, duly executed by the Issuer and in the same form entered into
by the Issuer with each of the Issuer&rsquo;s other directors. The Issuer shall maintain the number of independent directors on the Board
of Directors as required to ensure ongoing compliance with applicable listing standards of the Issuer&rsquo;s principal Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Issuer shall, notwithstanding any termination of this Subscription Agreement in accordance with <U>Section 8.b</U>, indemnify, defend
and hold harmless Subscriber and its Affiliates and their respective directors, officers, trustees, general partners, members, stockholders,
partners, managers, employees, investment advisors and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title) each Person who controls such Investor (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, stockholders, agents, members,
partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title) of such controlling persons (each such entity or person, an &ldquo;<U>Indemnified Person</U>&rdquo;)
to the fullest extent permitted by applicable law, from and against any and all reasonable and documented out-of-pocket losses, claims,
damages, liabilities and reasonable and documented costs (including, without limitation, reasonable and documented costs of preparation
and investigation and reasonable documented attorneys&rsquo; fees and disbursements) and all other reasonable and documented expenses
(collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, that arise out of or are based upon (i) any breach of any of the representations,
warranties, covenants or agreements made by or to be performed on the part of the Issuer under this Subscription Agreement or the other
Transaction Documents or (ii) any action instituted against any Indemnified Person in any capacity, or any of them or their respective
Affiliates, by any stockholder of the Issuer who is not an Affiliate of such Indemnified Person, with respect to any of the transactions
contemplated by the Transaction Document and will reimburse any such Person for all such amounts as they are incurred by such Person
solely to the extent such amounts have been finally judicially determined not to have resulted from such Person&rsquo;s fraud or willful
misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
Any person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party; <I>provided</I> that any person entitled to indemnification hereunder shall have the right to
employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense
of such person unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) the indemnifying party shall
have failed to assume the defense of such claim and employ counsel reasonably satisfactory to such person or (c) in the reasonable judgment
of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying
party with respect to such claims (in which case, if the person notifies the indemnifying party in writing that such person elects to
employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense
of such claim on behalf of such person); and <I>provided, further</I>, that the failure of any indemnified party to give written notice
as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give
notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that
the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more
than one separate firm of attorneys (and one local counsel) at any time for all such indemnified parties. No indemnifying party will,
except with the consent of the indemnified party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to
entry of any judgment or enter into any settlement unless such judgment or settlement (i) imposes no liability or obligation on, (ii)
includes as an unconditional term thereof the giving of a complete, explicit and unconditional release from the party bringing such indemnified
claims of all liability of the indemnified party in respect of such claim or litigation in favor of, and (iii) does not include any admission
of fault, culpability, wrongdoing, or wrongdoing or malfeasance by or on behalf of, the indemnified party. No indemnified party will,
except with the consent of the indemnifying party, which consent shall not be unreasonably withheld, conditioned or delayed, consent
to entry of any judgment or enter into any settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Termination</U>. This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations
of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest
to occur of (a) upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (b) if any
of the conditions to the Closing set forth in <U>Section 3</U> of this Subscription Agreement are not satisfied at, or are not capable
of being satisfied on or prior to the Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement
will not be or are not consummated at the Closing, or (c) at the election of Subscriber in the event that the Closing shall not have
occurred within four (4) business days of the date hereof, <I>provided</I> that nothing herein will relieve any party from liability
for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to
recover losses, liabilities or damages arising from any such willful breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
Each party hereto acknowledges that the other party hereto and the Placement Agent will rely on the acknowledgments, understandings,
agreements, representations and warranties contained in this Subscription Agreement. Prior to the Closing, each party hereto agrees to
promptly notify the other party hereto if any of the acknowledgments, understandings, agreements, representations and warranties made
by such party as set forth herein are no longer accurate in all material respects. Subscriber further acknowledges and agrees that the
Placement Agent is a third-party beneficiary of the representations and warranties of Subscriber contained in <U>Section 5</U> and the
Issuer further acknowledges and agrees that the Placement Agent is a third-party beneficiary of the representations and warranties of
the Issuer contained in <U>Section 4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
Subscriber agrees that none of (i) any Other Subscriber pursuant to Other Subscription Agreements entered into (including the affiliates
or controlling persons, members, officers, directors, partners, agents, or employees of any such Other Subscriber), (ii) the Placement
Agent, its affiliates or any of its respective affiliates&rsquo; control persons, officers, directors or employees, (iii) any affiliates
or any control persons, officers, directors, employees, partners, agents or representatives of any of the Issuer shall be liable to Subscriber
or to any Other Subscriber pursuant to this Subscription Agreement or the Other Subscription Agreements, as applicable, the negotiation
hereof or thereof or the subject matter hereof or thereof, or the transactions contemplated hereby or thereby, for any action heretofore
or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Securities. On behalf of itself and its
affiliates, Subscriber releases each of the entities or individuals described above in respect of any losses, claims, damages, obligations,
penalties, judgments, awards, liabilities, costs, expenses or disbursements related to this Subscription Agreement or the transactions
contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
The Issuer and Subscriber are entitled to rely upon this Subscription Agreement and each is irrevocably authorized to produce this Subscription
Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the
matters covered hereby to the extent required by law or by regulatory bodies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
Notwithstanding anything to the contrary in this Subscription Agreement, prior to the Closing, Subscriber may not transfer or assign
all or a portion of its rights and obligations under this Subscription Agreement, other than to one or more of its affiliates without
the prior consent of the Issuer; <I>provided</I> that such transferee or assignee agrees in writing to be bound by and subject to the
terms and conditions of this Subscription Agreement and makes the representations and warranties in <U>Section 5</U>; <I>provided, further</I>,
that, no assignment shall relieve the assigning party of any of its obligations hereunder,. In the event of such a transfer or assignment,
Subscriber shall complete the form of assignment attached as <U>Schedule C</U> hereto. Any attempted transfer or assignment of the rights
and obligations under this Subscription Agreement, other than as set forth in the preceding sentence, will be null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
The Issuer may request from Subscriber such additional information as the Issuer may reasonably deem necessary to evaluate the eligibility
of Subscriber to acquire the Securities and to register the Common Shares and the Conversion Shares for resale, and Subscriber shall
promptly provide such information as may be reasonably requested, to the extent readily available and to the extent consistent with its
internal policies and procedures; <I>provided</I> that the Issuer agrees to keep any such information provided by Subscriber confidential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations
and warranties, both written and oral, among the parties, with respect to the subject matter hereof other than the duties or obligations
as set forth in the other Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of, the parties hereto
and their respective affiliates and their respective heirs, executors, administrators, successors, legal representatives and permitted
assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by,
and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
If any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable,
the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected
or impaired thereby and shall continue in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
This Subscription Agreement may be executed in two (2) or more counterparts (including by electronic means), all of which shall be considered
one and the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being
understood that all parties need not sign the same counterpart.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.
Subject to the requirements of the Lead Investor Agreement, each party shall pay all of its own expenses in connection with this Subscription
Agreement and the transactions contemplated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or telecopied,
sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed
to be given and received (i) when so delivered personally, (ii) upon receipt of an appropriate electronic answerback or confirmation
when so delivered by telecopy (to such number specified below or another number or numbers as such person may subsequently designate
by notice given hereunder), (iii) when sent, with no mail undeliverable, &ldquo;bounceback&rdquo; or other rejection notice, if sent
by email or (iv) five (5) business days after the date of mailing to the address below or to such other address or addresses as such
person may hereafter designate by notice given hereunder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
  to Subscriber, to such address or addresses set forth on the signature page hereto;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
  to the Issuer, to:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualigen
Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5857
Owens Avenue, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlsbad,
California 92008</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Kevin A. Richardson II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
kevin@pridescapital.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
New Jersey 08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Joseph Lucosky, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
jlucosky@lucbro.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l.
This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Subscription Agreement
(whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement
of this Subscription Agreement, shall be governed by and construed in accordance with the laws of the State of New York, without giving
effect to the principles of conflicts of law thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW
YORK, THE SUPREME COURT OF THE STATE OF NEW YORK AND THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA LOCATED IN THE STATE OF NEW YORK
SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO
IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS
A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE
BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY
SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH
ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT
ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS
OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN <U>SECTION 9.m</U> OR IN SUCH OTHER MANNER
AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES
ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I)
NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN
THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE
FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS <U>SECTION 9.m</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m.
The Issuer shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately following the date of this Subscription
Agreement (the &ldquo;<U>Disclosure Time</U>&rdquo;), issue one or more press releases or furnish or file with the Commission a Current
Report on Form 8-K (collectively, the &ldquo;<U>Disclosure Document</U>&rdquo;) disclosing, to the extent not previously publicly disclosed,
all material terms of the transactions contemplated hereby, and any other material, nonpublic information that the Issuer has provided
to Subscriber at any time prior to the filing of the Disclosure Document. From and after the issuance of the Disclosure Document, to
the Issuer&rsquo;s knowledge, Subscriber shall not be in possession of any material, nonpublic information received from the Issuer and
the Placement Agent or any of their respective officers, directors or employees. In addition, unless it has already done so by filing
the Disclosure Document, on or before the fourth (4th) Business Day following the date of this Subscription Agreement, the Issuer shall
file with the SEC a Current Report on Form 8-K disclosing all material terms of the transactions contemplated by this Subscription Agreement.
Notwithstanding anything in this Subscription Agreement to the contrary, the Issuer shall not publicly disclose the name of Subscriber
or any of its affiliates, or include the name of Subscriber or any of its affiliates, without the prior written consent of Subscriber,
(i) in any press release or (ii) in any filing with the Commission or any regulatory agency or trading market, except (A) as required
by the federal securities law in connection with a Registration Statement or (B) to the extent such disclosure is required by law, at
the request of the staff of the Commission or regulatory agency or under the regulations of any Trading Market or by any other governmental
authority with competent jurisdiction, in which case the Issuer shall provide Subscriber with prior written notice of such disclosure
permitted under this clause (ii) and reasonably cooperate with such Subscriber regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.
In any jurisdiction in which an exemption from registration or qualification is not available, the Issuer will cooperate with the Placement
Agent and Subscriber in endeavoring to qualify the Securities for sale under the securities laws of such jurisdictions (United States
and foreign) as the Placement Agent and Subscriber may reasonably request and will make such applications, file such documents, and furnish
such information as may be reasonably required for that purpose, provided the Issuer shall not be required to qualify as a foreign corporation
or to file a general consent to service of process in any jurisdiction where it is not now so qualified or required to file such a consent,
and provided further that the Issuer shall not be required to produce any new disclosure document. The Issuer will, from time to time,
prepare and file such statements, reports and other documents as are or may be required to continue such qualifications in effect for
so long a period as the Placement Agent and Subscriber may reasonably request for distribution of the Securities. The Issuer will advise
the Placement Agent and Subscriber promptly of the suspension of the qualification or registration of (or any such exemption relating
to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose,
and in the event of the issuance of any order suspending such qualification, registration or exemption, the Issuer shall use its best
efforts to obtain the withdrawal thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o.
Certificates or book-entries evidencing the Securities shall not contain any legend (including the legends set forth in <U>Section 3.c(ii)</U>
hereof), (i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following
any sale of such Securities pursuant to Rule 144. The Issuer shall cause its counsel to issue a legal opinion to the Issuer&rsquo;s transfer
agent or the Subscriber promptly after the Effective Date (as defined in the Registration Rights Agreement) if required by the Issuer&rsquo;s
transfer agent to effect the removal of the legend hereunder. If requested, the Issuer shall provide a copy of such legal opinion to
the Issuer&rsquo;s transfer agent to a Subscriber. The Issuer agrees that following the Effective Date or at such time as such legend
is no longer required under this <U>Section 9.p</U>, it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number
of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Subscriber to the Issuer or
the Issuer&rsquo;s transfer agent of a certificate, book entry statement or other instrument representing Securities, as the case may
be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to each
Subscriber a certificate, book entry statement or other instrument representing such Subscriber&rsquo;s Securities that is free from
all restrictive and other legends. The Issuer may not make any notation on its records or give instructions to the Issuer&rsquo;s transfer
agent that enlarge the restrictions on transfer set forth in this <U>Section 9.p</U>. Certificates, book entry statements or other instruments
for Securities subject to legend removal hereunder shall be transmitted by the Issuer&rsquo;s transfer agent to the Investor by crediting
the account of the Issuer&rsquo;s prime broker with the Depository Trust Company System as directed by such Subscriber. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Issuer&rsquo;s
primary Trading Market with respect to the Common Shares as in effect on the date of delivery of Securities issued with a restrictive
legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p.
In addition to such Subscriber&rsquo;s other available remedies, the Issuer shall pay to a Subscriber, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Securities (based on the VWAP of the Common Stock on the Legend Removal Date) for which
the restrictive legend has not been removed pursuant to <U>Section 9.p</U>, $10 per Trading Day (increasing to $20 per Trading Day five
(5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal Date until such certificate or book entry
statement is delivered without a legend and (ii) (a) if the Issuer fails to issue and deliver (or cause to be delivered) to a Subscriber
by the Legend Removal Date a certificate or book entry statement representing the Securities that are free from all restrictive and other
legends and (b) if after the Legend Removal Date such Subscriber purchases (in an open market transaction or otherwise) shares of Common
Stock to deliver in satisfaction of a sale by such Subscriber of all or any portion of the number of Securities, or a sale of a number
of shares of Common Stock equal to all or any portion of the number of Securities that such Subscriber anticipated receiving from the
Issuer without any restrictive legend, then, an amount equal to the excess of such Subscriber&rsquo;s total purchase price (including
brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions
and other out-of-pocket expenses, if any) over the product of (A) such number of Securities that the Issuer was required to deliver to
such Subscriber by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during
the period commencing on the date of the delivery by such Subscriber to the Issuer of the applicable Securities and ending on the date
of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q.
This Subscription Agreement may not be amended, modified, supplemented or waived except by an instrument in writing, signed by the Issuer
and Subscriber; <I>provided</I>, that (i) no provision of this Subscription Agreement that references the Placement Agent may be amended,
modified, terminated or waived in any manner that is adverse to the Placement Agent without the written consent of both Placement Agent
and (ii) any rights (but not obligations) of a party under this Subscription Agreement, other than the provisions referenced in (i),
may be waived, in whole or in part, by such party on its own behalf without the prior consent of any other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">r.
The parties agree that irreparable damage would occur if any provision of this Subscription Agreement were not performed in accordance
with the terms hereof, and accordingly, that the parties hereto shall be entitled to seek an injunction or injunctions to prevent breaches
of this Subscription Agreement or to enforce specifically the performance of the terms and provisions of this Subscription Agreement
in an appropriate court of competent jurisdiction as set forth in <U>Section 9.m</U>, in addition to any other remedy to which any party
is entitled at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">s.
Defined terms herein shall apply equally to the singular and plural forms of the terms defined. The words &ldquo;include,&rdquo; &ldquo;includes&rdquo;
and &ldquo;including&rdquo; shall be deemed to be followed by the phrase &ldquo;without limitation.&rdquo; The word &ldquo;will&rdquo;
shall be construed to have the same meaning and effect as the word &ldquo;shall.&rdquo; Unless the context requires otherwise (i) any
definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument
or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements
or modifications set forth herein), (ii) any reference herein to any Person shall be construed to include such Person&rsquo;s successors
and assigns, (iii) the words &ldquo;herein,&rdquo; &ldquo;hereof&rdquo; and &ldquo;hereunder,&rdquo; and words of similar import, shall
be construed to refer to this Subscription Agreement in its entirety and not to any particular provision hereof, (iv) unless otherwise
noted all references herein to Sections and Schedules shall be construed to refer to Sections of, and Schedules to, this Subscription
Agreement, and (v) any reference to any law or regulation herein shall, unless otherwise specified, refer to such law or regulation as
amended, modified or supplemented from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
pages follow.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each of the Issuer and Subscriber has executed or caused this Subscription Agreement to be executed by its duly
authorized representative as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ISSUER:</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>QualIGEN
    THERAPEUTICS,</B></FONT><B> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INC.</FONT></B></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
    A. Richardson II</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
Page to Subscription Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSCRIBER:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Subscriber:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    of Subscriber:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    in which securities are to be registered (if different):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscriber&rsquo;s
    EIN:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone
    No:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile
    No:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Number of Common Shares subscribed for:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
    Number of Preferred Shares subscribed for:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    Price: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Payment and Purchase Price: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 43%">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    Cash: $ _________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    USDC: _________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    [OTHER]: _______________________________</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
must pay the Purchase Price by wire transfer of United States dollars in immediately available funds to the account specified by the
Issuer in the Closing Notice. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are paying the Purchase Price in Authorized Cryptocurrency, you must pay the total value of each such Authorized Cryptocurrency,
as applicable and set forth on Appendix A, free and clear of any liens, encumbrances or other restrictions, to the Issuer&rsquo;s wallet
address specified in the Closing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
Page to Subscription Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
A</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Form
of Certificate of Designations</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(see
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
B</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Form
of Stockholder Support Agreement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(see
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
C</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Form
of Registration Rights Agreement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(see
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
D</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Key
Stockholders</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
E</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Form
of Lead Investor Agreement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(see
attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
A</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>LIST
AND VALUES OF AUTHORIZED CRYPTOCURRENCIES</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Cryptocurrency</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bitcoin
    (BTC)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,486.60</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ethereum
    (ETH)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,589.57</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XRP
    Ledger (XRP)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Build
    and Build (BNB)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">988.37</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solana
    (SOL)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">248.74</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dogecoin
    (DOGE)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tronix
    (TRX)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cardano
    (ADA)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.93</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chainlink
    (LINK)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.55</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hyperliquid
    (HYPE)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.52</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
B</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>USE
OF PROCEEDS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
C</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>FORM
OF ASSIGNMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Subscription Assignment and Joinder Agreement (this &ldquo;<U>Assignment Agreement</U>&rdquo;), dated September [&#9679;], 2025, is made
and entered into by and between (&ldquo;<U>Subscriber</U>&rdquo;) and (&ldquo;<U>Assignee</U>&rdquo;) and acknowledged by Qualigen Therapeutics,
Inc., a Delaware corporation (the &ldquo;<U>Issuer</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Issuer and Subscriber entered into that certain Subscription Agreement (the &ldquo;<U>Subscription Agreement</U>&rdquo;), dated September
[&#9679;], 2025, pursuant to which Subscriber agreed to subscribe for and purchase shares of the Issuer&rsquo;s Common Stock (the &ldquo;<U>Common
Shares</U>&rdquo;) and/or shares of the Issuer&rsquo;s Series B Convertible Preferred Stock (the &ldquo;<U>Preferred Shares</U>&rdquo;
and, together with the Common Shares, the &ldquo;<U>Securities</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Subscriber and Assignee are affiliated entities; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
for administrative reasons, Subscriber desires to assign its rights to subscribe for and purchase of the Securities along with the rights
and obligations set forth in the Subscription Agreement of such Securities (the &ldquo;<U>Assigned Securities</U>&rdquo;) to Assignee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, pursuant to <U>Section 9.d</U> of the Subscription Agreement, and as further described in the table below, Subscriber
hereby assigns its rights to subscribe for and purchase the Assigned Securities to Assignee and Assignee hereby (i) accepts the rights
to subscribe for and purchase the Assigned Securities and agrees to be bound by and subject to the terms and conditions of the Subscription
Agreement, and (ii) expressly makes the representations and warranties in <U>Section 5</U> of the Subscription Agreement with respect
to the Assigned Securities. Notwithstanding the foregoing, this Assignment Agreement shall not relieve Subscriber of any of its obligations
under the Subscription Agreement. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the
Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following assignment by Subscriber to Assignee of its rights to subscribe for and purchase all or a portion of the Securities have been
made:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of Assignment</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscriber</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignee</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Common Shares and/or Preferred Shares Assigned</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscriber
    Revised Subscription Amount</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignee
    Subscription Amount</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, this Subscription Assignment and Joinder Agreement has been executed by Subscriber and Assignee acknowledged by
the Issuer by its duly authorized representative as of the date set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledgement
by the Issuer:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>QUALIGEN,
    </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INC.</FONT></B></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature
    of Subscriber:</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature
    of Assignee:</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignee&rsquo;s
    EIN: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of September 19, 2025, between Qualigen
Therapeutics, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each
such purchaser, a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Subscription Agreement, dated as of September 19, 2025, between the Company and the Purchasers named
therein (the &ldquo;<U>Subscription Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein that are defined in the Subscription Agreement shall have
the meanings given such terms in the Subscription Agreement. As used in this Agreement, the following terms shall have the following
meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 45<SUP>th</SUP> calendar
day following the Filing Date (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 60th calendar day following the
Filing Date) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c),
the 15<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or,
in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following the date hereof); <U>provided</U>,
<U>however</U>, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will
not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall
be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above,
provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next
succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 45th calendar day following the Closing
Date. With respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), &ldquo;Filing
Date&rdquo; means the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration
Statement related to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) the Common Shares and the Conversion Shares and (b) any securities
issued or then issuable upon any share split, dividend or other distribution, recapitalization or similar event with respect to the foregoing;
<U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be
required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as
(a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the
Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement,
(b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale
without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion
letter of counsel to the Company to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders and
any restrictive legend is removed to permit the delivery of the securities via facilities of the Depositary Trust Company (&ldquo;<U>DTC</U>&rdquo;)
(assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which,
such securities were issued or are issuable, were at no time held by any Affiliate of the Company, as reasonably determined by the Company,
upon the advice of counsel to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Shareholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 or such other appropriate form
in accordance herewith, subject to the provisions of Section 2(e)) and shall contain substantially the &ldquo;<U>Plan of Distribution</U>&rdquo;
attached hereto as <U>Annex A</U> and substantially the &ldquo;<U>Selling Shareholder</U>&rdquo; section attached hereto as <U>Annex
B</U>; <U>provided</U>, <U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s
express prior written consent. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration
Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities
Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use
its best efforts to keep such Registration Statement continuously effective under the Securities Act, and to be supplemented and amended
to the extent necessary to ensure that such Registration Statement is available or, if not available, that another Registration Statement
is available, for the resale of all the Registrable Securities held by the Holders until the date that all Registrable Securities covered
by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale
restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information
requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed
and acceptable to the Transfer Agent and the affected Holders and any restrictive legend is removed to permit the delivery of the securities
via the facilities of DTC (the &ldquo;Effectiveness Period&rdquo;). The Company shall telephonically request effectiveness of a Registration
Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via facsimile or by
e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness
with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m.
(New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission
as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure
to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d). When effective, a Registration Statement filed pursuant
to this Section 2(a) (including the documents incorporated therein by reference) will comply as to form in all material respects with
all applicable requirements of the Securities Act and the Exchange Act and will not contain an untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the
provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the
Registrable Securities in accordance with the SEC Guidance, including without limitation, Securities Act Rules Compliance and Disclosure
Interpretation Question 612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the
Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission
for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its
Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Second, the Company shall reduce Registrable Securities represented by Common Shares and Conversion Shares (applied, in the case that
some Shares and Conversion Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Shares
and Conversion Shares held by such Holders).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company
shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration
of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5)
Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration
Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective date of a Registration
Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in
respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that
such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering
for resale all of the Registrable Securities, subject to the cutback limitations set forth in Section 2(c) of this Agreement, is not
declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date
of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable
Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell
such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days
(which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such
five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded,
and for purpose of clause (iv) the date on which such five (5) or ten (10) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured to the reasonable satisfaction of the Holder, the Company shall pay to each Holder an
amount in cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure. If the Company fails to
pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest
thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing
daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The
partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the
cure of an Event. The Company shall provide written notice to each Holder of the occurrence of any Event (including the applicable Event
Date) within one (1) business day after becoming aware of such Event. For the avoidance of doubt, the time limitations set forth in this
clause (iv) shall apply notwithstanding the Company&rsquo;s rights under Section 3(k), and any suspension of the availability of a Registration
Statement or Prospectus permitted under Section 3(k) shall be included in calculating the periods set forth in this clause (iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company shall register the resale of the Registrable Securities on Form S-3 under the Securities Act (or in the event that the Company
is ineligible to use such form, such other form as the Company is eligible to use under the Securities Act provided that such other form
shall be converted into an S-3 as soon as Form S-3 becomes available to the Company), provided that the Company shall maintain and effectiveness
of and update as required the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering
the Registrable Securities has been declared effective by the Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any Underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Registration
Procedures</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to
the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C
</U>(a &ldquo;<U>Selling Shareholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing
Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries and the Company agrees that the Holders shall not have any duty of confidentiality to
the Company or any of its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis
of such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and
any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting
a filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company
shall pay the filing fee required by such filing within two (2) Business Days of receipt of a request therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Subscription Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and
registered in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section
3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall
suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly
as is practicable. The Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration
Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 30 consecutive calendar days or a total of 60 calendar days (which need not be consecutive days) in any 12-month period.
For the avoidance of doubt, the time period set forth in Section 2(d)(v) shall run concurrently with any suspension period permitted
by this Section 3(k), and the Company&rsquo;s rights under this Section 3(k) shall not be construed to extend or otherwise modify the
limitations in Section 2(d)(v).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing
if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company shall use its reasonable best efforts to obtain and maintain eligibility for use of Form S-3 (or any successor form thereto)
for the registration of the resale of the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control
over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of
the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Registration Expenses</U>. All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall
be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses
referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with
the Commission, (B) with respect to filings required to be made with any Trading Market on which the shares of Common Stock are then
listed for trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing
(including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions
of the Registrable Securities), and (D) if not previously paid by the Company with respect to any filing that may be required to be made
by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long
as the broker is receiving no more than a customary brokerage commission in connection with such sale, (ii) printing expenses (including,
without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses,
(iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance,
and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated
by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees
performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing
of the Registrable Securities on any securities exchange as required hereunder. The Company shall also be responsible for all reasonable
and documented legal fees and disbursements of one counsel incurred by the Holders in connection with the consummation of the transactions
contemplated by this Agreement. In no event shall the Company be responsible for any broker or similar commissions of any Holder or,
except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call), investment advisors and employees (and any other
Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act) and the officers, directors, members, shareholders, partners, agents and employees (and any other Persons with a functionally
equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person,
to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred in investigating,
preparing or defending against any litigation, commence or threatened, or any claim, arising out of or relating to (1) any untrue or
alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance
of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are
based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or
to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable Securities
and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in
any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the
case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or
otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or
otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(c). The
Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with
the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by
any of the Holders in accordance with Section 6(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading, but only to the extent, and only if, such untrue statement or omission results from such
Holder&rsquo;s negligence, bad faith, or knowing inaccuracy, is material, and (i) to the extent, but only to the extent, that such untrue
statement or omission is contained in any information at the time made so furnished in writing by such Holder to the Company expressly
for inclusion in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such information
at the time made relates to such Holder&rsquo;s information provided in the Selling Shareholder Questionnaire or the proposed method
of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration
Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or in any amendment or
supplement thereto; provided, however, that the Holder shall have no liability hereunder for any inaccuracy or omission that is immaterial.
In no event shall the aggregate liability of a selling Holder for all claims arising out of or relating to any offering of Registrable
Securities pursuant to such Registration Statement exceed the total dollar amount of proceeds received by such Holder from the sale of
such Registrable Securities in such offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Remedies</U>. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising
such right or remedy, shall not operate as a waiver thereof. In the event of a breach by the Company or by a Holder of any of their respective
obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights
granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under
this Agreement (without the necessity of showing economic loss and without any bond or other security being required). Each of the Company
and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by
it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in
respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities
are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall
not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new
securities are registered on any such existing registration statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Piggy Back Registrations</U>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering
all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating
to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to the Holder a written notice of such determination and, if within
fifteen (15) days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include
in such registration statement all or any part of such Registrable Securities such Holder requests to be registered; <U>provided</U>,
<U>however</U>, that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(d) that are
eligible for resale pursuant to Rule 144 (without volume restrictions or current public information requirements) promulgated by the
Commission pursuant to the Securities Act or that are the subject of a then effective Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the prior written consent of such disproportionately
impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities
pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered
for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable
Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger, subject to any successor
entity assuming in writing all of the obligations of the Company under this Agreement) its rights or obligations hereunder without the
prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights
hereunder in the manner and to the Persons as permitted under Section 5.7 of the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with
respect to any of its securities to any Person that have not been satisfied in full.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or DocuSign, such signature shall create a valid
and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such
facsimile or &ldquo;.pdf&rdquo; or DocuSign signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint
with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Further Acts</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents as any other party may reasonably request in order
to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Material Non-Public Information</U>. The Company acknowledges and agrees that, upon the effectiveness of the Registration Statement
and the public disclosure of the transactions contemplated hereby, all material, non-public information previously provided to any Holder
or its representatives in connection with the transactions contemplated by this Agreement (if any) shall be deemed disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUALIGEN THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware Corporation</FONT></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">By:</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Name:</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
    A. Richardson II</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Title:</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Registration Rights Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO qualigen therapeutics, inc., RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Plan
of Distribution</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the shares of common stock previously issued, to permit the resale of these shares of common stock by the holders of
the common stock from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling
stockholders of the shares of common stock. We will bear all fees and expenses incident to our obligation to register the shares of common
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby from time
to time directly or through one or more underwriters, broker-dealers or agents. If the shares of common stock are sold through underwriters
or broker-dealers, the selling stockholders will be responsible for underwriting discounts or commissions or agent&rsquo;s commissions.
The shares of common stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale,
at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve
crosses or block transactions,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the over-the-counter market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions otherwise than on these exchanges or systems or in the over-the-counter market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing of options, whether such options are listed on an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as
    principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">short
    sales;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>sales
    pursuant to Rule 144; broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated
    price per share; <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top"><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the selling stockholders effect such transactions by selling shares of common stock to or through underwriters, broker-dealers or agents,
such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling
stockholders or commissions from purchasers of the shares of common stock for whom they may act as agent or to whom they may sell as
principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those
customary in the types of transactions involved). In connection with sales of the shares of common stock or otherwise, the selling stockholders
may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of common stock in the
course of hedging in positions they assume. The selling stockholders may also sell shares of common stock short and deliver shares of
common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales.
The selling stockholders may also loan or pledge shares of common stock to broker-dealers that in turn may sell such shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock
from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision
of the Securities Act of 1933, as amended, amending, if necessary, the list of selling stockholders to include the pledgee, transferee
or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate
the shares of common stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will
be the selling beneficial owners for purposes of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, a selling stockholder that is an entity may elect to make an in-kind distribution of securities to its members, partners or
stockholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus with a plan of distribution.
Such members, partners or stockholders would thereby receive freely tradeable securities pursuant to the distribution through a registration
statement. To the extent a distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus
supplement in order to permit the distributees to use the prospectus to resell the securities acquired in the distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders and any broker-dealer participating in the distribution of the shares of common stock may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act, and any commission paid, or any discounts or concessions allowed to, any such broker-dealer
may be deemed to be underwriting commissions or discounts under the Securities Act. At the time a particular offering of the shares of
common stock is made, a prospectus supplement, if required, will be distributed which will set forth the aggregate amount of shares of
common stock being offered and the terms of the offering, including the name or names of any broker-dealers or agents, any discounts,
commissions and other terms constituting compensation from the selling stockholders and any discounts, commissions or concessions allowed
or reallowed or paid to broker-dealers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the securities laws of some states, the shares of common stock may be sold in such states only through registered or licensed brokers
or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified
for sale in such state or an exemption from registration or qualification is available and is complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the registration
statement, of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders and any other person participating in such distribution will be subject to applicable provisions of the Securities
Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange
Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling stockholders and any other
participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of common stock
to engage in market-making activities with respect to the shares of common stock. All of the foregoing may affect the marketability of
the shares of common stock and the ability of any person or entity to engage in market-making activities with respect to the shares of
common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay all expenses of the registration of the shares of common stock pursuant to the registration rights agreement, estimated to be
$[ ] in total, including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state securities
or &ldquo;blue sky&rdquo; laws; provided, however, that a selling stockholder will pay all underwriting discounts and selling commissions,
if any. We will indemnify the selling stockholders against liabilities, including some liabilities under the Securities Act, in accordance
with the registration rights agreements, or the selling stockholders will be entitled to contribution. We may be indemnified by the selling
stockholders against civil liabilities, including liabilities under the Securities Act, that may arise from any written information furnished
to us by the selling stockholder specifically for use in this prospectus, in accordance with the related registration rights agreement,
or we may be entitled to contribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
sold under the registration statement, of which this prospectus forms a part, the shares of common stock will be freely tradable in the
hands of persons other than our affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SELLING
SHAREHOLDERS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable
to the selling shareholders upon conversion of the Preferred Shares. For additional information regarding the issuances of those shares
of Common Stock and Conversion Shares, see &ldquo;Private Placement&rdquo; in the Subscription Agreement. We are registering the shares
of Common Stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership
of the shares of Common Stock, Preferred Shares, and Conversion Shares the selling shareholders have not had any material relationship
with us within the past three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of Common Stock by
each of the selling shareholders. The second column lists the number of shares of Common Stock beneficially owned by each selling shareholder,
based on its ownership of the shares of Common Stock and Conversion Shares, as of ________, 2025, assuming conversion of the Preferred
Shares held by the selling shareholder on that date, without regard to any limitations on conversions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of Common Stock being offered by this prospectus by the selling shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale
of the sum of the number of shares of Common Stock issued to the selling shareholders in the &ldquo;Private Placement&rdquo; described
in the Subscription Agreement. The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to
this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Selling Shareholder</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares of Common Stock Owned Prior to Offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 24%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Tmes, Serif; font-size: 10pt"><B>Maximum Number <BR> of shares of Common Stock</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be Sold Pursuant to this</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of shares <BR>
    of Common Stock Owned After <BR>
    Offering</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>QUALIGEN
THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
Shareholder Notice and Questionnaire</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUALIGEN
THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDER NOTICE AND QUESTIONNAIRE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
Address: Qualigen Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt">5857 Owens Avenue, Suite 300,
Carlsbad, California 92008</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder of shares of common stock of Qualigen Therapeutics, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;) understands that
the Company intends to file with the Securities and Exchange Commission a registration statement on Form S-3 (the &ldquo;<B><I>Registration
Statement</I></B>&rdquo;) for the registration and the resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities
Act</I></B>&rdquo;), of the Registrable Securities in accordance with the terms of the Subscription Agreement, dated September
19, 2025, by and among the Company and the several signatories thereto (the &ldquo;<B><I>Subscription</I></B><B><I> Agreement</I></B>&rdquo;).
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to sell or otherwise dispose of any Registrable Securities pursuant to the Registration Statement, a holder of Registrable Securities
generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as so supplemented,
the &ldquo;<B><I>Prospectus</I></B>&rdquo;) and deliver the Prospectus to purchasers of Registrable Securities (including pursuant to
Rule 172 under the Securities Act). Holders must complete and deliver this notice and questionnaire (&ldquo;<B><I>Notice and Questionnaire</I></B>&rdquo;)
in order to be named as selling stockholders in the Prospectus. Certain legal consequences arise from being named as a selling stockholder
in the Registration Statement and the Prospectus. Holders of Registrable Securities are advised to consult their own securities law counsel
regarding the consequences of being named or not named as a selling stockholder in the Registration Statement and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder (the &ldquo;<B><I>Selling Stockholder</I></B>&rdquo;) of Registrable Securities hereby gives notice to the Company
of its intention to sell or otherwise dispose of Registrable Securities owned by it and listed below in Item 3(b) pursuant to the Registration
Statement. The undersigned, by signing and returning this Notice and Questionnaire, understands and agrees that it will be bound by the
terms and conditions of this Notice and Questionnaire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is materially
accurate and complete:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUESTIONNAIRE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
legal name of the Selling Stockholder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
legal name of the registered holder (if not the same as Item 1(a) above) through which the Registrable Securities listed in Item (3)
below are held:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
legal name of any natural control person (which means a natural person who directly or indirectly alone or with others has power to vote
or dispose of the Registrable Securities listed in Item (3) below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices
  to Selling Stockholder:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
  person:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
address of contact person: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
  Ownership of Registrable Securities:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
and number of Registrable Securities beneficially owned:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>


<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of shares of Common Stock to be registered for resale pursuant to this Notice and Questionnaire:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker-Dealer
  Status:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
you a broker-dealer?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you answered &ldquo;yes&rdquo; to Item 4(a) above, did you receive your Registrable Securities as compensation for investment banking
services provided to the Company?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Note:
If you answered &ldquo;no&rdquo;, the SEC&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration
Statement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
you an affiliate of a broker-dealer?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you answered &ldquo;yes&rdquo;, provide a narrative explanation below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business,
and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly,
with any person to distribute the Registrable Securities?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Note:
If you answered &ldquo;no&rdquo;, the SEC&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration
Statement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
  Ownership of Other Securities of the Company Owned by the Selling Stockholder:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company, other
than the Registrable Securities listed above in Item 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
and amount of other securities beneficially owned:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationships
  with the Company:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
you or any of your affiliates, officers, directors or principal equity holders (owners of 5% or more of the equity securities of the
undersigned) held any position or office or have you had any other material relationship with the Company (or its predecessors or affiliates)
within the past three years?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your response to Item 6(a) above is &ldquo;yes&rdquo;, please state the nature and duration of your relationship with the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan
  of Distribution:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned has reviewed the form of Plan of Distribution attached as <U>Annex A</U> hereto, and hereby confirms that, except as set
forth below, the information contained therein regarding the undersigned and its plan of distribution is correct and complete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
any exceptions here:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                                                                                                                                                     </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned acknowledges that the Securities Act and the rules and regulations promulgated thereunder may require the undersigned to
promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof
and for so long as the undersigned holds Registrable Securities (as defined in the Registration Rights Agreement). In the absence of
any such notification, the Company shall be entitled to continue to rely on the accuracy of the information in this Notice and Questionnaire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 7 above
and the inclusion of such information in the Registration Statement and the Prospectus. The undersigned understands that such information
will be relied upon by the Company in connection with the preparation or amendment of any such Registration Statement and Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with the provisions
of the Exchange Act and the rules and regulations thereunder, particularly Regulation M in connection with any offering of Registrable
Securities pursuant to the Registration Statement. The undersigned also acknowledges that it understands that the answers to this Notice
and Questionnaire are furnished for use in connection with registration statements filed pursuant to the Subscription Agreement
and any amendments or supplements thereto filed with the SEC pursuant to the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned confirms that, to the best of his/her knowledge and belief, the foregoing answers to this Notice and Questionnaire are correct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Owner:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Entity</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 12%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 38%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ex10-3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEAD
INVESTOR AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
LEAD INVESTOR AGREEMENT</B> (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of September 19, 2025 (the
&ldquo;<U>Effective Date</U>&rdquo;) by and among Qualigen Therapeutics, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and Faraday Future Intelligent Electric Inc., a Delaware corporation (the &ldquo;<U>Lead Investor</U>&rdquo;). The Company and the Lead
Investor are collectively referred to herein as the &ldquo;<U>Parties</U>&rdquo; and each, a &ldquo;<U>Party</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company wishes to secure the commitment of the Lead Investor in a private offering (the &ldquo;<U>Private Placement</U>&rdquo;) of
shares of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), and shares of the Company&rsquo;s
Series B Convertible Preferred Stock, par value $0.001 per share (the &ldquo;<U>Preferred Stock</U>&rdquo;), to be issued and sold pursuant
to that certain subscription agreement, dated on or about the date hereof, between the Company and each of the purchasers identified
in the signature pages thereto (each, a &ldquo;<U>Subscription</U><U> Agreement</U>&rdquo; and, collectively, the &ldquo;Subscription
Agreements&rdquo;), and the Lead Investor wishes to offer such a commitment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Subscription Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the commitment of the Lead Investor to invest a minimum of $30 million in the Private Placement
and of the other covenants and undertakings specified herein, the Company and the Lead Investor hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Corporate
                                            Governance</U>.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1 <U>Treasury
Reserve Policy</U>. Effective upon the Closing, the Company shall adopt a treasury reserve policy that is satisfactory to the Lead Investor
(the &ldquo;<U>Treasury Reserve Policy</U>&rdquo;), under which the Company&rsquo;s treasury reserve assets will consist of (i) cash
and cash equivalents and short-term investments (&ldquo;<U>Cash Assets</U>&rdquo;) that exceed working capital requirements and (ii)
cryptocurrencies which will serve as the primary treasury reserve asset of the Company on an ongoing basis, subject to market conditions
and anticipated needs of the business for Cash Assets and oversight by the FF-Appointed Co-Chief Executive Officer (as defined below).
Prior to the appointment of the initial Director Designees (as defined below) to the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;),
the Treasury Reserve Policy shall not be amended, modified or waived without the prior written consent of Co-Chief Executive Officer.
After the appointment of the initial Director Designees to the Board, the Treasury Reserve Policy shall only be amended by vote of the
Board, which shall include the affirmative votes of each of the Director Designees or their successors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2 <U>Company
Board Representation and Management</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Concurrent with the Closing, the Company shall cause the Board to reduce the size of the Board to five members and request the resignations
of each of Campbell Becher, Robert B. Lim and Cody Price from the Board. In addition, concurrently with the Closing, each
of Jie Sheng and Chad Chen, as the initial Investor Designees, shall be appointed as directors of the Company effective upon the Closing
of the Private Placement to fill two of the vacancies created by such director resignations. Upon the Company&rsquo;s receipt of Stockholder
Approval following the Closing, the Company shall cause the Board to appoint, within five (5) Business Days of the Company&rsquo;s receipt
of a written request of the Lead Investor for the Board to do so, up to two (2) additional Investor Designees for appointment to the
Board, so that the total size of the Board shall be seven (7) members, unless otherwise requested in writing by the Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) From
and after the Closing Date, so long as the Lead Investor (and its Affiliates or any &ldquo;group&rdquo; of which the Lead Investor or
any of its Affiliates is a member) continues to beneficially own (as calculated in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder) at least 5% of the Company&rsquo;s beneficial ownership (voting rights) of the
Common Stock (the &ldquo;<U>Minimum Threshold</U>&rdquo;), except as otherwise required by applicable law, the Lead Investor shall have
the right to designate as nominees for election to the Board a number of directors that is proportionate to its beneficial ownership,
with any fraction rounded up (for example, if the Lead Investor has a 30% voting right and the Board is comprised of five members, the
Lead Investor will have the right to appoint 30%*5=1.5, round up to 2 directors), one of whom shall also be chairperson of the Board
(such nominees, the &ldquo;Investor Designees&rdquo;); <U>provided</U>, <U>however,</U> that in the event that Lead Investor ceases to
beneficially own a number of shares of Common Stock at least equal to the Minimum Threshold a result of a transaction entered into by
the Lead Investor to facilitate a Company financing (including, without limitation, (x) the implementation or enforcement of a pledge
of shares of Common Stock granted by the Lead Investor in favor of an investor in the Company or (y) the sale of Common Stock by the
Lead Investor to raise cash to pay amounts owed under a guarantee entered into by the Lead Investor for the benefit of the Company) (a
&ldquo;Financing Facilitation Transaction&rdquo;), the Lead Investor shall nonetheless be deemed to continue to hold the Minimum Threshold
until the Lead Investor disposes of additional shares in a transaction (other than a Financing Facilitation Transaction) following which
the Lead Investor does not beneficially own a number of shares of Common Stock at least equal to the Minimum Threshold. The Company agrees
to use its reasonable best efforts to take the Necessary Action (as defined below) to cause the Investor Designees to be elected to the
Board. Upon appointment or election, as applicable, to the Board, such Investor Designees shall be entitled to insurance coverage reasonable
satisfactory to the Lead Investor applicable to directors and officers. In the event that a vacancy is created at any time by the death,
disability, retirement, disqualification, resignation or removal (with or without cause) of any of the Investor Designees, the Lead Investor
shall have the right to designate a replacement to fill such vacancy and the Company shall take the Necessary Action to cause such vacancy
to be filled by the replacement so designated and the Board shall promptly elect such designee to the Board. The Lead Investor has the
right, at any time and from time to time, to request the removal or resignation any Investor Designee, and the Lead Investor has the
exclusive right to designate a replacement to fill any vacancy so created by such removal or resignation of such Investor Designee. The
Company shall use its reasonable best efforts to take or cause to be taken, to the fullest extent permitted by law, at any time and from
time to time, all Necessary Action to facilitate the removal of any of the Investor Designee that the Lead Investor intends to remove.
&ldquo;Necessary Action&rdquo; means, with respect to any party and a specified result, all actions (to the extent such actions are not
prohibited by applicable law, are within such party&rsquo;s control and do not directly conflict with any rights expressly granted to
such party in this Agreement or the certificate of incorporation or bylaws of the Company) reasonably necessary and desirable within
his, her or its control to cause such result, including, (i) promptly calling special meetings of the Board, any committee of the Board
and the stockholders of the Company, and (including with respect to the Company&rsquo;s obligations pursuant to Section 1.2 (b)) recommending
that stockholders vote (and soliciting proxies in a commercially reasonable manner) (x) in favor of the election to the Board of each
Investor Designee, and (y) in favor of the removal of any Investor Designee in respect of whom the Lead Investor delivered a removal
notice at all stockholder meetings, (ii) causing the Board or any committee of the Board to adopt relevant resolutions (subject to any
applicable fiduciary duties), (iii) voting or providing a proxy with respect to shares of Common Stock and other securities of the Company
generally entitled to vote in the election of directors of the Company Beneficially Owned by such party, (iv) causing the adoption of
stockholders&rsquo; resolutions and amendments to the certificate of incorporation or the bylaws of the Company, including executing
written consents in lieu of meetings, (v) executing agreements and instruments, (vi) causing members of the Board (to the extent such
members were elected, nominated or designated by the party obligated to undertake such action) to act (subject to any applicable fiduciary
duties) in a certain manner or causing them to be removed in the event they do not act in such a manner and (vii) making, or causing
to be made, with governmental, administrative or regulatory authorities, all filings, registrations or similar actions that are required
to achieve such a result</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) In
the event that any Investor Designee designated by the Lead Investor to stand for election (or re-election, as the case may be) at a
meeting of the Company&rsquo;s stockholders is, for any reason, not elected to serve on the Board at such meeting (any such person designated
by the Lead Investor but not so elected, a &ldquo;Non-Elected Designee&rdquo;), the Company shall, if the Lead Investor so requests in
writing, promptly expand the size of the Board by a number of seats equal to the number of Non-Elected Designees (an &ldquo;<U>Designee
Board Expansion</U>&rdquo;) and the Lead Investor shall have the exclusive right to fill the vacancy or vacancies on the Board created
by the Designee Board Expansion with new Investor Designees in accordance with Section 1.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Concurrent
with the Closing, the Company shall cause the Board to appoint Jiawei Wang (or such other person as the Lead Investor shall designate
prior to the Closing) as the Co-Chief Executive Officer of the Company (the &ldquo;FF-Appointed Co-Chief Executive Officer&rdquo;), effective
upon the Closing, and to appoint Koti Meka (or such other person as the Lead Investor shall designate prior to the Closing) as the Chief
Financial Officer of the Company, effective upon the Closing. The FF-Appointed Co-Chief Executive Officer shall report to the Board together
with the current Chief Executive Officer of the Company, and the FF-Appointed Co-Chief Executive Officer shall be solely responsible
for all business operations of the Company, including crypto-related businesses, except for the Company&rsquo;s medical-related business.
The FF-Appointed Co-Chief Executive Officer shall have sole access to all crypto-related accounts of the Company. Within the 30-day period
immediately following the Closing, the Company negotiate and, use commercially reasonable efforts to enter into, an advisory agreement
on terms reasonably acceptable to the Lead Investor appointing Mr. YT Jia as Chief Advisor to the Company. In such capacity, Mr. Jia
will provide strategic advisory services to the Board and the Company, including without limitation, in the areas of product, artificial
intelligence, user-ecosystem development, corporate strategy, human resources, and company management system design and implementation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Each
individual designated by the Lead Investor as an Investor Designee, including Non-Elected Designee, shall, at the time of such designation
and his or her appointment or election to the Board, meet the requirements for an &ldquo;independent&rdquo; director under the rules
of the Trading Market. Upon election to the Board, each Investor Designee shall be appointed as a member of the Audit Committee, the
Compensation Committee and the Nominating and Corporate Governance Committee of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Subject
to applicable law, no Investor Designee shall be obligated to present any particular business opportunity to the Company that he or she
becomes aware of by virtue of his or her position as an officer or employee of the Lead Investor or its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Any
election by the Lead Investor not to exercise (in whole or in part) the right to designate one or more Investor Designees pursuant to
this <U>Section 1.2</U> shall not constitute a permanent waiver or relinquishment of such right. If the Lead Investor elects not to exercise
its right to designate an Investor Designee pursuant to this <U>Section 1.2</U>, the Company shall have no right to fill such vacancy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) The
Lead Investor shall, and shall cause the Investor Designees to, use reasonable best efforts to timely provide the Company with accurate
and complete information relating to the Lead Investor and the Investor Designees, as the case may be, that may be required to be disclosed
by the Company under the Securities Act or the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Company shall not recommend to its stockholders or to the Board any amendment to the Company&rsquo;s organizational documents that would
alter or modify in an adverse manner the Lead Investor&rsquo;s rights under this <U>Section 1.2</U> without the written approval of the
Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3 <U>Lead
Investor Observer Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) In
the event that (x) the Lead Investor&rsquo;s beneficial ownership falls below the Minimum Threshold, such that it is no longer entitled
to nominate the Investor Designees pursuant to Section 1.2 or (y) either of the Investor Designees is not a current member of the Board
(for any or no reason), the Lead Investor shall be entitled to invite a representative of the Lead Investor (the &ldquo;<U>Faraday Observer</U>&rdquo;)
to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all
notices, minutes, consents, and other materials that it provides to the Board; <U>provided</U>, <U>however</U>, that such representative
shall agree to hold in confidence all information so provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4 The
Company shall not recommend to its stockholders or to the Board any amendment to the Company&rsquo;s organizational documents that would
alter or modify in an adverse manner any of the Lead Investor&rsquo;s rights under this Agreement, including but not limited to the Lead
Investor&rsquo;s rights under Sections 1.1, 1.2 and 1.3, without the written approval of the Lead Investor. The Company shall take all
actions within its power to cause the composition and powers of the Board and its committees to at all times satisfy and be subject to
the requirements of applicable law (including the rules of Nasdaq), this Agreement and the Company&rsquo;s organizational documents,
as amended from time to time. For the avoidance of doubt, nothing in this <U>Section 1.4</U> shall restrict or limit the Company&rsquo;s
ability to amend its organizational documents from time to time in accordance with their terms and applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 As
used in this <U>Section 1</U>, the term &ldquo;<U>applicable law</U>&rdquo; shall mean all applicable laws (including common law), statutes,
treaties, codes, ordinances, decrees, rules, regulations, directives or other legal requirements (including those of the SEC, the Nasdaq
and any other securities exchange and securities commission in any jurisdiction) issued, enacted, adopted, promulgated or implemented
by any governmental authority, binding or affecting the person referred to in the context in which such word is used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Participation
                                            in Future Financing. </U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 From
the Closing Date until the date the Lead Investor&rsquo;s beneficial ownership of Common Stock falls below the Minimum Threshold, upon
any issuance by the Company or any of its Subsidiaries of Common Stock, Common Stock Equivalents for cash consideration, indebtedness
or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;), the Lead Investor shall have the right to participate
in such Subsequent Financing up to an amount of the Subsequent Financing equal to the percentage of the Lead Investor&rsquo;s beneficial
ownership percentage of the Common Stock on the date of closing of such Subsequent Financing on the same terms, conditions and price
provided for in the Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2 At
least twenty (20) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver the Lead Investor a written
notice of its intention to effect a Subsequent Financing (&ldquo;<U>Pre-Notice</U>&rdquo;), which Pre-Notice shall ask the Lead Investor
if it wants to review the details of such financing (such additional notice, a &ldquo;<U>Subsequent Financing Notice</U>&rdquo;). Upon
the request of the Lead Investor, and only upon the request of the Lead Investor, for a Subsequent Financing Notice, the Company shall
promptly, but no later than one (1) Trading Day after such request, deliver a Subsequent Financing Notice to the Lead Investor. The Subsequent
Financing Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended
to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall
include a term sheet or similar document relating thereto as an attachment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3 The
Lead Investor must provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the fifteenth (15) Trading
Day after the Lead Investor has received the Pre-Notice that the Lead Investor is willing to participate in the Subsequent Financing,
the amount of the Lead Investor&rsquo;s participation, and representing and warranting that the Lead Investor has such funds ready, willing,
and available for investment on the terms set forth in the Subsequent Financing Notice. If the Company receives no such notice from the
Lead Investor as of such fifteen (15) Trading Day, the Lead Investor shall be deemed to have notified the Company that it does not elect
to participate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4 The
Company must provide the Lead Investor with a second Subsequent Financing Notice, and the Lead Investor will again have the right of
participation set forth above in this Section 2, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not
consummated for any reason on the terms set forth in such Subsequent Financing Notice within thirty (30) Trading Days after the date
of the initial Subsequent Financing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 The
Company and the Lead Investor agree that if the Lead Investor elects to participate in the Subsequent Financing, the transaction documents
related to the Subsequent Financing shall not include any term or provision whereby the Lead Investor shall be required to agree to any
restrictions on trading as to any of the Securities purchased in the Private Placement or be required to consent to any amendment to
or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written consent
of the Lead Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6 Notwithstanding
anything to the contrary in this Section 2 and unless otherwise agreed to by the Lead Investor, the Company shall either confirm in writing
to the Lead Investor that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its
intention to issue the securities in the Subsequent Financing, in either case in such a manner such that the Lead Investor will not be
in possession of any material, non-public information, by the tenth (10th) Trading Day following delivery of the Subsequent Financing
Notice. If by such tenth (10th) Trading Day, no public disclosure regarding a transaction with respect to the Subsequent Financing has
been made, and no notice regarding the abandonment of such transaction has been received by the Lead Investor, such transaction shall
be deemed to have been abandoned and the Lead Investor shall not be deemed to be in possession of any material, non-public information
with respect to the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
Notwithstanding the foregoing, this Section 2 shall not apply in respect of the issuance of (a) shares of Common Stock or options to
employees, officers, directors or consultants of the Company pursuant to the Company&rsquo;s existing stock option and/or restricted
stock plans or stock option and/or restricted stock plans which may come into effect following the date hereof, (b) securities upon the
exercise or exchange of or conversion of any Securities issued under the Subscription Agreements and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock, issued and outstanding on the date of this Agreement, or
pursuant to other agreements of the Company existing prior to the date hereof and listed on the Disclosure Schedules, provided that such
securities and/or agreements have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities, and (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, but shall not include a transaction in which the Company
is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Transition
                                            Period</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date of the Closing until the date of that the Company receives the Stockholder Approval, the Company shall effect each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 The
Company shall maintain a bank account (the &ldquo;<U>Bank Account</U>&rdquo;) under the sole control of an individual designated by the
Company&rsquo;s Chief Financial Officer. Any disbursements or payments from the Bank Account may only be made with the prior written
approval of (i) the Chief Financial Officer or (ii) any person designated in writing by the Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2 The
Company shall not appoint or remove any officers without the prior written approval of the Board, which approval shall include at least
one (1) of the Investor Designees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3 Any
business affairs of the Company that exist prior to the date of the Closing shall continue to be managed by the current Chief Executive
Officer of the Company, Kevin A. Richardson II. However, any new business affairs of the Company that arise on or after the date of the
Closing shall be managed by the FF-Appointed Co-Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4 The
Company may not enter into any agreements without the prior written approval of the FF-Appointed Co-Chief Executive Officer. The FF-Appointed
Co-Chief Executive Officer shall be the sole individual authorized to execute such agreements on behalf of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reimbursement
                                            of Expenses</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party shall pay all of its own expenses in connection with the Private Placement and the transactions contemplated by the Subscription
Agreements; provided, however, that the Company shall reimburse the Lead Investor, initially at the Closing, for its legal, accounting
and other professional fees and expenses incurred in connection with the Private Placement and such transactions, up to a maximum amount
equal to $500,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination</U>.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Lead Investor may terminate this Agreement upon five (5) days&rsquo; written notice of termination to the Company. Termination of this
Agreement will not relieve any Party of its obligations hereunder accruing prior to such termination. Each Party will diligently continue
to perform its obligations hereunder through the date of termination even if it has received notice of the other Party&rsquo;s election
to terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Representations
                                            and Warranties</U>.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1 <U>Mutual
Representations</U>. Each Party represents and warrants to each other that: (a) it has the full right, power, and authority to enter
into and perform its obligations under this Agreement; and (b) its performance under this Agreement will not violate any applicable laws
or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2 <U>Disclaimer</U>.
Except as expressly set forth in this Agreement, the Lead Investor makes no warranties, express or implied, including any warranties
of merchantability, fitness for a particular purpose, or non-infringement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U>.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1 <U>Notices</U>.
Any notice or approval required or permitted under this Agreement will be in writing and will be sent by registered or certified mail,
postage prepaid, or by email, to the addresses designated by prior written notice. Any notice sent by (i) mail will be deemed received
three (3) business days after its mailing and (ii) email will be deemed received on the day of its sending.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2 <U>Entire
Agreement</U>. This Agreement contains the entire understanding of the Parties regarding all matters contained herein, and supersedes
all prior oral or written agreements, arrangements and understandings relating thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3 <U>Amendment</U>.
This Agreement may be amended only by a writing signed by each of the Parties. The failure by any Party to enforce compliance with any
provision of this Agreement by any other Party will not operate or be construed as a waiver of such provision or of any other provision
of this Agreement, or of any subsequent breach by such Party of a provision of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4 <U>Severability</U>.
If any provision of this Agreement is determined to be invalid, illegal or unenforceable in any respect, all other provisions hereof
will continue in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Applicable
                                            Law; Dispute Resolution</U></B>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall be governed by and construed in accordance with the laws of New York, without regard to its conflicts of law principles.
Any dispute arising between the parties out of or in connection with this Agreement will be finally resolved in state or federal court
in New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties have executed this Agreement effective as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Qualigen Therapeutics, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin Richardson</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Faraday Future Intelligent Electric Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiawei Wang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>7
<FILENAME>ex10-4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAPITAL
MARKET ADVISORY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
AGREEMENT, dated as September 18, 2025, between Qualigen Therapeutics Inc (the &ldquo;Company&rdquo;), having its principal place of
business at 5857 Owens Avenue, Suite 300, Carlsbad, California 92008 and About Investment Pte. Ltd. (&ldquo;Consultant&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Consultant is engaged in the business of providing advisory services and advising companies in connection with their business and certain
capital market activities; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company desires to engage Consultant to perform certain advisory and consulting services for the Company and Consultant desires to
perform the services for the Company, subject to the terms and conditions of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THEREFORE</B>,
for the mutual promises contained herein, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ENGAGEMENT
    BY CONSULTANT</U>.</B>&nbsp;Company hereby engages Consultant and Consultant hereby agrees to hold himself available to render, and
    to render at the reasonable request of the Company, independent advisory and consulting services for the Company to the best of his
    ability (the &ldquo;Services&rdquo;), upon the terms and conditions hereinafter set forth.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duties</I>.
    Consultant shall perform those services as reasonably requested by the Company, including but not limited to the Services described
    herein. Consultant shall devote Consultant&rsquo;s commercially reasonable efforts and attention to the performance of the Services
    for the Company on a timely basis. Consultant shall also make himself available to answer questions, provide advice and Services
    to the Company upon reasonable request and notice from the Company. It is mutually understood that the Consultant shall not be accountable
    for operational duties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Responsibilities</I>.
    Assist with the strategic analysis of the Company&rsquo;s business objectives and specific advice on balancing these objectives with
    the expectations of the US capital markets.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Scope
    of Work.</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    Market Advisory &ndash; Provide an array of capital markets services enabling the Company to continue to be listed and perform on
    Nasdaq.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific
scope of services:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executing
    and closing a transaction with major investors including Faraday Future Intelligent Electric Inc. (&ldquo;Milestone Transaction&rdquo;);</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assisting
    the Company with structuring its cap table and preparing for any potential financing and M&amp;A opportunities;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assisting
    the Company with its corporate presentation and financial model; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rendering
    advice on methods of structuring various capital market transactions, assisting the Company in identifying and working with selected
    investors, placement agents and/or underwriters.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TERM</U>.</B>&nbsp;The
    term of this Agreement shall commence on the execution date and shall continue until terminated by both parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPENSATION</U>.</B>&nbsp;In
    consideration of the Services to be rendered hereunder, upon the execution of this Agreement, the Company agrees to issue to the
    Consultant, or its designees, shares of Company&rsquo;s common stock or convertible preferred stock equal to five percent (5%) of
    the Company&rsquo;s issued and outstanding shares on a post Milestone Transaction and fully diluted basis, which is calculated as
    1,205,124 shares. The Company shall use best efforts to register such shares along with the shares issued in the Milestone Transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEPENDENT CONTRACTOR</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is expressly agreed that Consultant is acting as an independent contractor in performing its services hereunder, and this Agreement is
not intended to, nor does it create, an employer-employee relationship nor shall it be construed as creating any joint venture or partnership
between the Company and Consultant. Consultant shall be responsible for all applicable federal, state and other taxes related to Consultant&rsquo;s
compensation hereunder and Company shall not withhold or pay any such taxes on behalf of Consultant, including without limitation social
security, federal, state and other local income taxes. Since Consultant is acting solely as an independent contractor under this Agreement,
Consultant shall not be entitled to insurance or other benefits normally provided by Company to its employees. While the foregoing duties
and responsibilities of Consultant may in a technical legal sense cause Consultant to be deemed an agent of Company, Consultant shall
have no authority to, nor shall he in any way attempt to, bind the Company to any agreements nor be responsible for its operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ASSIGNMENT</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is being entered into in reliance upon and in consideration of the singular skill and qualifications of Consultant. Neither
Consultant nor the Company shall voluntarily, or by operation of law assign or otherwise transfer the obligations incurred on its part
pursuant to terms of this Agreement without the prior written consent of the other party, except that Company may assign this Agreement
to its parent or any successor without the prior written consent of Consultant which shall be considered given by Consultant&rsquo;s
entry into this Agreement. Except as aforesaid, any attempt at assignment or transfer by either party of its obligations hereunder, without
such consent, shall be null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PROPRIETARY INFORMATION;
    WORK PRODUCT; NON-DISCLOSURE</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. Company
has conceived, developed and owns, and continues to conceive and develop, certain property rights and information, including but not
limited to its business plans and objectives, client and customer information, financial projections, marketing plans, marketing materials,
logos, and designs, and technical data, processes, know-how, formulae, databases, computer programs, and other trade secrets, intangible
assets and industrial or proprietary property rights which may or may not be related directly or indirectly to Company&rsquo;s business
and all documentation, media or other tangible embodiment of or relating to any of the foregoing and all proprietary rights therein of
Company are hereinafter referred to as &ldquo;Proprietary Information&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. <I>General
Restrictions on Use</I>. Consultant agrees to hold all Proprietary Information in confidence and not to, directly or indirectly, disclose,
use, copy, publish, summarize, or remove from Company&rsquo;s premises and/or control any Proprietary Information (or remove from the
control of Company any other property of Company), except (i) during the consulting relationship to the extent authorized and necessary
to carry out Consultant&rsquo;s responsibilities under this Agreement, and (ii) after termination of the consulting relationship, only
as specifically authorized in writing by Company. Notwithstanding the foregoing, such restrictions shall not apply to: (x) information
which Consultant can show was rightfully in Consultant&rsquo;s possession at the time of disclosure by Company; (y) information which
Consultant can show was received from a third party who lawfully developed the information independently of Company or obtained such
information from Company under conditions which did not require that it be held in confidence; or (z) information which, at the time
of disclosure, is generally available to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C. <I>Ownership
of Work Product</I>. All Work Product as defined hereinafter shall be considered work(s) made by Consultant for hire for Company and
shall belong exclusively to Company and its designees. If by operation of law, any of the Work Product, including all related intellectual
property rights, is not owned in its entirety by Company automatically upon creation thereof, then Consultant agrees to assign, and hereby
assigns, to Company and its designees the ownership of such Work Product, including all related intellectual property rights. &ldquo;Work
Product&rdquo; shall mean any writings (including excel, power point, emails, etc.), programming, documentation, data compilations, reports,
and any other media, materials, or other objects produced as a result of Consultant&rsquo;s work or delivered by Consultant in the course
of performing that work.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TERMINATION</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may also be terminated on the occurrence of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. A
material breach of this Agreement by Consultant, which breach has not been cured within thirty (30) days after a written demand for such
performance is delivered to Consultant by the Company that specifically identifies the manner in which the Company believes that Consultant
has breached this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. Any
material acts or events which inhibit Consultant from fully performing its responsibilities to the Company in good faith, such as (i)
a felony criminal conviction; (ii) any other criminal conviction involving Consultant&rsquo;s lack of honesty or Consultant&rsquo;s moral turpitude;
(iii) drug or alcohol abuse; or (iv) acts of dishonesty, gross carelessness or gross misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DISCLAIMER OF RESPONSIBILITY
    FOR ACTS OF COMPANY</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Consultant described in this Agreement consist solely of the furnishing of information and advice to the Company.
All final decisions with respect to acts of the Company or its affiliates, whether or not made pursuant to or in reliance on information
or advice furnished by Consultant hereunder, shall be those of the Company or such affiliates and Consultant shall under no circumstances
be liable for any expenses incurred or loss suffered by the Company as a consequence of such decisions except as provided in Section
10 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>GENERAL PROVISIONS</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. <I>Governing
Law and Jurisdiction</I>. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York. Each
of the parties hereto consents to such jurisdiction for the enforcement of this Agreement and matters pertaining to the transaction and
activities contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. <I>Attorneys&rsquo;
Fees</I>. In the event a dispute arises with respect to this Agreement, the party prevailing in such dispute shall be entitled to recover
all expenses, including, without limitation, reasonable attorneys&rsquo; fees and expenses incurred in ascertaining such party&rsquo;s rights, in
preparing to enforce or in enforcing such party&rsquo;s rights under this Agreement, whether or not it was necessary for such party to institute
suit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C. <I>Complete
Agreement</I>. This Agreement supersedes any and all of the other agreements, either oral or in writing, between the Parties with respect
to the subject matter hereof and contains all of the covenants and agreements between the parties with respect to such subject matter
in any manner whatsoever. Each party to this Agreement acknowledges that no representations, inducements, promises or agreements, oral
or otherwise, have been made by any party, or anyone herein, and that no other agreement, statement or promise not contained in this
Agreement shall be valid or binding. This Agreement may be changed or amended only by an amendment in writing signed by all of the Parties
or their respective successors-in-interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D. <I>Binding</I>.
Except as aforesaid, this Agreement shall be binding upon and inure to the benefit of the successors-in-interest, assigns and personal
representatives of the respective Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
<I>Unenforceable Terms</I>. Any provision hereof prohibited by law or unenforceable under the law of any jurisdiction in which such provision
is applicable shall as to such jurisdiction only be ineffective without affecting any other provision of this Agreement. To the full
extent, however, that such applicable law may be waived to the end that this Agreement be deemed to be a valid and binding agreement
enforceable in accordance with its terms, the Parties hereto hereby waive such applicable law knowingly and understanding the effect
of such waiver.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36.7pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
<I>Execution in Counterparts</I>. This Agreement may be executed in several counterparts and when so executed shall constitute one agreement
binding on all the Parties, notwithstanding that all the Parties are not signatory to the original and same counterpart.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
<I>Further Assurance</I>. From time to time each Party will execute and deliver such further instruments and will take such other action
as any other Party may reasonably request in order to discharge and perform their obligations and agreements hereunder and to give effect
to the intentions expressed in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
<I>Miscellaneous Provisions</I>. The various headings and numbers herein and the grouping of provisions of this Agreement into separate
articles and paragraphs are for the purpose of convenience only and shall not be considered a party hereof. The language in all parts
of this Agreement shall in all cases be construed in accordance with its fair meaning as if prepared by all Parties to the Agreement
and not strictly for or against any of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
<I>Entire Agreement</I>. This Agreement, together with the documents and exhibits referred to herein, embodies the entire understanding
among the parties and merges all prior discussions or communications among them, and no party shall be bound by any definitions, conditions,
warranties, or representations other than as expressly stated in this Agreement, or as subsequently set forth in writing, signed by the
duly authorized representatives of all of the parties hereto. This agreement, when executed shall supersede and render null and void
any and all preceding oral or written understandings and agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.
<I>No Oral Change; Waiver</I>. This Agreement may only be changed, modified, or amended in writing by the mutual consent of the parties
hereto. The provisions of this Agreement may only be waived in or by a writing signed by the party against whom enforcement of any waiver
is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
<I>Non-Circumvent.</I>&nbsp;The Company hereby expressly covenants and agrees not to engage in any discussions or negotiations or to
execute any agreement, understanding or undertaking whatsoever with any person or entity that introduced by the Consultant, without the
consent and approval of the Consultant including third parties who may be interested in providing or receiving financing of any kind
(a &ldquo;Financing&rdquo;) or in entering into a transaction, including, without limitation, a merger, acquisition or sale of stock
or assets (in which the Company may be the acquiring or the acquired entity), joint venture, collaboration, strategic alliance or other
similar transaction (any such transaction, a &ldquo;Transaction&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.
<I>Not Acting as a Broker-Dealer/Legal.</I>&nbsp;The Company hereby acknowledges that Consultant is not a licensed broker-dealer and
is not raising capital for the Company. The Company also acknowledges that the Consultant is not providing any legal services on behalf
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEMNIFICATION</U>.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant
agrees to indemnify and hold harmless the Company and its affiliates and their directors, officers and employees from and against all
taxes, losses, damages, liabilities, costs and expenses, including attorneys&rsquo; fees and other legal expenses, arising directly or
indirectly from or in connection with (i) any negligent, reckless or intentionally wrongful act of Consultant or Consultant&rsquo;s assistants,
employees, contractors or agents, (ii) a determination by a court or agency that the Consultant is not an independent contractor, (iii)
any material breach by the Consultant or Consultant&rsquo;s assistants, employees, contractors or agents of any of the covenants contained
in this Agreement and corresponding Confidential Information, (iv) any failure of Consultant to perform the Services in accordance with
all applicable laws, rules and regulations, or (v) any violation of a third party&rsquo;s rights resulting in whole or in part from the
Company&rsquo;s use of the deliverables of Consultant under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
agrees to indemnify and hold harmless the Consultant and its affiliates and their directors, officers and employees from and against
all taxes, losses, damages, liabilities, costs and expenses, including attorneys&rsquo; fees and other legal expenses, arising directly
or indirectly from or in connection with any negligent, reckless or intentionally wrongful act of the Company or the Company&rsquo;s
officers, directors, employees, contractors or agents.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>WARRANTIES AND REPRESENTATIONS.</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consultant&rsquo;s
advisory services are provided on a best-efforts basis and are based on his personal experience and expertise. There are no guarantees,
warranties or representations of any kind that Consultant&rsquo;s advice or services will produce any specific results for the benefit
of the Company. Actual results may substantially and materially differ from those suggested by Consultant. Consultant represents and
warrants to Company that (a) he is under no contractual or legal restriction or other restrictions or obligations that are inconsistent
with this Agreement, the performance of his duties and the covenants hereunder, and (b) he is under no physical or mental disability
that would interfere with his keeping and performing all of the agreements, covenants and conditions to be kept or performed hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Parties hereto have executed this Agreement as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>COMPANY</B>&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>CONSULTANT</B>&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUALIGEN THERAPEUTICS,
    INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABOUT INVESTMENT
    PTE. LTD.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin A. Richardson II, Interim
    CEO</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiaming Li, CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>8
<FILENAME>ex10-5.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VOTING
SUPPORT AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Voting Support Agreement (this &ldquo;<B>Agreement</B>&rdquo;), dated as of September 18, 2025, is entered into by and between Qualigen
Therapeutics, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and [&#9679;] (the &ldquo;<B>Supporting Stockholder</B>&rdquo;).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
on or prior to the date of this Agreement the Company is entering into, or has entered into, various subscription agreements substantially
in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Subscription Agreements</B>&rdquo;), with certain investors identified
on the signature pages thereto (together, the &ldquo;<B>Investors</B>&rdquo;), pursuant to which the Company will issue and sell to the
Investors, and the Investors will purchase from the Company shares of Common Stock, and/or shares of Series B Preferred Stock (the transactions
contemplated thereby, the &ldquo;<B>Transactions</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
as of the date hereof, the Supporting Stockholder is the record and/or &ldquo;beneficial owner&rdquo; (within the meaning of Rule 13d-3
under the Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the &ldquo;<B>Exchange
Act</B>&rdquo;)), of and is entitled to dispose of, or to direct the disposition of, and vote, or to direct the voting of, the number
of Covered Shares (as defined below) set forth on the Supporting Stockholder&rsquo;s signature page below (the &ldquo;<B>Owned Shares</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Owned Shares and any additional shares of Common Stock or Series A-2 Preferred Stock in which the Supporting Stockholder acquires
record and/or beneficial ownership after the date hereof, including, without limitation, by exercising any of the Company&rsquo;s outstanding
warrants or options to purchase shares of Common Stock, as a result of a stock dividend, stock split, recapitalization, combination,
reclassification, exchange or change of such securities, or upon exercise or conversion of any securities, are referred to herein as
the &ldquo;<B>Covered Shares</B>&rdquo;; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
as a condition and inducement to the willingness of the Investors to enter into the applicable Subscription Agreement, the parties
hereto desire to agree to certain matters as set forth herein.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Company and
the Supporting Stockholder hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) <U>Agreement
to Vote</U>. Subject to the earlier termination of this Agreement in accordance with <U>Section 4</U>, the Supporting Stockholder, in
its direct or indirect capacity as a stockholder of the Company, irrevocably and unconditionally agrees that, at any meeting of the Company&rsquo;s
stockholders (whether annual or special and whether or not an adjourned or postponed meeting, however called and including any adjournment
or postponement thereof) convened to seek a stockholder vote to approve the matters set forth in <U>Section 1(b)</U> below, the Supporting
Stockholder shall use commercially reasonable efforts to cause any other holder of record of any of the Supporting Stockholder&rsquo;s
Covered Shares to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) if
and when such meeting is held, appear at such meeting (and at every adjournment or postponement thereof) or otherwise cause the Covered
Shares owned as of the record date for such meeting to be counted as present thereat for the purpose of establishing a quorum;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) vote,
or cause to be voted (including via proxy), at such meeting all of the Covered Shares owned as of the record date for such meeting to
approve any matters necessary or reasonably requested by the Company to enable the Company to issue: (i) as part of the Transactions,
shares of Common Stock or Series B Preferred Stock and (ii) shares of Common Stock or Series B Preferred Stock that may be issuable upon
exercise of any warrants that may be issued to one or more advisors in connection with the Transactions, in each case that cannot be
issued without first obtaining the applicable stockholder approval (the &ldquo;<B>Proposed Company Stockholder Approval</B>&rdquo;) under
the rules and regulations of The Nasdaq Stock Market LLC (&ldquo;<B>Nasdaq</B>&rdquo;), including, without limitation, pursuant to Nasdaq
Rules 5635; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) vote,
or cause to be voted (including via proxy), at such meeting all of the Covered Shares owned as of the record date for such meeting against
any matters other than the Proposed Company Stockholder Approval for which any of the Company&rsquo;s stockholders shall seek a stockholder
vote (including any adjournment or postponement of any meeting) which would be reasonably likely to, in any material respect, impede
or delay the approval of the Proposed Company Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) <U>Prior
Proxies</U>. The Supporting Stockholder hereby revokes any and all previous proxies granted or has caused the holder(s) of record of
any Covered Shares to revoke any and all previous proxies granted with respect to the Covered Shares. For clarity, any vote cast pursuant
to <U>Section 1</U> will be calculated consistent with the Nasdaq Listing Rules, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) <U>Irrevocable
Proxy</U>. The Supporting Stockholder hereby appoints the Company and any designee of the Company, and each of them individually, until
the Termination Date (as defined below) (at which time this proxy shall automatically be revoked), as the Supporting Stockholder&rsquo;s
proxies and attorneys-in-fact, with full power of substitution and resubstitution, to vote or act by written consent during the term
of this Agreement with respect to the Covered Shares in accordance with <U>Section 1</U>, in each case if and only if the Supporting
Stockholder: (i) fails to vote, or (ii) attempts to vote (whether by proxy, in person or by written consent) in a manner which is inconsistent
with the terms of this Agreement. This proxy and power of attorney is given to secure the performance of the duties of the Supporting
Stockholder under this Agreement. The Supporting Stockholder shall take such further action or execute such other instruments as may
be necessary to effectuate the intent of this proxy. This proxy and power of attorney granted by the Supporting Stockholder shall be
irrevocable during the term of this Agreement, shall be deemed to be coupled with an interest sufficient in law to support an irrevocable
proxy, and shall revoke any and all prior proxies granted by the Supporting Stockholder with respect to the Covered Shares. The power
of attorney granted by the Supporting Stockholder herein is a durable power of attorney and shall survive the bankruptcy, death or incapacity
of the Supporting Stockholder. The proxy and power of attorney granted hereunder shall terminate upon the termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Termination</U>. This Agreement shall automatically terminate, without any notice or other action by any parties hereto, be void <I>ab
initio</I> and no parties hereto shall have any further obligations or liabilities under this Agreement, upon the earlier of (i) the
Company obtaining the Proposed Company Stockholder Approval by a stockholder vote or written consent and (ii) the termination of the
Transactions in accordance with the terms of the Subscription Agreements (the earliest such date under clause (i) or (ii)
being referred to herein as the &ldquo;<B>Termination Date</B>&rdquo;); <U>provided</U>, that termination of this Agreement shall not
relieve any parties hereto from any liability for any breach of, or actual and intentional fraud in connection with, this Agreement prior
to such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) <U>Representations
and Warranties of the Supporting Stockholder</U>. The Supporting Stockholder hereby represents and warrants as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Supporting Stockholder is the beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) and/or record owner of, and,
directly or indirectly, has good, valid and marketable title to, the Owned Shares, free and clear of liens (other than as created by
this Agreement or the organizational documents of the Company or arising under applicable securities laws). As of the date hereof, other
than the Owned Shares, the Supporting Stockholder does not own beneficially or of record any shares of Common Stock or Series A-2 Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Supporting Stockholder (i) except as provided in this Agreement, has full or, with an Affiliate of the Supporting Stockholder, shared
voting power, full power of disposition and full power to issue instructions with respect to the matters set forth herein, in each case,
with respect to the Supporting Stockholder&rsquo;s Covered Shares, (ii) has not entered into or caused or permitted any Affiliate to
enter into any voting agreement or voting trust with respect to any of the Supporting Stockholder&rsquo;s Covered Shares that is inconsistent
with the Supporting Stockholder&rsquo;s obligations pursuant to this Agreement, (iii) has not granted or caused or permitted any Affiliate
to grant a proxy or power of attorney (other than the proxy described in <U>Section 3</U> above) with respect to any of the Supporting
Stockholder&rsquo;s Covered Shares that is inconsistent with the Supporting Stockholder&rsquo;s obligations pursuant to this Agreement
and (iv) has not entered into or caused or permitted any Affiliate to enter into any agreement or undertaking that is otherwise inconsistent
with, or would interfere with, or prohibit or prevent it from satisfying, its obligations pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Supporting Stockholder is duly organized, validly existing and, to the extent such concept is applicable, in good standing under the
laws of the jurisdiction of its organization and has all requisite corporate or other power and authority and has taken all corporate
or other action necessary in order to, execute, deliver and perform its obligations under this Agreement and to consummate the transactions
contemplated hereby. This Agreement has been duly executed and delivered by the Supporting Stockholder and constitutes a valid and binding
agreement of the Supporting Stockholder enforceable against the Supporting Stockholder in accordance with its terms, except as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
execution, delivery and performance of this Agreement by the Supporting Stockholder do not, and the consummation of the transactions
contemplated hereby, will not, constitute or result in, (i) a breach or violation of, or a default under, the certificate of incorporation,
bylaws, limited liability company agreement or similar governing documents of the Supporting Stockholder, (ii) with or without notice,
lapse of time or both, a breach or violation of, a termination (or right of termination) of or a default under, the loss of any benefit
under, the creation, modification or acceleration of any obligations under or the creation of a lien (other than as created by this Agreement
or the organizational documents of the Company or arising under applicable securities laws) on the Covered Shares pursuant to any contract
binding upon the Supporting Stockholder or under any applicable law to which the Supporting Stockholder is subject, (iii) a conflict
with, or a breach, violation, or default (or an event which with notice or lapse of time or both would become a default) in any respect
under, or give to others any rights of termination, amendment, acceleration or cancellation of, any contract, agreement, indenture or
instrument to which the Supporting Stockholder is a party, or (iv) any change in the rights or obligations of any parties hereto under
any contract legally binding upon the Supporting Stockholder, except, in the case of clauses (ii) through (iv) directly above, for any
such breach, violation, termination, default, creation, loss, acceleration, lien or change that would not, individually or in the aggregate,
reasonably be expected to prevent or materially delay or impair the Supporting Stockholder&rsquo;s ability to perform its obligations
hereunder or to consummate the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) As
of the date of this Agreement, there is no action, proceeding or, to the Supporting Stockholder&rsquo;s knowledge, investigation pending
against the Supporting Stockholder or, to the knowledge of the Supporting Stockholder, threatened against the Supporting Stockholder
that questions the beneficial or record ownership of the Supporting Stockholder&rsquo;s Owned Shares, the validity of this Agreement
or the performance by the Supporting Stockholder of its obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) No
consent, approval, order, or authorization of, or registration, declaration, or filing with, any governmental entity or any other Person
on the part of the Supporting Stockholder is required in connection with the valid execution and delivery of this Agreement. If the Supporting
Stockholder is an individual, no consent of the Supporting Stockholder&rsquo;s spouse is necessary under any &ldquo;community property&rdquo;
or other laws in order for the Supporting Stockholder to enter into and perform its obligations under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Supporting Stockholder is a sophisticated stockholder and has adequate information concerning the business and financial condition of
the Company to make an informed decision regarding this Agreement and the Transactions and has independently and without reliance upon
the Company and based on such information as the Supporting Stockholder has deemed appropriate, made its own analysis and decision to
enter into this Agreement. The Supporting Stockholder acknowledges that the Company has not made and does not make any representation
or warranty, whether express or implied, of any kind or character except as expressly set forth in this Agreement. The Supporting Stockholder
acknowledges that the agreements contained herein with respect to the Covered Shares held by the Supporting Stockholder are irrevocable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6) <U>Certain
Covenants of the Supporting Stockholder</U>. Except in accordance with the terms of this Agreement, the Supporting Stockholder shall
not, and shall cause each of its Affiliates not to, at any time prior to the Termination Date, (i) enter into any voting agreement or
voting trust with respect to any of the Supporting Stockholder&rsquo;s Covered Shares that is inconsistent with the Supporting Stockholder&rsquo;s
obligations pursuant to this Agreement, (ii) grant a proxy or power of attorney (other than the proxy described in <U>Section 3</U> above)
with respect to any of the Supporting Stockholder&rsquo;s Covered Shares that is inconsistent with the Supporting Stockholder&rsquo;s
obligations pursuant to this Agreement, (iii) enter into any agreement or undertaking that is otherwise inconsistent with, or would interfere
with, or prohibit or prevent it from satisfying, its obligations pursuant to this Agreement or (iv) transfer or commit to transfer any
Covered Shares unless such Covered Shares remain subject to the terms of this Agreement upon such transfer or commitment to transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7) <U>Definitions</U>.
When used in this Agreement, the following terms shall have the meanings assigned to them in this <U>Section 7</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by or is under common control
with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of such Person, or
any venture capital fund or other investment fund now or hereafter existing that is controlled by one (1) or more general partners, managing
members or investment adviser of, or shares the same management company or investment adviser with, such Person; <U>provided, however</U>,
that in no case shall the Company or any of its Subsidiaries be deemed to be an Affiliate of the Supporting Stockholder. For purposes
of this definition, the term &ldquo;<B>control</B>&rdquo; (including, with correlative meanings, the terms &ldquo;controlling,&rdquo;
&ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo;), as used with respect to any Person, means the possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the ownership
of voting securities, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; means the Company&rsquo;s Common Stock, par value $0.001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and any governmental entity or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
A-2 Preferred Stock</B>&rdquo; means the Company&rsquo;s Series A-2 Convertible Preferred Stock, par value $0.001 per share</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Series
B Preferred Stock</B>&rdquo; means the Company&rsquo;s Series B Convertible Preferred Stock, par value $0.001 per share</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8) <U>Further
Assurances</U>. From time to time, at the Company&rsquo;s request and without further consideration, the Supporting Stockholder shall
execute and deliver such additional documents and take all such further action as may be reasonably necessary or reasonably requested
to effect the actions and consummate the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9) <U>Amendment
and Modification</U>. This Agreement may not be amended, modified, supplemented or waived except by an instrument in writing, signed
by the party against whom enforcement of such amendment, modification, supplement or waiver is sought; provided that any rights (but
not obligations) of a party under this Agreement may be waived, in whole or in part, by such party on its own behalf without the prior
consent of any other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10) <U>Notices.</U>
Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or telecopied,
sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed
to be given and received (i) when so delivered personally, (ii) upon receipt of an appropriate electronic answerback or confirmation
when so delivered by telecopy (to such number specified below or another number or numbers as such person may subsequently designate
by notice given hereunder), (iii) when sent, with no mail undeliverable, &ldquo;bounceback&rdquo; or other rejection notice, if sent
by email or (iv) five (5) business days after the date of mailing to the address below or to such other address or addresses as such
person may hereafter designate by notice given hereunder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
to the Company:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualigen
Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5857
Owens Avenue, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlsbad,
California 92008</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Kevin A. Richardson II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
kevin@pridescapital.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (for informational purposes only) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
New Jersey&nbsp;08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&nbsp;Peter
Campitiello</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:&nbsp;pcampitiello@lucbro.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            to the Supporting Stockholder, to such address indicated on the Company&rsquo;s records with
                                            respect to the Supporting Stockholder or to such other address or addresses as the Supporting
                                            Stockholder may from time to time designate in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
such notices, requests and other communications will be deemed to have been delivered: (i) upon receipt, when delivered personally; (iii)
upon delivery, when sent by electronic mail; or (iii) two Business Days after deposit with a U.S. nationally recognized overnight courier
service, in each case properly addressed to the party to receive the same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11) <U>Entire
Agreement</U>. This Agreement and the documents and instruments and other agreements among the parties hereto as contemplated by or referred
to herein constitute the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior
agreements and understandings, both written and oral, among the parties hereto with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)
<U>Third-Party Beneficiaries</U>. <FONT STYLE="background-color: white">Each of the Supporting Stockholder and the Company acknowledges
and agrees that this Agreement is being entered into in order to induce the Investors to execute and deliver the Subscription
Agreement, and without the representations, warranties, covenants and agreements of the Supporting Stockholder set forth herein, the
Investors would not enter into the Subscription Agreements.</FONT> Notwithstanding the foregoing, this Agreements is intended
only for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor
may any provision hereof be enforced by, any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13) <U>Governing
Law and Venue; Service of Process; Waiver of Jury Trial</U>. This Agreement, and any claim or cause of action hereunder based upon, arising
out of or related to this Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution,
performance or enforcement of this Agreement, shall be governed by and construed in accordance with the laws of the State of New York,
without giving effect to the principles of conflicts of law thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW
YORK, THE SUPREME COURT OF THE STATE OF NEW YORK AND THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA LOCATED IN THE STATE OF NEW YORK
SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS AGREEMENT
AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR
PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN
SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH
COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED
BY SUCH NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH
PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION,
SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 13 OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT
SERVICE THEREOF.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH
PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR
THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY
OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES
THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL
WAIVER AND CERTIFICATIONS IN THIS SECTION 13.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)
<U>Assignment; Successors</U>. No party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder,
by operation of law or otherwise, without the prior written approval of the other party hereto and, in the case of assignment by the
Supporting Stockholder, without the prior written approval of the Investors representing a majority of the shares of Common Stock and
Series B Preferred Stock being purchased under the Subscription Agreements. Subject to the preceding sentence, this Agreement
will be binding upon and will inure to the benefit of, and be enforceable by, the parties hereto and their respective successors and
permitted assigns. Any purported assignment of this Agreement without the consent required by this <U>Section 14</U> is null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15) <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Company will
be entitled to specific performance hereunder. The parties agree that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations contained in this Agreement and hereby agree to waive and not to assert in any action
for specific performance of any such obligation the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16) <U>Severability</U>.
If any provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable,
the validity, legality or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby
and shall continue in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17) <U>Counterparts</U>.
This Agreement may be executed in two (2) or more counterparts (including by electronic means), all of which shall be considered one
and the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being understood
that all parties need not sign the same counterpart.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[(17) <U>Duties</U>.
The Supporting Stockholder is entering into this Agreement solely in his or her capacity as a holder or beneficial owner of Covered
Shares, and nothing in this Agreement shall apply to the Supporting Stockholder serving in his or her capacity as a director or
officer of the Company. The Company acknowledges and agrees that any actions taken by a director or officer of the Company in his or
her capacity as such shall not constitute actions taken by or on behalf of a holder or beneficial owner of shares of Common Stock or
Series A-2 Preferred Stock. For the avoidance of doubt, nothing in this Agreement shall be construed to prohibit the Supporting
Stockholder (or be construed to create any obligation on the Supporting Stockholder) who is an officer or member of the
Company&rsquo;s Board of Directors (the &ldquo;<B>Board</B>&rdquo;) from taking any action (or failure to act) in his or her
capacity as an officer, member of the Board or director or officer any of the Company&rsquo;s subsidiaries, and no action taken in
any such capacity as an officer or director of the Company or any of its subsidiaries shall be deemed to constitute a breach of this
Agreement.]<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>The
remainder of this page is intentionally left blank</I>.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP>
<B>Note to Draft</B>: This provision to be included in Voting Support Agreements executed by directors and officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
                                            WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable,
                                            by their respective officers or other authorized Persons thereunto duly authorized) as of
                                            the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUALIGEN
    THERAPEUTICS, INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other
authorized Persons thereunto duly authorized) as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUPPORTING STOCKHOLDER:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&#9679;]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned Shares Held Directly or Indirectly:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock: [&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A-2 Preferred Stock: [&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Votes: [&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subscription</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>
Agreement</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>9
<FILENAME>ex10-6.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENCY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
19, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Univest
Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75
Rockefeller Plaza, Suite 1838</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions herein (this &ldquo;<U>Agreement</U>&rdquo;) and the Transaction Documents (defined below), Qualigen Therapeutics
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), has agreed to issue and sell (i) shares of the Company&rsquo;s common
stock (the &ldquo;<U>Common Shares</U>&rdquo;), par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), and (ii) shares of
the Company&rsquo;s Series B convertible preferred stock (the &ldquo;<U>Preferred Shares</U>&rdquo;), par value $0.001 per share (the
&ldquo;<U>Series B Preferred Stock</U>&rdquo;) directly to one or more investors (each, an &ldquo;<U>Investor</U>&rdquo; and, collectively,
the &ldquo;<U>Investors</U>&rdquo;) through Univest Securities, LLC (the &ldquo;<U>Placement Agent</U>&rdquo;), as placement agent. The
Securities (as defined below) shall be offered and sold pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended (the
&ldquo;<U>Securities Act</U>&rdquo;). The documents executed and delivered by the Company and the Investors in connection with the Offering
(as defined below), including, without limitation, a subscription agreement (the &ldquo;<U>Subscription Agreement</U>&rdquo;), the Certificate
of Designation of Preferences, Rights and Limitations of Series B Preferred Stock (the &ldquo;<U>Series B Certificate</U>&rdquo;), a
registration rights agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) and all other agreements executed in connection
therewith, shall be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo; The Placement Agent may retain
other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Offering (as defined below). The
Common Shares, the Preferred Shares and the shares of Common Stock issuable upon conversion of the Preferred Shares (the &ldquo;<U>Conversion
Shares</U>&rdquo;) are hereafter collectively referred to as the &ldquo;<U>Securities</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby confirms its agreement with the Placement Agent as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1. Agreement to Act as Placement Agent</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and
conditions of this Agreement, the Placement Agent shall be the exclusive Placement Agent in connection with the offering and sale by
the Company of the Securities pursuant to Section 4(a)(2) under the Securities Act, with the terms of such offering (the
&ldquo;<U>Offering</U>&rdquo;) to be subject to market conditions and negotiations between the Company, the Placement Agent and the
prospective Investors. The Placement Agent will act on a reasonable best efforts basis and the Company agrees and acknowledges that
there is no guarantee of the successful placement of the Securities, or any portion thereof, in the prospective Offering. Under no
circumstances will the Placement Agent or any of its &ldquo;Affiliates&rdquo; (as defined below) be obligated to underwrite or
purchase any of the Securities for its own account or otherwise provide any financing. The Placement Agent shall act solely as the
Company&rsquo;s agent and not as principal. The Placement Agent shall have no authority to bind the Company with respect to any
prospective offer to purchase Securities and the Company shall have the sole right to accept offers to purchase Securities and may
reject any such offer, in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and
delivery of, the Securities shall be made at one or more closings (each a &ldquo;<U>Closing</U>&rdquo; and the date on which each
Closing occurs, a &ldquo;<U>Closing Date</U>&rdquo;). As compensation for services rendered, on each Closing Date, the Company shall
pay to the Placement Agent the fees and expenses set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A cash fee equal to 5.5% of the gross proceeds received by the Company from the sale of the Securities at such Closing to Investors
(collectively, the &ldquo;<U>Cash Fee</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Company also agrees to pay to the Placement Agent $150,000 for out-of-pocket expenses, including the reasonable fees and
expenses of Placement Agent&rsquo;s counsel and due diligence analysis; <U>provided</U>, <U>however</U>, that in the event that the
Offering is terminated prior to any Closing, the Company agrees to reimburse the Placement Agent pursuant to Section 6
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company hereby agrees to issue to the Placement Agent (and/or its designees) on each Closing Date, warrants (&ldquo;<U>Placement
Agent&rsquo;s Warrants</U>&rdquo;) to purchase that number of shares of Common Stock equal to 6% of the sum of (i) the Common
Shares, and (ii) the Conversion Shares, placed at such Closing with an exercise price equal to 110% of the price per Common Share
paid by Investors at such Closing. The Placement Agent&rsquo;s Warrants shall be exercisable, in whole or in part, commencing on the
Closing Date (as defined in the Subscription Agreement) and shall be exercisable for a period of five years. In the event that there
is not an effective registration statement permitting for the resale of the shares underlying the Placement Agent&rsquo;s Warrants,
the Placement Agent&rsquo;s Warrants shall be exercisable on a cashless basis. The Placement Agent&rsquo;s Warrants and the shares
of Common Stock issuable upon exercise thereof (the &ldquo;<U>PA Warrant Shares</U>&rdquo;) are hereinafter referred to together as
the &ldquo;<U>Placement Agent&rsquo;s Securities</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The term of the Placement Agent&rsquo;s exclusive engagement will be until the completion of the Offering (the &ldquo;<U>Exclusive
Term</U>&rdquo;). Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality,
indemnification and contribution contained herein and the Company&rsquo;s obligations contained in the indemnification provisions
will survive any expiration or termination of this Agreement, and the Company&rsquo;s obligation to pay fees actually earned and
payable and to reimburse expenses actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to be
reimbursed under FINRA Rules, will survive any expiration or termination of this Agreement. Nothing in this Agreement shall be
construed to limit the ability of the Placement Agent or its Affiliates to pursue, investigate, analyze, invest in, or engage in
investment banking, financial advisory or any other business relationship with Persons (as defined herein) other than the Company.
As used herein (i) &ldquo;<U>Persons</U>&rdquo; means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision
thereof) or other entity of any kind and (ii) &ldquo;<U>Affiliate</U>&rdquo; means any Person that, directly or indirectly through
one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and
construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2. Representations and Warranties of the Company</B>. The Company represents and warrants to the Placement Agent, as of the date
hereof and as of each Closing Date, all of the representations, warranties and agreements of the Company that were made by the
Company to the Investors in Section 4 of the Subscription Agreement are true and correct with the same force and effect as of the
date hereof and as of each Closing Date as if made on the date hereof and each Closing Date, and that such representations and
warranties set forth in Section 4 thereof are hereby incorporated by reference herein. In addition to the foregoing, the Company
represents and warrants to the Placement Agent that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
(i) the Company has full right, power and authority to enter into this Agreement, to issue the Placement Agent&rsquo;s Securities
and to perform all of its obligations hereunder and consummate the transactions contemplated hereby and thereby; (ii) this Agreement
has been duly executed and delivered by the Company and this Agreement constitutes its legal, valid and binding obligation,
enforceable against it in accordance with its terms; (iii) the Placement Agent&rsquo;s Warrants have been duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents, will and constitutes valid and binding obligations of
the Company enforceable in accordance with its terms; (iv) the execution and delivery of this Agreement and the Placement
Agent&rsquo;s Warrants and the consummation of the transactions contemplated hereby and thereby (including without limitation, the
issuance of the Placement Agent&rsquo;s Warrants and the issuance of the PA Warrant Shares issuable upon exercise thereof) have been
duly authorized by the Company&rsquo;s Board of Directors and no further consent or authorization of the Company, its Board of
Directors, or its shareholders is required; and (v) the execution and delivery of this Agreement and the Placement Agent&rsquo;s
Warrants and the consummation of the transactions contemplated hereby and thereby does not conflict with or result in a breach of
(x) the Company&rsquo;s certificate of incorporation or bylaws or other charter documents, (y) any agreement to which the Company is
a party or by which any of its property or assets is bound or (z) any of the other documents or agreements filed with the
Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All disclosure provided by the Company to the Placement Agent regarding the Company, its business and the transactions contemplated
hereby, taken together with all reports, schedules, forms, statements and other documents required to be filed by it with the
Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) pursuant to the reporting requirements of the Exchange Act
(all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules
thereto and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred to
herein as the &ldquo;<U>SEC Filings</U>&rdquo;), is true and correct in all material aspects and does not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light
of the circumstances under which they were made, not misleading. To the best of the Company&rsquo;s knowledge and belief, other than
the current capital raising (of which this Agreement forms part), no event or circumstance has occurred or information exists with
respect to the Company or its business, properties, prospects, operations or financial conditions, which, under the applicable laws,
rules or regulations of the Commission, requires public disclosure or announcement by the Company but which has not been so publicly
announced or disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company has not taken and will not take any action, directly or indirectly, so as to cause the Offering to fail to be entitled
to rely upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act. In effecting the Offering, the
Company agrees to comply in all material respects with applicable provisions of the Securities Act and any regulations thereunder
and any applicable laws, rules, regulations and requirements (including, without limitation, all U.S. state law and all national,
provincial, city or other legal requirements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Issuance
of Placement Agent&rsquo;s Warrant and PA Warrant Shares</U>. The PA Warrant Shares are, or at the consummation of the Offering will
be, duly authorized for issuance and, upon exercise of the Placement Agent&rsquo;s Warrants in accordance with their respective
terms, will be validly issued, fully paid and non-assessable shares of Common Stock, and free from all taxes, liens, claims and
encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders
of the Company and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3. Delivery and Payment</B>. Each Closing shall occur at the offices of Sullivan &amp; Worcester LLP, 1251 Avenue of the Americas,
19th Floor New York, New York 10020 (or at such other place as shall be agreed upon by the Placement Agent and the Company) (&ldquo;<U>Placement
Agent Counsel</U>&rdquo;). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities
sold on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall
be registered in such name or names and shall be in such denominations, as the Placement Agent may request at least one (1) Business
Day before the time of purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deliveries
of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent Counsel. All
actions taken at a Closing shall be deemed to have occurred simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4. Covenants and Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Blue
Sky Compliance</U>. The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify the Securities
for sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and the Investors may
reasonably request and will make such applications, file such documents, and furnish such information as may be reasonably required
for that purpose, provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to
service of process in any jurisdiction where it is not now so qualified or required to file such a consent, and provided further
that the Company shall not be required to produce any new disclosure document other than the Transaction Documents. The Company
will, from time to time, prepare and file such statements, reports and other documents as are or may be required to continue such
qualifications in effect for so long a period as the Placement Agent may reasonably request for distribution of the Securities. The
Company will advise the Placement Agent promptly of the suspension of the qualification or registration of (or any such exemption
relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any
such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company
shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Amendments
and Supplements to the Transaction Documents and Other Matters</U>. The Company will comply with the Securities Act and the
Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), and the rules and regulations of the Commission
thereunder, so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and the
Transaction Documents. If, prior to the termination of the Offering, any event shall occur as a result of which, in the judgment of
the Company or in the opinion of the Placement Agent or Placement Agent Counsel, it becomes necessary to amend or supplement the
Transaction Documents in order to make the statements therein, in the light of the circumstances under which they were made, as the
case may be, not misleading, or if it is necessary at any time to amend or supplement the Transaction Documents, the Company will
promptly prepare and furnish at its own expense to the Placement Agent and to dealers, an appropriate amendment or supplement to the
Transaction Documents that is necessary in order to make the statements therein as so amended or supplemented, in the light of the
circumstances under which they were made, as the case may be, not misleading, or so that the Transaction Documents, as so amended or
supplemented, will comply with applicable laws related to the Offering. Before amending or supplementing Transaction Documents in
connection with the Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment or supplement and
will not disseminate any such amendment or supplement to which the Placement Agent reasonably objects. Notwithstanding any provision
of this Section 4(b), the Company and its counsel shall be afforded a reasonable opportunity to demonstrate why such amendment or
supplement may not be necessary or advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Copies
of any Amendments and Supplements to the Transaction Documents</U>. The Company will furnish the Placement Agent, without charge,
during the period beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of
the Transaction Documents and any amendments and supplements thereto as the Placement Agent may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Registration
Statement</U>. As soon as practicable (and in any event by the Filing Date (as defined in the Registration Rights Agreement)), the
Company shall file a registration statement on Form S-3 (or other appropriate form if the Company is not then S-3 eligible)
providing for the resale by the Placement Agent of the PA Warrant Shares issued and issuable upon exercise of the Placement Agent
Warrants. The Company shall use commercially reasonable efforts to cause such registration statement to become effective by the
Effectiveness Date (as defined in the Registration Rights Agreement) and to keep such registration statement effective at all times
until the Placement Agent no longer owns any Placement Agent Warrants or PA Warrant Shares issuable upon exercise
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Transfer
Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Registration
of Securities; Exchange Approval</U>. The Common Stock is registered under the Exchange Act and, as of the Closing Date, the Common
Shares and the Conversion Shares shall be listed and admitted and authorized for trading (subject to any restrictions or conditions
that may be imposed by the Trading Market in accordance with any Nasdaq rule that may be applicable to the Company as a Foreign
Private Issuer) on the Nasdaq Capital Market (the &ldquo;<U>Trading Market</U>&rdquo;) or other applicable U.S. national exchange
and satisfactory evidence of such action shall have been provided to the Placement Agent. For a period of three (3) years, the
Company shall take no action designed to, or likely to have the effect of terminating the registration of the Common Stock under the
Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable U.S. national
exchange and the Company has not received any information suggesting that the Commission or the Trading Market or other U.S.
applicable national exchange is contemplating terminating such registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Additional
Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or
the Investors reasonably deem necessary or appropriate to consummate the Offering, all of which will be in form and substance
reasonably acceptable to the Placement Agent and the Investors. The Company agrees that the Placement Agent may rely upon, and each
is a third-party beneficiary of, the representations and warranties, and applicable covenants, set forth in any such purchase,
subscription or other agreement with Investors in the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>No
Manipulation of Price</U><I>. </I>The Company will not take, directly or indirectly, any action designed to cause or result in, or
that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board
of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement
Agent&rsquo;s prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5. Conditions of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to
the accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date
hereof and as of each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations
hereunder on and as of such dates, and to each of the following additional conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>No
Untrue Statements</U>. The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date
that the SEC Filings contains an untrue statement of a fact which, in the opinion of Placement Agent&rsquo;s Counsel, is material or
omits to state any fact which, in the opinion of such counsel, is material and is required to be stated therein or is necessary to
make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Compliance
with Regulatory Requirements.</U> No order having the effect of ceasing or suspending the distribution of the Securities or any
other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock
exchange and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company,
contemplated by any securities commission, securities regulatory authority or stock exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Transaction Documents, and
the registration or exemption therefrom, sale and delivery of the Securities, shall have been completed or resolved in a manner
reasonably satisfactory to the Placement Agent Counsel, and such counsel shall have been furnished with such papers and information
as it may reasonably have requested to enable such counsel to pass upon the matters referred to in this Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>No
Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date (if there
shall be more than one Closing Date then prior to each Closing Date), in the Placement Agent&rsquo;s sole judgment after
consultation with the Company, there shall not have occurred any Material Adverse Effect (as defined in the Subscription
Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Stock
Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market, and the
Company shall not have taken any action designed to terminate, or likely to have the effect of terminating, the registration of the
Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall the
Company have received any information suggesting that the Commission or the Trading Market is contemplating terminating such
registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Placement
Agent&rsquo;s Warrants</U>. On or before each Closing Date, the Placement Agent shall have received executed copies of the Placement
Agent&rsquo;s Warrants with respect to such Closing, provided the Company has received the Placement Agent&rsquo;s designees for
such Placement Agent&rsquo;s Warrant at least one (1) Business Day prior to such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Additional
Documents</U>. On or before each Closing Date, the Placement Agent and counsel for the Placement Agent shall have received such
information and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the
Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the
satisfaction of any of the conditions or agreements, herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by
the Placement Agent by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability
on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution)
and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6. Payment of Expenses</B>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the
performance of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation:
(i) all expenses incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs);
(ii) all fees and expenses of the registrar and transfer agent of the Common Stock; (iii) all necessary issue, transfer and other stamp
taxes in connection with the issuance and sale of the Securities; (iv) all fees and expenses of the Company&rsquo;s counsel, independent
public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing,
filing, shipping and distribution of the Transaction Documents, and all amendments and supplements thereto, and this Agreement; (vi)
all filing fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company or the Placement Agent in connection with qualifying
or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities for offer and sale
under the state securities or blue sky laws or the securities laws of any other country; (vii) the fees and expenses associated with
including the Securities on the Trading Market; and (viii) the fees and expenses of out-of-pocket expenses, including the reasonable
fees and expenses of Placement Agent&rsquo;s counsel and due diligence analysis not to exceed $150,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7. Indemnification and Contribution</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company agrees to indemnify and hold harmless the Placement Agent, its Affiliates and each person controlling the Placement Agent
(within the meaning of Section 15 of the Securities Act), and the directors, officers, agents and employees of the Placement Agent, its
Affiliates and each such controlling person (the Placement Agent, and each such entity or person, an &ldquo;<U>Indemnified Person</U>&rdquo;)
from and against any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<U>Liabilities</U>&rdquo;),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for
all Indemnified Persons, except as otherwise expressly provided herein) (collectively, the &ldquo;<U>Expenses</U>&rdquo;) as they are
incurred by an Indemnified Person in investigating, preparing, pursuing or defending any Actions, whether or not any Indemnified Person
is a party thereto, (i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material
fact contained in any Transaction Document or by any omission or alleged omission to state therein a material fact necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading (other than untrue statements or alleged
untrue statements in, or omissions or alleged omissions from, information relating to an Indemnified Person furnished in writing by or
on behalf of such Indemnified Person expressly for use in the Transaction Documents) or (ii) otherwise arising out of or in connection
with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated
thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or transactions; <U>provided</U>,
<U>however</U>, that, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person that are finally
judicially determined to have resulted solely from such Indemnified Person&rsquo;s (x) gross negligence or willful misconduct in connection
with any of the advice, actions, inactions or services referred to above or (y) use of any offering materials or information concerning
the Company in connection with the offer or sale of the Securities in the Offering which were not authorized for such use by the Company
and which use constitutes gross negligence or willful misconduct. The Company also agrees to reimburse each Indemnified Person for all
Expenses as they are incurred in connection with enforcing such Indemnified Person&rsquo;s rights under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Upon receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity
may be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by
any Indemnified Person so to notify the Company shall not relieve the Company from any liability which the Company may have on
account of this indemnity or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by
such failure. The Company shall, if requested by the Placement Agent, assume the defense of any such Action including the employment
of counsel reasonably satisfactory to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person
shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense
and employ counsel or (ii) the named parties to any such Action (including any impeded parties) include such Indemnified Person and
the Company, and such Indemnified Person shall have been advised in the reasonable opinion of counsel that there is an actual
conflict of interest that prevents the counsel selected by the Company from representing both the Company (or another client of such
counsel) and any Indemnified Person; provided that the Company shall not in such event be responsible hereunder for the fees and
expenses of more than one firm of separate counsel for all Indemnified Persons in connection with any Action or related Actions (as
defined herein), in addition to any local counsel. The Company shall not be liable for any settlement of any Action effected without
its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without the prior written
consent of the Placement Agent (which shall not be unreasonably withheld), settle, compromise or consent to the entry of any
judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification or contribution may
be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or
termination includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for which
indemnification or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments of
the amount thereof during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is
due and payable. &ldquo;<U>Action</U>&rdquo; means any action, suit, inquiry, notice of violation, proceeding or investigation
affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or
administrative agency or regulatory authority (federal, state, county, local or foreign).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the
Company shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is
appropriate to reflect (i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other
Indemnified Person, on the other hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the
immediately preceding clause is not permitted by applicable law, not only such relative benefits but also the relative fault of the
Company, on the one hand, and the Placement Agent and any other Indemnified Person, on the other hand, in connection with the
matters as to which such Liabilities or Expenses relate, as well as any other relevant equitable considerations; provided that in no
event shall the Company contribute less than the amount necessary to ensure that all Indemnified Persons, in the aggregate, are not
liable for any Liabilities and Expenses in excess of the amount of fees actually received by the Placement Agent pursuant to this
Agreement. For purposes of this paragraph, the relative benefits to the Company, on the one hand, and to the Placement Agent on the
other hand, of the matters contemplated by this Agreement shall be deemed to be in the same proportion as (a) the total value paid
or contemplated to be paid to or received or contemplated to be received by the Company in the transaction or transactions that are
within the scope of this Agreement, whether or not any such transaction is consummated, bears to (b) the fees paid to the Placement
Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation within the meaning of
Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty of fraudulent
misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or
otherwise) to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant
to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with
any such advice, services or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially
determined to have resulted solely from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with
any such advice, actions, inactions or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this
Agreement and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified
Person&rsquo;s services under or in connection with, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8. Representations and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and
other statements of the Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made
pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement
Agent, the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive
delivery of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to the Placement Agent,
or to the Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity,
contribution and reimbursement agreements contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9. Notices</B>. All communications hereunder shall be in writing and shall be mailed, hand delivered or telecopied and confirmed to
the parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Placement Agent to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Univest
Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75
Rockefeller Plaza, Suite 1838</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention
Edric Yi Guo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>yguo@univest.us</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to: </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1251
Avenue of the Americas, 19<SUP>th</SUP> Floor</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10020</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
David Danovitch, Esq.</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>ddanovitch@sullivanlaw.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualigen
Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5857
Owens Avenue, Suite 300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carlsbad,
California 92008</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Kevin A. Richardson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>kevin@pridescapital.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">with
a copy (for informational purposes only) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
New Jersey 08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Joseph Lucosky, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
<U>jlucosky@lucbro.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address for receipt of communications by giving written notice to the others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. [Reserved]. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11. Successors</B>. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the
employees, officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal
representative, and no other person will have any right or obligation hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12. Partial Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall
not affect the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision
of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13. Governing Law Provisions</B>. This Agreement shall be deemed to have been made and delivered in New York City and both this
Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all
other respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the
Placement Agent and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement
and/or the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the
United States District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the
venue of any such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court,
County of New York, and the United States District Court for the Southern District of New York in any such suit, action or
proceeding. Each of the Placement Agent and the Company further agrees to accept and acknowledge service of any and all process
which may be served in any such suit, action or proceeding in the New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York and agrees that service of process upon the Company mailed by certified
mail to the Company&rsquo;s address shall be deemed in every respect effective service of process upon the Company, in any such
suit, action or proceeding, and service of process upon the Placement Agent mailed by certified mail to the Placement Agent&rsquo;s
address shall be deemed in every respect effective service process upon the Placement Agent, in any such suit, action or proceeding.
Notwithstanding any provision of this Agreement to the contrary, the Company agrees that neither the Placement Agent nor its
Affiliates, and the respective officers, directors, employees, agents and representatives of the Placement Agent, its Affiliates and
each other person, if any, controlling the Placement Agent or any of its Affiliates, shall have any liability (whether direct or
indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement and transaction described herein
except for any such liability for losses, claims, damages or liabilities incurred by us that are finally judicially determined to
have resulted from the bad faith or gross negligence of such individuals or entities. If either party shall commence an action or
proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by
the other party for its reasonable attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
14. General Provisions</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all
contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be
executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and
hereto were upon the same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto,
and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to
benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agent has acted at arms&rsquo;
length, are not agents of, and owe no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company
only those duties and obligations set forth in this Agreement and (iii) the Placement Agent may have interests that differ from
those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Placement
Agent arising from an alleged breach of fiduciary duty in connection with the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[The
remainder of this page has been intentionally left blank.]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUALIGEN THERAPEUTICS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
    Richardson II</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><U>Address for notice:</U></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Qualigen Therapeutics, Inc.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">5857 Owens Avenue, Suite 300</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Carlsbad, California 92008</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Attention: Kevin A. Richardson</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
kevin@pridescapital.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to as of the date first written above:</FONT></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Univest Securities, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edric Yi Guo</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO and Head of Investment Banking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for notice:</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75 Rockefeller Plaza, Suite 1838</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Edric Yi Guo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">Email: yguo@univest</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>10
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Faraday
Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LOS
ANGELES and CARLSBAD, September 19, 2025 </B>&ndash; <FONT STYLE="background-color: white">Faraday Future Intelligent Electric Inc. (NASDAQ:
FFAI) (&ldquo;Faraday Future&rdquo;, &ldquo;FF&rdquo; or &ldquo;Company&rdquo;), a California-based global shared intelligent electric
mobility ecosystem company, and Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (&ldquo;QLGN&rdquo;), </FONT>jointly announced that they have
entered into a securities purchase agreement (the &ldquo;Agreement&rdquo;) for a private investment in public equity (PIPE) in QLGN&rsquo;s
common stock and preferred stock, and will start a crypto and web3-related business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of the required stockholder approval process, it is expected that QLGN will rebrand as CXC10, <FONT STYLE="background-color: white">fully
focusing on its three growth engines in crypto and ecosystem buildup for Web3.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
PIPE financing is being led by Faraday Future and its Founder and Global Co-CEO YT Jia, together with other investors including SIGN
Foundation, a blockchain technology company backed by Binance Labs, Sequoia Capital (US, India, China), IDG, and Circle, building software
infrastructure for governments and the next generation of capital markets. The total financing is approximately $41 million. Jerry Wang,
the President of FF, also participated in this financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Under
the terms of the Agreement, Faraday Future has agreed, subject to closing conditions, to invest approximately $30 million in QLGN at
an effective price of $2.246 per share, representing beneficial ownership of approximately 55% of QLGN&rsquo;s outstanding common stock.
In addition, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YT Jia intends to personally invest approximately
$4 million, representing ownership of about 7% of QLGN&rsquo;s common stock. As a cornerstone investor, YT Jia has also agreed to a two-year
voluntary lock-up on his personal investment. QLGN already obtained majority shareholder support of this transaction via voting support
agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the closing of this transaction, YT Jia will serve as a Chief Advisor of QLGN, Jerry Wang will be appointed as Co-CEO of QLGN, and FF
CFO Koti Meka will be appointed as CFO. FF will also have the right to nominate two of the five independent directors. If the proposal
is approved at the stockholders&rsquo; meeting, FF&rsquo;s nomination rights could increase to four of the seven seats. FF will also
have participation rights as to QLGN&rsquo;s future financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
completion of the PIPE, Faraday Future and its Founder and Global Co-CEO YT Jia are expected to beneficially own over 62% of <FONT STYLE="background-color: white">QLGN</FONT>&rsquo;s
outstanding common stock, based on shares outstanding as of the pricing date, giving pro forma effect to the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
structure will allow FFAI to concentrate on advancing its EV strategy while QLGN can focus on driving growth in crypto and Web3, creating
strategic synergies, unlocking new financing channels, and maximizing stockholder value without additional dilution to FFAI stockholders
for the crypto-related business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;This
strategic investment represents an important milestone in our evolution,&rdquo; said YT Jia, Founder and Global Co-CEO of Faraday Future.
&ldquo;I believe that FFAI will truly become a company powered by Dual Flywheel synergy and Dual Bridge empowerment&mdash;connecting
EAI with crypto, and bridging Web2 with Web3.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;This
is a very exciting day for all stakeholders of Qualigen Therapeutics,&rdquo; said Kevin A. Richardson, CEO of QLGN.&rdquo; The company
will be embracing the new economy and technology which will reshape the future. The board unanimously voted to move forward with this
transformative transaction and stand behind the leadership FF brings to our company.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Univest
Securities is the sole placement agent in this transaction. FF is represented by Pryor Cashman and QLGN is represented by Lucosky Brookman.
QLGN also hired a capital market advisory to support this transaction and future capital-market-related activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>ABOUT
FARADAY FUTURE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Faraday
Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company&rsquo;s mission
is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future&rsquo;s
flagship model, the FF91, exemplifies its vision for luxury, innovation, and performance. The new FX strategy aims to introduce mass
production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low
price range offerings. For more information, please visit <U>https://www.ff.com/us/</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
registering for this event, attendants agree to provide certain personal information, which will be used to manage their participation
in the event and communicate important updates. Faraday Future values your privacy and will handle provided personal information in accordance
with its privacy policy. To learn more about how FF collects, uses, and protects personal data, please review FF&rsquo;s full privacy
policy at FF.com/us/privacy-policy/.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>ABOUT
QUALIGEN THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information about Qualigen Therapeutics, Inc., please visit www.qlgntx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FORWARD
LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release includes &ldquo;forward looking statements&rdquo; within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. When used in this press release, the words &ldquo;plan to,&rdquo; &ldquo;can,&rdquo;
&ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;future,&rdquo; &ldquo;potential,&rdquo; and variations of these words or similar expressions
(or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements,
which include statements regarding the intentions for its crypto assets and subsidiaries and their potential benefits, the Company&rsquo;s
investments in crypto currency, and the Dual-flywheel, Dual-bridge Eco Strategy are not guarantees of future performance, conditions
or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are
outside the Company&rsquo;s control, which could cause actual results or outcomes to differ materially from those discussed in the forward-looking
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Important
factors, among others, that may affect actual results or outcomes include, among others: the Company&rsquo;s ability to consummate the
Spin-Off in a timely manner, if at all; the separate listed entity&rsquo;s ability to raise future capital on attractive terms, if at
all; the Company&rsquo;s ability to control the management and operations of the separate listed entity; the Company&rsquo;s ability
to successfully execute on a new crypto-based strategy; the Company&rsquo;s ability to raise funds to support a new crypto-based strategy;
the inherent volatility and regulatory uncertainty associated with cryptocurrency investments; current and potential litigation involving
the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under
the Bankruptcy Code; general economic and market conditions impacting demand for the Company&rsquo;s products; circumstances outside
of the Company&rsquo;s control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil
unrest; and the Company&rsquo;s ability to develop and protect its technologies; the Company&rsquo;s ability to protect against cybersecurity
risks. You should carefully consider the foregoing factors and the other risks and uncertainties described in the &ldquo;Risk Factors&rdquo;
section of the Company&rsquo;s Form 10-K filed with the SEC on March 31, 2025, and other documents filed by the Company from time to
time with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>CONTACTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investors (English): <U>ir@faradayfuture.com</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Investors
(Chinese): <U>cn-ir@faradayfuture.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U></U>Media: <U>john.schilling@ff.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>qlgn-20250919.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaA2bP9z5Z8mekhvWB9balqzyIo3MpLaCYkLLp2wXsH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:QLGN="http://qlgntx.com/20250919" elementFormDefault="qualified" targetNamespace="http://qlgntx.com/20250919">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://qlgntx.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="qlgn-20250919_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="qlgn-20250919_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>qlgn-20250919_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>qlgn-20250919_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="qlgn-20250919.xsd#Cover" roleURI="http://qlgntx.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://qlgntx.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 19,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Qualigen Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001460702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3474527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5857
    Owens Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Carlsbad<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">452-8111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock (par value $0.001 per share)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">QLGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://qlgntx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>qlgn-20250919.xsd</File>
    <File>qlgn-20250919_lab.xml</File>
    <File>qlgn-20250919_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "QLGN",
   "nsuri": "http://qlgntx.com/20250919",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "qlgn-20250919.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "qlgn-20250919_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "qlgn-20250919_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://qlgntx.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://qlgntx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001493152-25-014965-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-014965-xbrl.zip
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MG ^8'WX+;N ,MGU:-0DT35M76\/[@K=O5L"4-BM4$F&W3E9KN-?T8K67&K1
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M"Q^JCTK740(+%/RI-)SQ089;8X%7@,3G.0A). %UULKC!8(+\$HA<\Z,A$7
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M=[0JH&.CW]81)JO_>#"DB $962X8U(>BO 9I<H%D;\3DY,07VBE88T9"^O$
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M0[5:-LAT#QW$D!^QWL.!-Z99C"4F$]BFV6J!>BBT-'.JMABSXQ%9?E6:,YX
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MC2/ =,-JD;0 3M3C5R8]=R>Z#W(53U(;.KEA,6=8I'_I"D3#"X Y!S?G[<'
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M-TZE'H_Z=.H>#3H@@N;.]8A<6\\;PTZ!L4N$=/#6HD-;TW' 2L2*XV[J*AW
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MVIG^/95E%7%.\DX7M8:92J6HI'7 "4A(N.ELCDHNAZG7HS><5+-2BEFK+@7
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MC[^;9F2Y9>GG*,.MLQPXN4#;,5ZA 9]S$JN5]UK["W@HK!Z%U[(\,"U*E.,
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M;5PP[+Y6W& >GP V53ZNV%'KV H_E)I1S2188.'?4'1+@)KX$/#(E!.I:T&
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M<8;7^K]/0.%''U!8;D#A1Q]0>'HG;:F8,6U,4&09;T,?E%U0&EU$.=#@3KU
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MB4%7_B$FG,$_<: $&:-D'$=7T0(127U6K79H6F"85$Q'GS:;HV8L$R/T#>1
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M+AWG?MMRZ)(/W>_+ #+R1,KX[4Y;;Q<,XC;P6P(;4V!++=4=+2ZX!>88 86
M+:CC7(H'E)>9IU&[6-S>ACU; C^&N&G!QLOB<C/84Z?U(+SS";5]W&6TW&;#
M/5AP#9@3%=0<*',F@J]A\,6==A9A!R[&"BQ#"U8IY3-;/J@<3 BY3TT)+-@"
MFK/A:0EUEMNTU;\<S']710(,**#"V['  :VL]6:#>NDE M!@R4?=V%[^*,>W
M3D+*="P<3<15'C!(<!;2,L/%]CDJ='/)C?8FELZH$C(JXB%>C(91!KN=&X O
MC%'4=6X$YKD0\%!$],*HB$(AW=C;K&L'/S3'(3;?%C!0D(D"IJA@SX37@%-&
M(_4/E^I:BA6@7J3^K* B<(U.93D^T'(( *D1Q!P80C)".#D"P:KZK]9C7E X
MR_1?K;*E0BZS^(>&<]E#%?F-RDM%E4U2VV=A!0[&%-/;8%SNH0U^-DA3>$4U
M,N/Q',CEBS ;ZK:(YDO+4PD7IO:[VA1''M91%[Q+\&G'!Y^6&WS:>3K!)W_(
MEDE0@CA)B?0;M1"-M' /L1P?D5[QMZ1X9O;]!Z+\WUBEH#O Q]SP50--.@H+
MP;.6Y'1=FX<R*B9F5 #]V&%6ZF;YHS=E5$Y$UD1<3>LV=*]TTQS>)C</-LZ2
M&*\:NL\%0Q"/ >S$I@(7+6O7I4F60$?5=4YHA#&IE)\%QU.:* @J&BFJ?"<I
M($ VE,1*;#;N#OY)BL6(<DE"U HS;%;<,AAUM<KC>63>M9:6^DW*&L"FP5"\
MYZKA!,T[#& I2'4R[9=AR3/5')Z00O-<:7,.CUVC58@FA? ,F$UH3 @_J6IY
M,S&S4*'ZFB"_:?I4IZNRY3B76 4PCY-+X-18NMI0VX>G+@>WQ !#4Q/5/?1
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M ?PW$!<T0/E$_0V^LW!HW +XXQY\(R'E$9L!G631*,HR:E!5\TGKS^6/DK#
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MIPQ3[-G*LY5G*U]6>S\,LK*GS*^=7[OOO78K*M+OM83['N:XDLOH&= SH&?
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MRF6YM#K+E4N)U4[_(E B_@!DL>Q[!@<(DV2_0Z7V"]_72=C5*7'W! !Y.@)
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M>8LXN)%HXUZ):YZ-N*7MQBV-Y^G^S]-QQAP$7D^!>5W-4/X;-*WA/8+MCOR
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M9>WB39AA<7B55"E+"W@0!=7MX9"(R]2J,(\>F/A%&ZM\?0Y3/' ^Z*F_)^H
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MVF<*1G-YBWN-Z 5"'<!G+*4*=2W$YCE#NISCLH@F<TYR9GQA6R).!UC,'U
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M,U.04@N?'L2[7!)OI=>=KU@S0ZO#NL,<Z.G$-!W<,_%%%79.,]'2N5JK.:H
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M8]I5%VCP=EO<$M'1]"VIKKK,;=QX[GT_-G8A1VPNSVWY>Y6?<:&^X#IG+I!
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M?NR'C#9OIGU1@P1MO(6.0[7GSC 91N;XQY8)U!WAA:A7^DVI*[S&)<^NSLY
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M\LHY[#/DHJTVM"?$W^;85DH55]AKJF 6QUE=)IDNRYB!U8H?4R6.(M<T(-O
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M.P:*OHQ^PP+RD7YFD'[FS@EB[CYV\^U/[][\%YF=OY[^X[<?_W]02P,$%
M  @ M(@Y6\&<B@>L)@  ^O,   H   !E>#$P+3,N:'1M[5WK<]-(MO_N*O\/
MNM3NE'-+,2&9P%Y@J H0=MB%P)+L3LW'MM2.>Y EK1X)GK_^GE>W6@\;P@1(
M&,\')K:E?IX^S]\Y_?CGL]>OGHQ'CW\^/GH._P_PO\=G+\]>'3]Y?)?_#[_>
ME9\?/WWS_-?@].S75\<_W9EG:?4PN+>75\&96>HR.-&7P;MLJ=*0OPB#4UV8
M^1UX$5Y]>]7W'@5+59R;]&& C^X]"BK]H=I5B3F'KR*=5KJX\^2'=%;FCQ[?
M??LE.BG,^:*Z\^3QTR?''Q9F9BIH<'KP^.[3)U^HPZ\R*]O)XQ=O3L[\EG?G
M:FF2U<./M4W/EN9WS4.A!7H%!#(>O3SYS_'IV9MWP='?WQT?OSX^.>/%PIZ^
MU)K]5I>5F:_D2Y/&&AO=FQZ:])KG:'?E^YG1V<\O3\<CW+M@>.N"2;4P9?!#
M$O^WSAX]_O>3H_-"ZR4,Z/'=?S_YH:"O=P)X9*EB':@T#HBZ=!R8M,H"50;9
M'$:05WHYTT5P[__"8']O_Q#;U>-1T^[Q?*ZCRESHX+FJ=*OQV8K:5<LL/0_^
M5>,BZ30X6^A"Y;JN3 1S?)E&TS!0P7.=J$M5Z"#*BCPK5&6RE/KRIO L6^8J
M7?E]A.,1=O%"%2I6J^!%7=70QDN824*]5<%Q L,K3'2EGEYI%<,+%[JLLL+O
M;XK##V0@-#M\$1^',R3/!]QXDO"Z)*N@T'-=X-+"PL+LM4EQ?=M=OE5%973I
M=<:;HJ(%CKK]H+\&T^^%IK^_4_K+S\?OCH].<4I J)5'.9>F7$!K0 ^ECI!D
M\<<H6RY-A6<4SYXE+$>' 9)-D!?F @X:/ $T9>!@=4CWK?S^-E%1_[QG\_&H
M7 "!EK8+&=$/18E/E#0(.!#08?0^#')5!!<JJ77PE[WIWMZ]( =>0 T,'$Y\
M[Q3?:YU0(N.-?8Y'N(;P\U/X!28+!V&6P S<L3F]ZF ZK[;' XL^T\#YRAI^
MI\%E21SD=5'6*JU@GS(8I*I W!:5@C4OZUD9%28G1J$L&PV#&)8Y#N [//*S
MK*YH;O@M'?)L'D(_U:4&GE=UF :>:KL8T'&T4*4NRL @*9JYT<!-#+]5 LDJ
M8FJY.M?$- H-(YST&<.I-TZ<,7P5#'%]'$'88E"ASXO\9L8CUT#9WM ^=38D
M3:0)RP9S5!Y1;QG5C9U1FU$]4[FI8 R_H\32Q;(,ZE*.2IH!;T(:A-T&6M=S
MD\(O(M/@*"9)L% 7S,Z66J7 H$I@<17T6E2+0(C:)[&&1,LM@=S8&9V\^04(
MXPS)Y,6;=\=$*+B;49:6P+5$BQ*.]C$Y!BS"T-_ 'I8F-<MZB0_^Y6 //H+>
M!BT)H?2$&:M[TBH1(O1VH5-@W"41: V+ &S[/1->KB-BIT*A88\1]P>'3Z+B
MBE2)6MH<^&1V63Z\[IWD?Z</8*\Z^[?[=4GR[.CIJ^/@V?&K5V^/GC]_>?+W
MG^[LW:'/IV^/GMG/,HQ+$U<+;';OK]S/56:^6V4YS=Y],<NJ*EO2=S#*LW=7
M7U/2%B*5V",!7:#;XO'9\ZNW)9/[$LM_;]I:^K/G3SYCA-<\)E+:V 32XD#Z
MQ/_^#D>N@#,7D;W7G]K=LW?X#Q+6M1Z6YJQ\709H#\\7X0#?:E+WIO<"((&S
M0JNR+E;CT3L-2BC([K=98B*R,*=!8]W7>29Z;)*5P%W;O)1%OXJS')EZ)6V"
MX<M-YM0DJ]4&^#*(BW*N(N"WJX#4[0X7'H\Z"KT=9= ?9*.7$N\/+A<&%,\A
MTZ8W+%6":E+"N8>QDR0K26)-S$X0J7+!P@;_"O1_:Y!$B;9BIER /K.+RI&(
M,E)@@HEG#^%K1]1!RP*C-= ?(@U2Z3(K4%!!%Z1PP;B@FX*5(>IF8LS.>!05
MJQS,F!H,FC1".XFG2,.V$V%3HC! 8:LU$^U87VBY*)#9Z7F&8Y@IF'Z(QLYO
ML..X*]#4>W@+%B8V*-Y+7@\0M28R.1D_*<S"676S&NA"ER@RB\";/LT$.4:)
M7EGT"N'3+U[L'N4Y=(WM/,MVGRV,G@?''\ <)GI[,Y\;L,"""<S-ZIDS#:)X
M9SH>@5[ >@2VI+@97]\ I:(RL*#/8361RH+G&@TI#6O7;\^V\S13!>D6]JVN
MO=JU,NF%CC<*GUA#K')(4(4&^U/!>&,-AM@RBUE'01M*P=2!+DRUL/9D3E.]
M+$Q5:=:W9)[KUPP6Z&@.M/D9J^,O!9_PS9/)TF3ES08W]R(C[T1 ?D)IB F6
M7S%IE-0QFP@*!EPL%0T>WZ,5]XWC@2%F-"]#!F8$Y ;[]'T8#E]&RGPCV;(?
M- Y;(0.@H!P94EJQM8!LX;5*U;ES4%S[/F[UANN?U$2!2'J6I2R/*F)6'U,,
M(E67VF.RP&8*'=>1%A_7[Y9C-+_/D2<L*?C $@2%(]J,^%2AV2_&4LGC&<_4
M,@>NG@1/=0267 AS@@:JX.DT>&66U,ZS+%ZA80F=SXMLV?0Z!?4#5!@6=N@@
MLU-,5@.3Q!ZIZW\8'9PN-(A0:GVA\!\-#8A0MMS669B.E86R.C/'I='+ N)I
MG?S1:[4Q&LF@Q<QK";U4EYEM[T)%BC6)"+A[Q7R;_'6VZ]8*3X-_N^XZ*A4\
MK4U.DH4\K8LL 1T,Y$^>%QDH3&(^HX)Q=1*110EI]4W*)#$YW F>6DWCN5JM
M=63+T&AEE!.@EHH&'1-SEBW-".(L*#-0+',2C+" D_T=1R*#>TIM^#*7):J3
MA*4XE[&;*D.EKT_]CBI*?0%#GCS8L0<!==P$)][XX&1"%+>C69(RM^K/[D_!
M7&%:_[.[&[PP.HD?!F]!MCR"!F"%P%:%%X/=7<%*/'[^\C]V&!UGQ'UT4,RR
M @C9??<4CM/[X!Y,N 3U)T9GQ57<)M(:^MQ57L)([%_.Z=!X5-IF>N,3&?!T
MM-<]T7-ZX_F LZ99KJY]_O@NK,3 HLR ,[S?G6F@9QA-3BOINW'NT_#>MM=0
M/#D-"J+5NK<S=W%K>#>N@1*W,OMC,GNV$[P 82<6G#,.A!]3Z)YX4X*A>A%<
M;=XXP3<-6'-'H+,G1E6LBB,#%XOHO,CJW,:8@*$UAGB[)33OR?Z<=]LS)7J$
MB=7MH/P%7E:S43+3*=AL$<A1$,;994IF'!R&J$Z4\#X517#*T"G%TOH4126(
MK7L'DWC',MCC#]%"I4!Z1Y'XDDF=J(&IBI)QCBVBU /+*UO6R3FU3V$W\B\
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M 8"X[9/"6&T#+I-@X&=#AX)_&'6I3?"+0I:025(BFS["%P:#W=RN8QGH4O$
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M3J*52D=RWQ(A$]I46$HN*^;9^QA+>)6\<WR.*&Q/&0W;&,?6 OS\Y?_;S;0
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MO# :-&6B2?RS/&2](R4N%\_S\*S 7IZOBL!ZOF:#)K0QF&B9IL>@POZ"+,1
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M'QYV>^_^_NCI(_Y[>-(^T'^K&=1H$]*HO$5**]&_O2)9.\W.L9>G_U.WN=%
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MQ:=J5UAR?GOQK<ZA4$XQ9275.6F6TU3%EBD[05WE5ZR\?$.M9=D!Y(H]![A
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MN+#])[[/5 EWX7KN-=-QPE4-'15J$<89 ^)&8\":SHQWD]9 - _9R$45-\[
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M[3UEBNIQ@5*Z"_(AR5+JY*@2\U0IFLD^+#46J/8&'?L6G4@#Z(#1H*@@EE;
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M<&M40$6HL$SP'SI"S2>=P5 8@$!%#XQAS$/$0_Z!31ZW1[1>_3 8P,DI+;%
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M'S4;:F),I@Y;[TAK4@5WW_+>#=O*+>*Y/VSCN=MX[I:$:EQIWXNWOLVN5'B
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MV]6$1G250^?KD!5.N>+9$(WN$<:!95^0R_0V]TH,7;_#-UL+?H&C2R*E7%B
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M3J5/W#P_&$;AU171,'/<Q%_4"KL?Z)$[TA),Z M$ P6_W'A7E<\4!SW+9D)
MWQIN-B)VN\S8S5_6:"*B )4%$UOMV6KKO5;9# S#N?&PPD6HLRIA]R,Z5%)5
M.<':MZX3V3E3AWI F .\WW?-O,DKY*_HW8S9 [ZLSD2AY]=DP!:*I77@R[$.
MM>_T(BG)FP4/3%21X6\IZH>T3(#.%::](&GG&6<84)X$>\*J(AG7]$%S^*8?
MSY!'/*7ZE?(C8:#-U]CI#0=$PK(N+I"T*(]!E4R$XR%O$SW.$-0/.JR?CE:
M65>=5""=4GA)5&2<J4)N*V(O-):K AJEUOP,-.&ZT'DW^D'Z<9=JN"^N1'J:
MW77(?X1[,],9*W1@RAMC"5'\=/3F_4'POD[Q]/X5 M%!HG-#.^%^9;@XQ75
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MRE1>E^GRZ\J"K0KZ&2KH=[MP"D W-.D,!WTIF.WD49O'X0X@/IP5T&O#P:W
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M<"!TE(-&%XE3U.FBY$&:8[6=KMU=:0*V3O64HTJV>JZE>UB(6,L J+JI!V\
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M$^+#()-65\?K YCF$RJ4EYZZ+6:FC0CDSX[]4*JJ2JU1;^?"6382G0##;CA
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M@<%7,,KW"4F/\J@I6NL <DQ4FM_TBM)3O,T"%_-YV8(OO_39\Y/]V=_I['5
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M6X9@0V4IO5[QJOHPJE)@=(G(0J+C82B.%DM*-&N$+BR0(#YQ8)A\":9\V4$
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MUN"[:S;?O9CK5H>+8[/_NME*OGGZH8X&6%_0&J0E?W$F/M#8(<(*=G0;Q@/
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M*D\CA:\9J&IY^X;!SAB-DUBB%U*L2.CD3B)+Q/I0),$)DG@>1KGCM;KUA9\
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M4-=-R?J8^"@-TD>T8I@V)Q9EC Q*+M6X\/AT:UJ'L_A3&0UWT47B)]BK!JX
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M;B1H /Q *IMPFPFB/.[OT)-8U93OT#MJ>5L$OV,_62([O$*&4.").JTX5\2
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MIRH4G6%)6A!S-):I<5*3+L+T1IPN+:L:Q:O+]B99! 3%JF(0S><9$,H+T )
MS>-';6D,+!"?3')0ZBI@B4C(,!OZ&Q!D<%9&,0[Z-BH_),)AQVELY+P_(,V?
MF#:J=D#4_UDD%:LP\D6>H$Y1PQ"@N]+@N-1!OR=JI_M*G,;518KWQ7]3Y\SA
MAI4)J$XU[]7KK"C0F#H/#G?>@1(XCBI_>?O1DG6SYR^>[(+FK)3%P-<502(]
M?;'[V*B3_A.@AX$^PB2,&WY\MO?WUS@W_,L_<,ZH,;9O[&61+6#3KA(,IZ!X
M M%51N?)-;M-W(24YFNV&-?LS0>VBDAD$HTS(+>M23>5B*;;LM]TY+*>EE<
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M)&'C,?D(LT6&!&_@FZS4_6 >I9J;R:^_$G$&"_M?V]O!FS3)XA?!.Z#;ES
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MU>^!YM<\=M:_ER*\09$&>1S5BQ(^@]'!$HO(XN.OZ1]*247;#YU6$<BW*/^
MS@9RD)&""&2C-4:4]M&BO@!!_%]4]6"X$I@0D!A)Q"RZ0K%:)K,(1IAD!:BL
M+P.8^;PL+M,XB7'2(7YP45PEE^S/9>,!]']8/GHX4C0W&S-BZ8O:W!BMB@1,
M7'S5^,;S">(%R7[95E 4ENC7O2AFB6QGJ+^[2#+@VW"TVW,008WO\R+?AN-
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M@Y+GJY<M$].ZY1=W%E\HB4V(Q/9$VS1 K()%-U6%P6Q,67JWJM1A(#J,+8@
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M\TLE'<R6[N*1$Q1JE5.NDD0KB@VQ0[/4<XKLW/*.\G:5IN=:'U%')//Q5CP
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MI\-L#BN^>+9')4MM_S;SE:30=P5OR!<LOQ+>:\81C=*]8\2(GO,HZWZ<^:^
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M'$A1$89DG">2:K<A>AAJ*5W3 U@UN3%D01%C]P:RHN2HT/N'Y)+&@Q"I='X
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M2E!1B^WWR^N;KL4GL5EO$G^M<$;$EO\"4$L#!!0    ( +2(.5O""7#R5P<
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M,"TS+FAT;5!+ 0(4 Q0    ( +2(.5LWR4J6G!\  $W=   *
M  "  <9* 0!E>#$P+30N:'1M4$L! A0#%     @ M(@Y6^4GN@VM*@  "QX!
M  H              ( !BFH! &5X,3 M-2YH=&U02P$"% ,4    " "TB#E;
M<6O/0ZDZ  #AE $ "@              @ %?E0$ 97@Q,"TV+FAT;5!+ 0(4
M Q0    ( +2(.5M/N306&%\  &-X @ )              "  3#0 0!E>#0M
M,2YH=&U02P$"% ,4    " "TB#E;W!8-,P)0  !)_ $ "0
M@ %O+P( 97@T+3(N:'1M4$L! A0#%     @ M(@Y6^=<-\#O$   J4T   H
M             ( !F'\" &5X.3DM,2YH=&U02P$"% ,4    " "TB#E;,!+O
MRQ(D  "O^@  "P              @ &OD ( 9F]R;3@M:RYH=&U02P$"% ,4
M    " "TB#E;8D$JTR<#  #<"P  $0              @ 'JM ( <6QG;BTR
M,#(U,#DQ.2YX<V102P$"% ,4    " "TB#E;(/O6)/T*  !_A@  %0
M        @ % N ( <6QG;BTR,#(U,#DQ.5]L86(N>&UL4$L! A0#%     @
MM(@Y6\()</)7!P  T%<  !4              ( !<,," '%L9VXM,C R-3 Y
@,3E?<')E+GAM;%!+!08     #0 - /0"  #ZR@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="qlgn-20250919.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001460702</identifier>
        </entity>
        <period>
            <startDate>2025-09-19</startDate>
            <endDate>2025-09-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-19" id="Fact000004">0001460702</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-19" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-19" id="Fact000010">2025-09-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-19" id="Fact000011">Qualigen Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-19" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-19" id="Fact000013">001-37428</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-19" id="Fact000014">26-3474527</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-19" id="Fact000015">5857     Owens Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-19" id="Fact000016">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-19" id="Fact000017">Carlsbad</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-19" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-19" id="Fact000019">92008</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-19" id="Fact000020">(760)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-19" id="Fact000021">452-8111</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-19" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-19" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-19" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-19" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-19" id="Fact000026">Common     stock (par value $0.001 per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-19" id="Fact000027">QLGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-19" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-19" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
